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Abstract
According to the National Cancer Institute, in 2019, there were approximately 17
million cancer survivors in the United States, of whom 3.7 million were prostate cancer (PC)
survivors. Due to an increase in life expectancy, extensive screening, and novel therapies, this
number is expected to continue rising in the coming years. PC survivors in advanced stages
(III, IV, or recurrent) are particularly prone to experience a wide range of harmful effects that
stem from cancer and the many treatments they undergo during this cancer’s long trajectory.
Past research has highlighted the importance of implementing supportive care as a standard
for cancer survivors due to its multiple benefits, such as reducing morbidity and improving
both quality of life (QOL) and health outcomes. However, little is known about supportive
care needs and implementation among this subset of survivors. This information is vital to
inform future patient-centered, holistic supportive care strategies that aim to optimize this
population’s QOL and rehabilitation.
This dissertation work found robust guidance from the Supportive Care Framework
for Cancer Care due to its comprehensive taxonomy and holistic view of the cancer
continuum. The first manuscript explored the supportive care interventions available to men
with advanced prostate cancer. Next, a holistic needs assessment in American advanced
disease PC survivors was conducted using a mixed-methods approach in order to provide a
more comprehensive picture of their perceived supportive care needs. Finally, an exploration
of the existing barriers and facilitators to supportive care implementation was performed
before taking the next step in this line of research.
The results of the three manuscripts included in this dissertation reported that
advanced disease PC survivors suffer from unmet needs that affect every dimension of the
individual. Existing supportive care interventions were promising but limited, focusing
primarily on specific domains of needs. Implementing supportive care can only become a
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standard of care if researchers and clinicians find ways to minimize identified barriers while
they maximize facilitators.

Keywords: Prostate cancer, advanced stage, survivors, supportive care, interventions, unmet
needs, quality of life
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Introduction
Over the last few decades, research and implementation of new cancer treatments
have led to an increasing number of cancer survivors.1 However, the need for effectively
addressing the unmet supportive care needs in advanced disease prostate cancer (PC)
survivors still exists. The incidence of PC varies globally. In the United States specifically, it
remains the leading type of cancer, accounting for 21% of all cancers detected in males. One
in eight men will develop PC in the course of their lives, up to 30% of whom will suffer from
a recurrence or progression.2 This trend will continue its ascending trajectory as direct results
of a higher life expectancy, improvements in screening, and innovative treatments.3 As the
number of survivors increase, advanced PC has subsequently become a significant health and
economic challenge for the American society and healthcare system. 4 Given the fact that 3.7
million PC survivors currently live in the United States and that they will most likely deal
with the advanced PC effects for the remainder of their lives, it is essential to provide them
with more cost-effective, holistic, and patient-centered supportive care that meets their
current and future needs.5
Advanced PC Cancer Survivor
There are multiple definitions in the existing literature of what constitutes a PC
survivor. In the past, general definitions of “cancer survivors” focused primarily on
individuals who had completed curative treatment and were in remission or cured.6 However,
in 2013, the National Cancer Institute (NCI) presented the National Coalition of Cancer
Survivors’ more inclusive definition along with some survivorship guidelines, that were later
endorsed by the National Comprehensive Cancer Network (NCCN). According to this new
standard, the term “cancer survivor” refers to any individual with cancer “from the time of
diagnosis, through the balance of his or her life.”7 Advanced PC survivors are considered
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men with a diagnosis of regionally advanced (III), metastatic (IV), or recurrent/refractory PC,
no matter their treatment status or the years that have passed since the initial diagnosis. 8
Debilitating Disease Effects on Advanced PC Survivors
PC may follow an indolent course and be asymptomatic at the early stages (I and II)
of the disease remaining that way for long periods of time, contributing to its chronic
nature.3,9 Precisely because of this natural long-term trajectory, survivors usually undergo
several types of treatment throughout the course of the illness to control progression or
alleviate ongoing symptoms.10 Prostatectomy, androgen deprivation therapy, radiation,
chemotherapy, and cryotherapy are the most usual treatments for advanced PC. These
therapies’ harmful effects are varied and noteworthy, including toxicity, urinary and bowel
dysfunctions, impotence, decreased libido, hot flushes, fatigue, pain, weight changes, anxiety,
depression, cognitive decline, and even increased risk for suicide.1,11,12 Since survivors must
continuously live with these effects, they are more susceptible to suffer from a lower quality
of life (QOL) and develop long term supportive care needs that will require continued access
to multidisciplinary supportive care.
Supportive Care Needs and Supportive Care
Although supportive care needs can be diverse, they are often needs arising from
chronic illnesses such as cancer, the treatments, and the follow-up, at any time between the
initial diagnosis and end of life.13 Greater number of supportive care needs are often
associated with an increased risk for morbidity and distress. Since the diagnosis of advanced
cancer can affect the physical, psychological, spiritual, and social dimensions of the being, it
can lead to more complex and overlapping supportive care needs in these survivors. In
addition, the survivor may experience lack of information and practical issues that can make
coping with this illness even more dismal.13,14
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Supportive care has been used as a euphemism for palliative care in past literature.15
While both are important aspects of cancer care, there are some differences between them.
Palliative care refers to a subspecialty that focuses on issues that are frequently seen at the
end of life.15,16 According to the Multinational Association of Supportive Care in Cancer
supportive care attempts to prevent and manage the adverse effects and associated needs of
the cancer and treatment.16,17 It is a patient-centered and holistic approach that ensures the
provision of all necessary interventions to prevent further deterioration and optimizes both,
rehabilitation and QOL.13,14
During the last decades, supportive care in cancer has gained momentum among
researchers and healthcare providers alike. Several factors have contributed to accepting
supportive care as the new benchmark to improve health outcomes and QOL in cancer
survivors. Its multiple benefits—improved treatment-related health outcomes and QOL,
reduced morbidity and mortality, and decreased healthcare resource usage—have made this
approach an indispensable component of high-quality standard cancer care. Furthermore, the
integration of supportive care services has been progressively regarded favorably as part of
modern oncology.17-19
Quality of Life in Cancer Survivorship
There is no accepted definition of QOL. The World Health Organization defines QOL
as the self-report of the individual’s position in life in relation to their life expectations, goals,
standards, and concerns.20 It is a broad, multifaced, and subjective construct. Despite the
variations, there is a consensus that QOL must include domains such as physical health,
emotional/psychological functioning, social life, roles, and overall quality of life.21 Specific
to cancer survivorship, achieving a good QOL often means finding wholeness after the lifechanging experience, which in turn restores a sense of purpose in life.22
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Due to the steady rise in prostate and other cancer survivors, there has been an
increasing interest in researching QOL in these populations.23 QOL research emphasizes how
well these survivors are living instead of how long.21 Among its multiple important
applications, QOL research data may be used to assess the needs and quality of supportive
care received by advanced PC survivors who experience persistent or late effects of diverse
treatments to guide patient-centered, holistic interventions.21
Theoretical Frameworks
Advanced PC survivors suffer from a wide variety of unmet supportive care needs
that affect every dimension of the person. Although multiple theoretical foundations have
been used in past cancer needs assessments, this dissertation work found robust guidance
from Fitch’s Supportive Care Framework for Cancer Care (SCFCC). This framework
outlines a comprehensive taxonomy of seven domains of needs (i.e., physical, emotional,
social, spiritual, informational, practical psychological), formulated to ensure that cancer
survivors were cared for in a holistic manner from the time of diagnosis to the end of life
(Figure 1).13 This multidomain framework has a successful record of assessing the unmet
needs of several advanced cancer survivors’ populations, including breast and
gynecological.25,26 It has also guided supportive care intervention development in studies
from the United States and abroad.26
The SCFCC domains of needs provided guidance for the three manuscripts of this
dissertation in several ways: (1) defining the criteria for the article selection during the
integrative and the scoping reviews, (2) selecting a validated instrument to measure the
comprehensive set of unmet SC needs for the mixed methods study, (3) informing the
qualitative interview guide development, (4) organizing the data of all three manuscripts, and
(5) categorizing and interpreting the findings according to the framework seven domains of
needs.
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Figure 1: SCFCC Diagram Applied to Advanced PC Survivors (with permission)15

To complement the application of the SCFCC, this work also used the Theoretical
Domains Framework (TDF) to explore the barriers and facilitators to supportive care
implementation (manuscript 3). The TDF includes a schema derived from theory that assists
with identifying behavioral factors that may affect the implementation of supportive care.
This schema classifies the factors in 14 different domains: Knowledge; Skills; Memory,
Attention, and Decision Processes; Behavioral Regulation; Social/Professional Role and
Identity; Beliefs About Capabilities; Optimism; Beliefs About Consequences; Intentions;
Goals; Reinforcement; Emotions; Environmental Context and Resources; and Social
Influences. This theoretical foundation was appropriate for manuscript 3 because it has been
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used in multiple previous literature reviews investigating barriers and facilitators of care
implementation. The TDF structured the analysis and the categorization of the existing
barriers and facilitators in implementing supportive care interventions among advanced PC
survivors.27-29
Research Gaps
Following the recent publications of the American Society of Clinical Oncology
survivorship agenda and the American Cancer Society survivorship guidelines, Jacobsen et
al. reported that more research focusing on optimal supportive care for cancer survivors was
needed.10 This dissertation attempts to address several research gaps. First, current literature
on supportive care interventions for advanced PC survivors is limited as most focuses on PC
localized disease. Therefore, there was a need to synthesize the existing evidence with
regards to the availability and effectiveness of these interventions in addressing the unmet
supportive care needs and QOL in advanced PC survivors. Second, most reports on advanced
PC have focused primarily on describing the survivors’ experiences with the disease or on the
results of piloting diverse psychosocial and exercise interventions.12,30,31 Several holistic
supportive care needs assessments have been conducted, reporting a wide range of unmet
needs in a large proportion of advanced PC survivors.1,16,32-34 However, none has been
performed in American men specifically. Since many of these U.S. survivors are also at risk
for a wide array of long-term needs, this was a necessary step to inform future design,
development, and implementation of individualized, multidimensional, cost-effective
supportive care interventions. And third, to better understand why supportive care is not
being consistently delivered, it was essential to investigate the primary barriers and
facilitators potentially affecting its implementation.35,36 Altogether, these gaps have formed
the premise for this dissertation work. The conclusions of the manuscripts have expanded the
state of the science on supportive care for advanced disease PC survivors, directing special
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attention to specific areas that have been recognized as essential to be addressed by future
studies: common cancers aside from breast cancer, older populations (>65 years), long-term
survivors, and QOL during survivorship.10
Manuscripts
This dissertation comprises three interrelated manuscripts contributing to supportive
care in advanced PC survivors. The first manuscript, Supportive Care Interventions and
Quality of Life in Advanced Disease Prostate Cancer Survivors: An Integrative Review of the
Literature, initiated this work by critically appraising and characterizing the evidence-based
supportive care interventions and their effects on QOL in this subset of survivors. The
conclusion was that these types of interventions were needed but scarce. This conclusion led
to the second manuscript, Unmet Supportive Care Needs in Advanced Disease Prostate
Cancer Survivors: A Mixed-Methods Exploration of the Prevalence and Association with
Quality of Life, which explored the unmet supportive care needs in advanced PC survivors
living in the United States. Part of the study also identified a preliminary association between
the prevalence of those unmet needs and QOL in this population. This work enhanced the
understanding of supportive care needs and represents a necessary step before embarking on
developing new holistic, patient-centered supportive care interventions. The third and last
manuscript, Barriers and Facilitators to Supportive Care Implementation in Advanced
Disease Prostate Cancer Survivors: A Theory-Informed Scoping Review, achieved a dual
purpose. First, it helped identify commonly implemented supportive care interventions for
advanced PC survivors in the sample of reviewed studies. Second, it synthesized the main
barriers and facilitators to implementing those supportive care interventions among this
subset of survivors in practice. This information is vital for continuing with this line of
inquiry successfully. Developing and implementing novel supportive care interventions will
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significantly depend on the ability to focus on the most prevalent needs, overcoming existing
barriers while maximizing facilitators.
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Abstract
Background: Supportive care interventions can improve quality of life and health outcomes
of advanced prostate cancer survivors. Despite the high prevalence of unmet needs,
supportive care for this population is sparse.
Methods: The databases PubMed, SCOPUS, CINAHL, and ProQuest were searched for
relevant articles. Data were extracted, organized by thematic matrix, and categorized
according to the seven domains of the Supportive Care Framework for Cancer Care.
Results: The search yielded 1678 articles, out of which 18 were included in the review and
were critically appraised. Most studies were cross-sectional with small, non-diverse samples.
Supportive care interventions reported for advanced prostate cancer survivors are limited
with some positive trends. Most outcomes were symptom-focused and patient self-reported
(e.g., anxiety, pain, self-efficacy) evaluated by questionnaires or interview. Interventions
delivered in group format reported improvements in more outcomes.
Conclusions: Additional supportive care intervention are needed for men with advanced
prostate cancer. Because of their crucial position in caring for cancer patients, nurse scientists
and clinicians must partner to research and develop, patient-centered, culturally relevant
supportive care interventions that improve this population’s quality of life and health
outcomes. Efforts must concentrate on sampling, domains of needs, theoretical framework,
guidelines and measurement instruments.

KEYWORDS
Integrative review; prostate cancer; advanced disease; supportive care interventions.
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Prostate cancer (PC) is the most commonly diagnosed non-cutaneous malignancy in
men, with more than 1.2 million new cases diagnosed every year worldwide. Due to
favorable prognoses and advances in treatment, the number of PC survivors has progressively
grown, amounting to more than 3.6 million in the United States alone (ASCO, 2019).
Presently, there are variations in defining cancer survivors. According to the National
Comprehensive Cancer Network, PC survivor refers to any man with a history of PC, from
the time of the initial diagnosis until the end of life (Delinger et al., 2015). While the 5-year
survival rate for early-stage PC is exceedingly high, once the disease has spread, the survival
rate decreases to 30%, with higher illness-related mortality and morbidity than men with
early-stage PC (Dickey & Ogunsanya, 2018; NCI, 2015). Most PC survivors receive the
diagnosis in earlier stages of the disease, but up to one third will progress into regionally
advanced (stage III) or metastatic (stage IV) disease, remaining treatable but no longer
curable (Holm et al., 2018; PCEC, 2019). Men with stage III or IV PC are identified as
“advanced disease survivors”.
Men surviving PC report an array of overlapping supportive care needs associated
with the debilitating effects of the various treatment modalities. These needs stem from pain,
urinary incontinence, bowel and sexual dysfunction, fatigue, hot flashes, depression, and
distress (Crawford-Williams, 2018). Advanced disease survivors are often treated with
chemotherapy, androgen-deprivation therapy (ADT), or participation in clinical trials to slow
progression or control disease (Jacobsen et al., 2017). While these treatments prolong life,
they are associated with additional physical effects, such as treatment toxicity, deteriorating
bone health, increased fat mass, and reduced vitality. Also, the treatment impacts can also
increase the susceptibility for certain psychological problems, such as risk for suicide and
cognitive decline. Altogether, these challenges affect advanced PC survivors’ quality of life
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(QOL) and functional well-being beyond their physical needs (Chambers et al., 2018;
Darwish-Yassine et al., 2014).
In 2005, the Institute of Medicine recommended consistent, quality survivorship care
for all cancer survivors (NRC, 2005). In 2014, the American Cancer Society published a set
of PC survivorship guidelines, later endorsed by the American Society of Clinical Oncology
to assist clinicians in caring for these survivors. The guidelines ensure uniformity and
coordination of care through individualized interventions to meet the specific and often
complex needs of PC survivors (Handberg et al., 2018; Noonan et al., 2016; Skolarus et al.,
2014). Supportive care is a holistic, patient-centered approach to prevent and manage the side
effects of the cancer and its therapies, with the goal of optimizing rehabilitation and QOL
(Fitch, 2008). Despite the reported benefits, supportive care is delivered inconsistently due to
reduced clinician time, insufficient evidence on optimal care delivery modes, and providers’
lack of knowledge about survivors’ specific needs (Post & Flanagan, 2016).
Literature on PC survivors covers diverse topics, such as available psychosocial
interventions or unmet supportive care needs while undergoing specific treatments (Holm et
al., 2018; McIntosh et al., 2019; Parahoo et al., 2013). A systematic review and qualitative
synthesis by King et al. (2015) that explored men’ experiences of and needs for supportive
care, reported that more patient-centered, nurse-led supportive care is required. A separate
systematic review by Crawford-Williams et al. (2008) identified that survivorship
interventions did not address the real needs of this vulnerable population. Recent studies
show that 33% to 81% of PC survivors report inadequate support for their unmet needs (King
et al., 2015; Watson et al., 2016).
Due to the high prevalence of unmet needs among PC survivors, an apparent lack of
adequate supportive care, and the underrepresentation of the topic in the literature, a synthesis
of the available supportive care interventions and their effect on QOL is needed. Thus, the
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aim of this integrative review was to critically appraise and characterize existing evidencebased supportive care interventions and their effects on QOL for advanced disease PC
survivors through the lens of the Supportive Care Framework for Cancer Care (SCFCC)
(Fitch, 2008). Results of this review may assist clinicians caring for this population and better
inform future intervention development according to the current practice guidelines and
recommendations.
Methods
Theoretical Framework and Application to Population
The SCFCC was initially formulated as a tool to help healthcare providers ensure that
cancer patients’ supportive care needs were being met throughout the various stages of
illness, including survivorship (Fitch, 2008). The framework outlines a comprehensive
taxonomy of seven domains of needs. The physical domain encompasses an absence of
physical symptoms and the ability to carry out normal daily activities (ADL) (Fitch, 2008).
Common adverse effects of advanced PC, measured as outcome indicators within this
domain, include body composition, physical activity, fatigue, and urinary dysfunction, which
impact QOL negatively (Dickey & Ogunsanya, 2018; Park et al., 2017; Shakeri et al., 2015).
For example, up to 38.5% of advanced disease PC survivors report clinically relevant fatigue
affecting overall well-being (Antolin et al., 2019).
The emotional domain relates to a sense of reassurance in times of distress (Fitch,
2008). Advanced disease PC survivors face many emotional unmet needs, including
depression, anxiety, distress, fear of recurrence, or lifestyle changes due to the illness and the
various treatments, which can lead to a lower overall QOL (Paterson et al., 2015). The need
for information relates to improving decision-making and decreasing misunderstanding
between survivors and providers (Fitch, 2008; Freire et al., 2014).
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Cancer affects not only the patient but also the family and the community, potentially
leading to higher levels of social withdrawal, a commonly reported unmet need. Positive
social roles and support are indicators of higher health-related QOL in many cancer
survivors, including PC (Shakeri et al., 2015). The same is true for the practical domain.
Leaving practical needs unattended can reduce the survivors’ overall QOL as they are a
supporting vehicle to perform their usual ADL (Fitch, 2008; Park et al., 2017).
Advanced PC can often generate spiritual distress, leading to despair, suffering, and
existential crises. The spiritual domain relates to a sense of purpose in life (Fitch, 2008).
Unmet spiritual needs could lead to a loss of dignity and values, as the spiritual dimension of
QOL is commonly a priority in people s’ lives (Freire et al., 2014). The psychological
domain relates to coping with the disease (Fitch, 2008). Past evidence has outlined the
relationship between coping styles and psychological-related QOL (Park et al., 2017).
This multidomain framework has been used successfully in past studies assessing the
unmet needs of breast and gynecological cancer survivors (Fitch & Steel, 2010; Fitch, 2012).
It has also guided supportive care and educational oncology interventions in the U.S. and
abroad (Busolo & Woodgate, 2016; Cheah et al., 2016). The SCFCC guided criteria for
article selection, extraction and organization of data during analysis, and presentation of
findings for this review, according to the framework domains of needs.
Design and Search Strategy
To ensure the highest rigor, this integrative review followed the five-stage process
proposed by Whittemore and Knafl (2005). This process includes problem identification,
literature search, data evaluation, data analysis, and presentation. The search strategy was
designed after consulting with an expert research reference librarian. A comprehensive
literature search was performed in the following electronic databases: PubMed, SCOPUS,
CINAHL, and ProQuest, following an identical format. Key words included: (advanced-
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disease OR advanced-stage OR late-disease OR late-stage OR metastatic OR stage III OR
stage IV) AND (prostate cancer OR prostate neoplasm OR prostate tumor) AND
(interventions OR intervention). Hand searching of studies’ reference lists identified
additional records for evaluation.
Inclusion and Exclusion Criteria
Studies were eligible if they were peer-reviewed, and reported quantitative,
qualitative, or mixed methods original research focused on supportive care interventions for
advanced PC, and included reported outcomes corresponding with one or more SCFCC
domains. Exclusion criteria addressed studies targeting other types of neoplasms, solely
localized PC, and unrelated subjects such as purely pharmacological or surgical interventions
with curative or palliative intent. The search was limited to studies published in English from
2009 to 2019 to capture the most relevant articles. The PRISMA statement and flow chart
(2015) guided the screening and selection of the relevant publications (Figure 1).
Data Extraction and Methodological Quality Assessment
During the first electronic database search, a total of 1678 articles were initially
identified. Hand searching identified ten additional articles. After duplicates were removed
(n=466), the first author (AS) independently screened 1,222 titles and abstracts for eligibility,
with 1,190 articles excluded because they did not meet the inclusion criteria. A final count of
32 articles underwent a thorough full-text review by the first author, with 14 studies excluded
because they did not report the full study results, were single-case studies, or involved an
instrument validation or a palliative care intervention (care for those with a time limiting
cancer). Twenty percent of the title, abstracts, and full-text were reviewed by a second
reviewer (SQ) for validity and trustworthiness of the studies selected. All authors agreed on
the final 18 studies that met the criteria for inclusion.
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Data analysis proceeded through the development of a comprehensive evidence table,
which included authors, year, purpose, design, setting, sample, intervention, outcomes,
results, domain, and MMAT number of “Yes” (Table 1). Data on the reported intervention
components and outcomes were extracted and categorized according to the domains of the
SCFCC framework (Laughery & Woodgate, 2015). The findings were organized from the
most to the least prevalent SCFCC domains. The methodological quality of the studies was
appraised using the Mixed Methods Appraisal Tool (MMAT). The MMAT provides
checklists that guide the concurrent appraisal of quantitative, qualitative, and mixed-methods
studies in systematically conducted reviews (Hong et al., 2018). It is rooted in an extensive
systematic literature review posing seven questions according to the study design:
randomized-controlled trial, non-randomized, descriptive, mixed-methods, and qualitative
(Hong et al., 2018). Methodological are evaluated as “Yes”, “No”, or “Can´t tell”. More
“Yes” responses indicate greater methodological quality. The final evidence table was
reviewed by all authors to ensure accuracy of the findings.
Results
Overall Characteristics of the Sample Studies
The sample of selected studies (n=18) reported on original intervention research.
Sixteen used quantitative designs and two studies used a qualitative or mixed-methods
methodology. Twelve of the quantitative studies were randomized controlled trials (Table 1).
The remaining used a quasi-experimental, a prospective observational cohort, and a
retrospective descriptive design. Overall, sample sizes across studies were moderately small,
ranging from 19 to 189 participants, with the exception of one study including 859 subjects
(Beydun et al., 2014). All studies included advanced stage PC survivors (III, IV), either
exclusively or in combination with earlier stage PC. The majority of studies included only
White participants; only three included Black participants (Badger et al., 2011; Yanez et al.,
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2015; Yennurajalingam et al., 2012). Studies were conducted in Turkey (n=1), United States
(n=4), Canada (n=1), Europe (n=6), and Australia/New Zealand (n=6). The methodological
quality of the reviewed studies was high: 44.4% of the studies met all criteria (5/5 “Yes” out
of 5 in the MMAT tool), while the remaining 55.6% met 4 out of 5 criteria. None of the
studies ranked lower than 4.
Addressing the multidomain supportive care needs is an essential part of the
therapeutic management of cancer to maintain QOL (Afiyanti et al., 2018; Comert et al.,
2013). All the studies included supportive care interventions that aimed to support QOL,
improve coping with the disease and the side-effects, and maintain their dignity by
addressing one or more SCFCC domains (Fitch, 2008). Three major intervention categories
emerged from the studies: 1) exercise; 2) cognitive-behavioral/psychosocial; and 3)
educational (Table 2). Two studies combined psychosocial counseling and educational
components and one combined a physical activity intervention with daily life education
(Badger et al., 2011; Beydun et al., 2014; Huri et al., 2015). One study included all three
categories (Bourke et al., 2014). Interventions that were delivered face-to-face or were
supervised, reported improvements in a greater number of study outcomes compared to
interventions delivered using technology or teleconferencing. Four interventions were
unsupervised or used mixed delivery methods (some components delivered in person and
components unsupervised) (Table 1).
The number of outcomes measured in the studies ranged from one to 13. All studies
reported various primary outcomes, typically more than three (Tables 1 & 2). Over half of the
outcomes assessed a wide array of symptoms and perceptions (e.g., anxiety, pain, QOL, selfefficacy), were patient self-reported, and were measured either by questionnaires or
individual interviews. The remaining outcomes were objectively measured (e.g., biomarkers,
blood pressure, weight). None of the studies reported the psychometric properties of the
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measurement instruments. Only the physical domain was assessed using objective measures
such as biomarkers (e.g., maximum oxygen consumption, resting heart rate).
Self-reported QOL was measured as an outcome in 12 studies using various
instruments (e.g., FACT, EORTC, SF-36) (Table 1). The results across these studies reported
that although there were no significant differences observed in the overall QOL total score,
some improvements were noted on the physical, emotional, and social subscale scores.
Summary of Interventions by SCFCC Domain
Physical Domain
The physical domain encompasses physical comfort and the ability to carry out usual
ADL (Fitch, 2008). This domain was represented most frequently in the selected evidence.
Fourteen studies reported on interventions aiming to alleviate ongoing effects pertaining to
the physical domain (Tables 1 & 2). The most frequent primary outcomes included fatigue,
body composition changes, physical activity function, muscle strength, and urinary
symptoms. Additional outcomes associated with the physical domain included pain, vitality,
and survival. Overall, most studies representing this domain reported a moderate degree of
improvement in one or more of the outcomes measured.
Fatigue: Ten studies attempted to decrease fatigue, but only 5 reported statistically
significant improvements (Badger et al., 2011; Bourke et al., 2014; Paterson et al., 2018;
Taaffe et al., 2017; Yennurajalingam et al., 2012). Interventions included several modalities
of health education, exercise training programs (impact loading, aerobic, or resistance),
bladder rehabilitation, individual needs assessment, interpersonal counseling, or a
combination of these. One study testing a multimodal supportive care intervention reported a
7% reduction in fatigue after 3 months (Paterson et al., 2018). Another study evaluating two
exercise modalities (impact loading and aerobic with resistance training) reported a reduction
of 5 points in the fatigue module of the measuring instrument (Taaffe et al., 2017). The
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interventions occurred in three different settings: hospital, exercise clinics, or at home via
telephone. The intervention adherence ranged from 67% to 94%. Some interventions were
supervised, and some were independently managed. The duration of the interventions ranged
from 8 weeks to 12 months.
Body Composition: One of the most effective advanced PC treatments is ADT.
However, changes in body composition including gains in fat mass and losses in bone health
have been often reported by PC survivors (Comert et al., 2013; Mina et al., 2013). Six studies
evaluated interventions by measuring body composition through body weight, body mass
index (BMI), waist and hip circumference, body fat mass, whole-body and appendicular lean
mass, and certain biomarkers (e.g., leptin and insulin-like grown factors 1,3) (Table 1). Only
one study that tested combined resistance and aerobic exercise with an education program
reported a statistically significant reduction in waist and hip circumference (p<0.0001)
(Beydun et al., 2014). A home-based aerobic versus resistance exercise training intervention
showed a decrease in body weight and BMI associated with a non-significant reduction in
leptin (Mina et al., 2013). An unsupervised exergaming intervention (exercise through
videogames) reported numerical reduction in fat mass and increase in lean mass, though these
were also not statistically significant (Villumsen et al., 2019). All other exercise interventions
with or without an educational component reported modest or no changes in body
composition. The interventions were implemented at home or in exercise clinics and had a
duration from 10 weeks to 12 months. When reported, adherence was high, ranging from 70
to 91%.
Muscle Strength and Physical Activity: Five studies tested interventions that targeted
muscle strength. Measures included resistance, muscular power, and chest and leg extension
muscle strength. All interventions reported a significant improvement in the measures, were
supervised, and shared common components, such as aerobic, impact, and resistance training.
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A resistance exercise intervention resulted in an 11% improvement in muscle strength when
measuring leg extension (Cormie et al., 2013). Regarding physical activity, the majority of
the studies assessing physical activity measures reported a positive improvement favoring the
intervention group, three of them with statistical significance (p<0.001). Measurements
included ambulation, exercise behavior, chair rise time(s), 6-Minute Walking Ability Test
(6MWT), Godin Leisure-Time Exercise score, and self-reported physical function. An
intervention testing resistance exercises improved ambulation by 12% (Cormie et al., 2013).
A home-based exergaming intervention reported a 4.2% improvement in physical activity
function by assessing the 6MWT (Villumsen et al., 2019). The interventions targeting muscle
strength and physical activity were all delivered at a hospital, exercise clinics, or were homebased. All interventions ranged from 10 weeks to 12 months.
Urinary Symptoms: One study involved a progressive urinary rehabilitation program
with the purpose of reducing prostate-related urinary symptoms, resulting in a moderate
reduction of difficulty, frequency, and nocturia (Serda et al., 2010). Four other studies tested
interventions measuring the prostate-specific QOL, including urinary symptoms, via a selfadministered instrument (FACT-P, UCLA PC Index, or EORTC-QOQ-30 PR25) but did not
include urinary-specific outcome measures (Badger et al., 2011; Bourke et al., 2014; Huri et
al., 2015; Villumsen et al., 2019).
Social Domain
The social domain addresses needs related to relationships, communication, and
support systems within the family and the community (Fitch, 2008). This domain was the
second most frequently represented within the body of evidence based on the nature of the
intervention delivery. Thirteen studies delivered the intervention in a group format either
face-to-face or via technology (Table 1). Outcomes included social well-being, social
support, social functioning, sense of belonging, peer learning, and socialization. These
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outcomes were secondary in all studies except in one, which measured social well-being and
social support with instruments (Social Well-Being scale & PSS-FA) (Badger et al., 2011).
The interventions that included a psychosocial component such as group counseling,
cognitive-based occupational therapy, or stress reduction reported an improvement in social
well-being among the participants in the treatment group (Badger et al., 2011; Huri et al.,
2013; Yanez et al., 2015). Group mindfulness sessions delivered by teleconference provided
an increased sense of social belonging to the participants (Chambers et al., 2017; Chambers
et al., 2012). There were also interventions evaluating various exercising modalities, such as
aerobic, impact loading, or resistance training conducted in groups (Beydun et al., 2014;
Bourke et al., 2014; Cornie et al., 2013; Galvao et al., 2014; Serda et al., 2010; Taaffe et al.,
2017; Winters-Stone et al., 2015). Despite a lack of social-specific outcomes, all group
exercising programs resulted in better social functioning and group interaction by
encouraging socialization among participating survivors. Additionally, one study evaluating a
multimodal supportive care intervention that included group seminars reported an
improvement in social support (Primeau et al., 2017). All interventions took place at home
via teleconference, at a hospital, or at exercise clinics. They were implemented for periods of
8 weeks to 12 months and demonstrated high adherence rates (65%-100%).
Informational Domain
Fitch’s SCFCC associates the informational domain with adequate information
regarding the disease trajectory, treatments, care processes, and available resources (2008).
Although every type of intervention can be considered “educational” to some degree, 10
studies included interventions that represented the informational domain, by presenting
resources to the participants and/or the caregivers; educating on diet; exercise, relaxation and
self-management; or by informing them about symptom-related burdens (Table 1). No
specific informational outcomes related to informational supportive care needs were
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measured in any of the studies. Three studies included nutritional education. One intervention
contained nutrition advice seminars and reported a non-statistically significant reduction in
total fats consumption (Bourke et al., 2014). A polyamide-reduced diet proved its safety and
suggested an increase in the participants’ median cancer-specific survival time to 36 months,
versus 17 months in the control group (Cipolla et al., 2010). The health promotion group in
the study by Yanez et al. (2015) was provided with health educational information on sleep,
nutrition, and physical fitness, proven to be “somewhat” helpful.
One commonality across studies was that the majority of the information
disseminated in these interventions was about cancer treatments or supportive care. After an
educational intervention about the effects of the ADT, 98% of the participants reported a
positive impact from this information on physical fitness level and no further deterioration
from the adverse effects of ADT (Yennurajalingam et al., 2012). A web-assisted group
intervention with education on stress awareness and reduction resulted in better coping skills
regarding prostate-related symptomatology (Yanez et al., 2015). The two studies that
included an educational seminar about ADT side effects, self-management, emotion and
stress control, nutrition, exercise, and financing reported fewer unmet informational needs
about treatment choices and disclosure of test results (Paterson et al., 2018; Primeau et al.,
2017). In addition, an early outpatient palliative care consultation addressing symptom
burden resulted in an increased sense of general well-being and an increased lifespan
(Yennurajalingam et al., 2012). Despite not having a direct effect on QOL, the interventions
including an informational component had a positive effect on some of the outcomes
measured, such as fat intake, mindfulness, survival, and overall well-being.
Emotional Domain
The emotional domain relates to the need for comfort and reassurance when adjusting
to stressful situations (Fitch, 2008). Eight studies assessed an intervention with at least one

25

component addressing emotional needs (Table 1). Intervention methods included
interpersonal counseling, occupational therapy, stress reduction, or mindfulness. Depression,
anxiety, stress, and cancer-specific distress were the most commonly measured primary and
secondary outcomes. The duration of the interventions averaged between 8 weeks and 12
months. Half were delivered via telephone and half were face-to-face at the hospital.
Two studies tested mindfulness-based cognitive therapy in groups using self-help
materials and meditation CD delivered via teleconference (Chambers et al., 2012; Chambers
et al., 2017). Although not statistically significant, one reported improved levels of anxiety,
fear of recurrence, and avoidance in the subscales of the distress-measuring instruments
(Chambers et al., 2012). An 8-week telephone intervention combining interpersonal
counseling and cancer education reported a statistically significant reduction in depression
and disease-related stress (p<0.001) (Badger et al., 2011). A multimodal supportive care
intervention (ThriverCare) demonstrated no improvement in reducing stress, anxiety, or
depression in the treatment group, but did report lower prevalence of fear and worries
(Paterson et al., 2018). A technology-assisted psychosocial intervention to reduce stress also
reported better scores in relaxation and fewer depressive symptoms upon completion (Yanez
et al., 2015). One additional study evaluating the impact of an outpatient palliative care
consultation on symptom burden in advanced PC survivors improved seven out of the 10
symptoms, including depression and anxiety (Primeau et al., 2017). Despite the mixed results
of some of the interventions, several reported a statistically significant improvement in the
emotional needs (e.g., depression, anxiety) of the study participants (p < 0.05).
Practical Domain
Practical needs associated with the cancer journey include supports that reduce the
demands on the person’s life at home (e.g., finances), facilitate transportation to the care
center, and access to supportive care and resources, childcare, and shopping (Fitch, 2008).
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Across multiple studies, intervention accessibility was facilitated through alternatives to inperson participation (e.g., telephone, teleconference or Web-assisted) (Table 1). The majority
of these technology-assisted interventions were psychosocial in nature, such as interpersonal
counseling, mindfulness, or stress reduction, and reported no significant differences in most
primary outcomes (e.g., fatigue, QOL, physical function, psychological well-being) despite
the degree of “feasibility and helpfulness.”
The practical domain was addressed by one study that explored the relationship
between ADL and consequences of the PC treatments (Huri et al., 2015). The intervention
included a combination of individualized ADL training, group recreational activity, and
education about PC and relaxation. Practical issues that were negatively affected by advanced
PC included: personal activities such as grooming, driving, bathing, or dressing; productive
activities such as typing, storing groceries, home repair, leisure, walking the pet, moving after
rest, using the phone, or reading the newspaper in bed. Participants reported some
improvement in functioning upon completion of the intervention. A web-based exergaming
intervention, implemented in the participants’ home using devices that can be acquired
inexpensively in any technology-selling store, indicated modest, non-significant
improvement of the physical activity outcomes (Villumsen et al., 2019). Overall,
interventions representing the practical domain were limited to facilitating study
participation. Despite being helpful, they did not report any specific practical outcomes.
Spiritual Domain
The spiritual domain relates to finding a personal sense of meaning in life and the
need to practice some sort of spirituality, whether in the form of a religious or alternative
beliefs (Fitch, 2008). Only one study addressed the spiritual domain as a secondary outcome
(Badger et al., 2011). The study compared an 8-week interpersonal counseling via
teleconference with education (interventional group) and 8-weeks of health education by
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telephone using written materials regarding nutrition, exercise, resources, and quitting
smoking (control group). The influence of the participants’ illness on spiritual well-being was
measured with the 8-item spiritual well-being subscale of the Quality-of-Life Breast Cancer
version questionnaire. The study reported a statistically significant improvement in spiritual
well-being in the health education by telephone group (p<0.01).
Psychological Domain
The primary feature of the psychological domain is the development of skills to cope
effectively with illness-related stressors (Fitch, 2008). One study testing web-based group
sessions for stress reduction, coping skills, and social network (CBSM) addressed the
psychological domain (Yanez et al., 2015). The intervention included stress awareness
development, learning stress reduction skills, changing negative stressor appraisals, and
developing effective coping skills. The retention rate was 85%. Despite not having outcomes
for those targets, results reported high interventional endorsement and feasibility. Statistically
significant intervention effects were consistent with medium effect sizes on the health-related
QOL scale domains (measured with the Functional Assessment of Cancer Therapy–General
scale and subscales of the Measure of Current Status) favoring the intervention.
Discussion
This integrative review confirms that supportive care interventions for advanced PC
exist but they remain limited in number and scope despite the disease’s uncurable nature, its
growing prevalence, and the most current supportive care guidelines. Advanced PC is often
associated with long-term challenges leading to greater levels of unmet needs and decreased
QOL (Chambers et al., 2012; Cockle-Hearne et al., 2013). Evidence indicates that supportive
care interventions are an acceptable and potentially efficacious way to improve some aspects
of PC and other cancer survivors’ QOL (Chambers et al., 2018; Forbes et al., 2019; Young et
al., 2020).

28

The majority of interventions in this review focused on supportive care needs from
the physical domain, such as fatigue, muscle strength, or body composition changes. Despite
the mixed results in reducing fatigue, physical outcomes such as muscle strength, specific
anthropometric measures (waist circumference), and physical function improved across all
studies. Possible explanations for the mixed results in fatigue could be that the studies
considered different outcomes, utilized various measuring instruments, or that the
interventions lacked implementation fidelity (intervention dose, intensity, or frequency). This
finding is consistent with past studies that have reported supportive care interventions being
ineffective in improving QOL in diverse cancer populations due to inadequate doses or
variable timeframes (Carey et al., 2012). Supervised interventions with adequate dosages and
frequency to increase functional capacity, QOL, and ability to conduct ADL, such as
exercise, have shown effectiveness among advanced PC and other cancer survivors (Dickey
& Ogunsanya, 2018). Moreover, all exercise interventions that were delivered in group
formats motivated socialization, social support, and sense of belonging among participating
survivors despite social well-being not being a specific outcome measured.
The high prevalence of emotional needs in this population is commonly associated
with more advanced stages of the disease, uncertainty about the future, and the harmful
effects of the treatments (Paterson et al., 2015). Interventions addressing emotional needs are
limited and often lack demonstrated efficacy. Only five in this review reported significant
improvements in outcomes, such as depression, anxiety, distress, or fear. The heterogeneity
of these studies makes it difficult to draw conclusions about the most effective way to
provide emotional supportive care. Barriers to emotional health may include traditional
masculine stoic roles, a restricted emotional response, and embarrassment (Ettridge et al.,
2018; Wood et al., 2017).
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A similar situation was found within the spiritual, practical, and psychological
domains. Evidence shows that despite 79% of Americans identifying with some spiritual
doctrine, spiritual needs are the least represented in cancer research, and the studies reviewed
are no exception (Busolo & Woodgate, 2016). Challenges in coping with advanced PC can
lead to increased suffering, grief, and loss, contributing to a poorer overall QOL (Laughery &
Woodgate, 2015). Educational interventions have showed promising results in enhancing
study participants’ spiritual well-being.
A study involving web-based group sessions of stress reduction, coping skills, and
social network (CBSM) contributed to the psychological domain and reported improvements
on the health-related QOL subscales (Yanez et al., 2015). However, the study did not use any
exiting instrument to assess patients’ coping such as the Cancer-Coping Questionnaire
(Moorey et al., 2003). No studies specifically targeted practical needs, but one study
described the impact of advanced PC on daily life, and other studies reported intervention
delivery acceptability. Interventions using teleconferencing or the Web were implemented
conveniently in the comfort of the home. The majority of those, predominantly psychosocial
interventions, reported moderate acceptability and feasibility, with high compliance and
retention rates. However, they had mixed results: only one resulted in significant decreases in
anxiety, fear, and mindfulness abilities (Chambers et al., 2012). This result coincides with a
study reporting that telemedicine care delivery was moderately effective in addressing
survivorship symptomatology (Agochukwu et al., 2018). More extensive studies are
warranted to demonstrate the usefulness of these delivery formats for advanced PC survivors.
All the studies included advanced disease PC survivors, exclusively or in conjunction
with varying disease stages. However, there was a noteworthy lack of racial and ethnic
diversity in the studies. Interestingly, the three studies with participants other than White
were conducted in the U.S. The majority of the studies reviewed were exploratory with small
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sample sizes. Also, studies used different outcome measures and the interventions varied in
dose, frequency (ranging from 1 to 5 days per week), and length (8 to 24 weeks), making it
difficult to determine which supportive care interventions were the most effective (Bossert et
al., 2020; Carey et al., 2012). Despite some promising results, it is premature to generalize
the findings to practice in all the settings caring for these survivors. Longitudinal
confirmation of the most effective interventions that meet this group’s unique and complex
needs is needed from more rigorous, multicenter, blinded RCTs that are sufficiently and
diversely sampled (Ross et al., 2020).
There were three noteworthy findings from this review. First, the interventions
delivered in a group format, whether in person or via technology, resulted in significant
improvements in social-related measures (social support, social well-being, or a sense of
belonging). This finding supports conclusions from past reviews reporting that the social
domain is positively associated with a better overall QOL in advanced PC and breast cancer
survivors (Dickey & Ogunsanya, 2018; Post & Flanagan, 2016). Second, the intervention
results do not appear to be dependent on the number of domains addressed by the
intervention. Some interventions showed positive trends, whether they addressed only one or
several of the SCFCC domains. Third, some of the SCFCC domain —social or the practical
domains—were impacted by the intervention even when they were not explicitly targeted.
Limitations
Several methodological limitations may limit the generalizability of the findings. The
majority of studies were of high methodological quality. However, none of the studies
reported a theoretical framework guiding the intervention development or delivery. It is
possible that relevant articles were missed since our focus was on supportive care
interventions in advanced PC survivors. The search terms were narrow to reflect this specific
interventional category, dropping other areas that may have produced additional relevant
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evidence. Limiting studies to the English language and the last ten years could have resulted
in the omission of relevant evidence.
Implications for Research
This review highlights several gaps. First, different sampling approaches need to be
considered to advance research in this area. Future research must include racial and ethnic
diversity to reduce health disparities and promote QOL across communities suffering from
chronic illnesses such as advanced PC (NINR, 2016). Second, researchers must focus on
studying interventions that combine several components addressing the maximum number of
supportive care domains since those interventions can be more cost-efficient in the long run.
Third, interventions need to be guided by a theoretical framework and align with the
recommended guidelines for survivorship care (ASCO, 2019; CCO, 2019). An absence of
theory makes it difficult to understand how and why the interventions were or were not
successful in addressing this growing population’s unmet supportive care needs (Nilsen,
2015). Finally, some of the mixed results may be attributable to the dissimilarities in
psychometric properties of the instruments used across studies, making a comparison of the
results very challenging. Future research must consider assessing the validation properties
and quality of all measurement instruments as well as utilizing the same instruments to
measure the same outcomes. Also, there is a need to diversify research methodologies and
include more qualitative and mixed methods research studies. These methodologies can
provide a more in-depth understanding of advanced disease PC survivors’ experiences and
perceptions of regarding supportive care interventions.
Conclusion
Supportive care in advanced PC remains underserved and overlooked. This review
reveals valuable insights regarding available supportive care interventions that improve the
QOL in this growing population. Findings suggest that the majority of the interventions
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reported some effectiveness. However, no intervention can be recommended over another
and the results must be interpreted with caution due to the existing limitations. This review
supports the need for further interventional research, specifically longitudinal studies with
larger, more racially diverse samples and methodologies. Future directions may include
multi-domain designs and systematic use of theories and cancer survivorship guidelines.
Finally, it also is critical to focus on the spiritual, practical, and psychological domains, as
they can significantly enhance these survivors’ overall QOL and sense of overall meaning.
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Table 1. Evidence Table of Selected Studies
Authors
(Year)

Badger TA, Segrin
C, Figueredo AJ, et
al. (2011)

Study Purpose

To test the
effectiveness of
two 8-week
telephone
psychosocial
interventions for
maintaining and
improving QOL

Study
Design

Setting;
Sample
Description &
Size (N)

Intervention

Randomized
experimental
design

Cancer and Veteran
Affairs Centers,
Arizona (USA)

TIP-C Arm (n=36):
8-week telephone
interpersonal
counseling +
cancer education

Prostate cancer
survivors (all stages)
N=71
Survivors’ caregivers
N=71

HEAC arm (n=35):
8-week telephone
health education
attention condition
+ written materials
(nutrition, exercise,
resources, quitting
smoking)

Primary
Outcomes

At baseline, 12
and 24 weeks

Differences between
groups:

- Depression
- Positive &
negative affect
- Stress

- Survivors in TIP-C
did not exhibit any
significant changes on
any of the QOL
outcomes.

To examine if a
community-based
centrally
managed
combined
resistance and
aerobic exercise
+ education
program can
ameliorate the
adverse effects of
androgendeprivation
therapy

Prospective
cohort study

South New Wales
(Australia)
Survivors with
relapsed or metastatic
prostate cancer
N = 859

Face-to-face
(n=396):
10-week
supervised group
exercise sessions
At-home (n=255):
Video + resistance
bands + coach calls
for 6 months
Man Plan (208):
Phone line support,
magazines and
education on lowintensity exercise,
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SCFCC
Domain

Physical

MMAT
(# of YES)

4 out of 5

Social

- Fatigue
- Prostate health
QOL
- Social well-being
- Social support
- spiritual wellbeing

Beydun N, Bucci
JA, Chin YS, et al.
(2014)

Results

At baseline and
10-weeks
- Height, weight,
BMI, waist and hip
circumference
- BP
- Resting HR
- Resistance
exercises

Informational
Emotional
Practical

- Survivors in the
HEAC showed
significant changes in 5
outcomes: depression,
negative affect, stress,
fatigue, spiritual wellbeing, and in the 4
dimensions of the QOL

Spiritual

- Modest reduction in
mean weight not
statistically significant

Physical

- Statistically
significant
reduction of mean
waist & hip
circumference

Informational

- No change in BMI
- Mean BP reduced
from baseline
- Not statistically

Social

4 out of 5

diet and
psychosexual
function

significant lower
resting HR
- Significant decrease
in mean time for the
400-m test
- Statistically
significant
improvements in all
measured variables
- 98% reported a
positive impact on their
overall fitness +
socialization
- No further
deterioration from
treatment while on
intervention

Bourke L, Gilbert
S, Hooper R, et al.
(2014)

To assess the
effects of a
combined tapered
supervised
exercise training
program with
healthy eating
advice on
improving and
sustaining
changes in
disease specific
QOL, BP and
fatigue

2-armed,
single-blind
randomized
controlled
trial

London & Sheffield,
U.K.
Survivors with
locally advanced
(n=20) or metastatic
(n=80) prostate
cancer
N = 100

Complex arm
(n=50):
Supervised aerobic
& resistance
exercise twice/
week + behavioral
component
(barriers to
exercise, goal
setting, social
support) + nutrition
advice seminars
Usual care arm
(n=50):
Care by oncology
nurse
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At baseline, 12
weeks and 6
months
- Exercise
behavior,
adherence &
biochemical safety
- Disease-specific
QOL
- Fatigue
- BP
- BMI
- Weight
- Biomarkers:
PSA, testosterone,
free androgen
index, & hormonebinding globulin

-Significant
improvements in total
exercise behavior
maintained at 6 months

Physical
Social
Informational

-No differences in
biochemical safety
markers
-Adherence 94% and
82% in supervised and
independent exercise
respectively
-Significant, clinically
relevant improvement
in disease-specific QoL
but not maintained
after supervision

5 out of 5

- Dietary behavior:

-No changes in BP,
weight or PSA
-Significant clinically
relevant improvements
in fatigue at 12 weeks
& 6 months
-Reduction of fats
intake, non-statistically
significant

Chambers SK,
Newton RU.
(2012)

To investigate
feasibility and
effectiveness of
an 8-week
intensive
mindfulnessbased cognitive
therapy

Mixedmethods pilot
study

Rural and urban
healthcare centers,
Queensland,
Australia
Advanced stage
prostate cancer
survivors

2-hour
teleconference
group session weekly session
handbook + selfhelp materials +
meditation CD
(daily 35 min
session minimum)

N = 19

At baseline, after
completion, and 3
months after

- Improved anxiety,
avoidance & fear of
recurrence

- Psychological
distress
- Cancer-specific
distress

- No changes in QOL

- QOL

- Ideal quotas in urban
centers

- Perceived global
QOL
- Mindfulness
skills
- Program
Evaluation:
acceptability &
frequency
- Qualitative
assessment:
overall experience
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- Increased mindfulness
over time

- 80% attended all 8week sessions
- At 3 months, 54%
reported regular
mindfulness meditation
- Majority found it very
helpful
- Thematic analysis
Group identification
(belong); Diversity
acceptance; Peer
learning (new ways of
dealing with
challenges);

Social
Emotional

5 out of 5

Acceptance of disease
progression

Chambers SK,
Occhipinti S, Foley
S, et al.
(2017)

To assess the
effectiveness of
MBCT in
reducing
psychological
distress

2-armed
randomized
controlled
trial

Griffin University,
several hospitals
Queensland,
Australia
Men with metastatic
or castration-resistant
prostate cancer
N = 189

Cipolla BG,
Havouis R,
Moulinoux JP.
(2010)

To present results
of observance,
safety, and effect
of PRD diet on
QOL
(performance
status and pain
control)
To compare
survival between
PRD diet and
control patients
on normal diet

Prospective
cohort study

Centre Hospitalier de
Saint-Gregoire,
France
Consecutive
metastatic HRPC
patients

N = 42

MBCT arm (n=94):
8 group MBCT
sessions at weekly
intervals via
teleconference
Enhanced care arm
(n=35):
Education on
advanced PC,
relaxation CD,
nutrition, support
services

At baseline, 3, 6,
and 9 months
- Psychological
distress
- Cancer-specific
distress
- Anxiety

- No significant
changes or
improvements in any of
the measured outcomes

PA reduced diet
(n=26):
5-day/week meals
from food tables
given to patients +
partial intermittent
intestinal tract
cleansing

At baseline and
regularly until 36
months

Observance: no patient
stopped the diet

Usual diet controls
(n=16)

- Biomarkers:
PSA, Hb, WBC,
platelets, serum
proteins, and red
blood count
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Emotional
Practical

- No improvements in
emotional distress over
time
- Intervention not
efficacious

Physical
4 out of 5
Informational

- No adverse effects

- Survival:
assessment &
comparison early
versus late PRD
initiation

5 out of 5

- 72% rated the
intervention as
extremely helpful

- QOL
- Post-traumatic
Growth Inventory
- Mindfulness
skills

- Toxicity
- Performance
- Pain
- Weight

Social

- No significant
differences in weight,
performance, pain, or
blood counts
- Significant median
cancer-specific survival
time of PRD patients
was 36 months versus
17 months in controls
- PRD diet is safe and
well-observed as
nutritional therapy

Cormie P, Newton
RU, Spry N et al.
(2013)

To provide initial
experimental data
on safety and
efficacy of
resistant exercise
in metastatic
prostate cancer
survivors

Pilot singleblinded, 2armed
prospective
randomized
controlled
trial

Perth, Western
Australia
Men with metastatic
Prostate cancer
N = 20

Exercise arm
(n=10):
12-week,
twice/week
supervised group
resistance exercise
sessions
Usual care (n=10):
offer of exercise
program after
intervention was
finished

At baseline and
12 weeks
- Incidence &
severity of adverse
events
- Pain
- Compliance,
tolerance and
rating of perceived
exertion
- Muscle strength
- Ambulation
- Exercise capacity
- Muscle power
- Balance
- Falls
- Physical activity
- Regional &
whole-body lean
and fat mass

- No adverse events

Physical

- No change in pain
medication use

Social

5 out of 5

- High attendance
(70%)
- Exercise sessions well
tolerated
- Trends towards
improvement in
physical function in
exercise arm
- No difference in
balance
- Significant favorable
change in whole body
and appendicular lean
mass in exercise arm
- No differences in fat
mass

- QOL
- Distress
- Fatigue

Galvao DA, Spry
N, Denham J, et al.
(2014)

Effectiveness of
exercise training
(resistance and
aerobic) in
cardio-respiratory
fitness, physical
functioning,
patient-reported
outcomes,

Multicenter,
2-armed,
prospective
randomized
controlled
trial

Three Health centers
Australia and New
Zealand
Men at stages II, III,
IV prostate cancer
N= 100

EX arm (n=50):
progressive
resistance and
aerobic training
with a 6-month
supervision
PA arm (n=50):
PA-modified
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At baseline, 6 and
12 months
- Cardiovascular
fitness: 400-m
walk
- Physical activity
- QOL

- No significant
differences in QOL,
fatigue or distress

- EX arm exhibited
improvement in fitness,
muscle strength and
physical function
- EX arm showed
improved QOL, social
functioning at 6
months, role emotional
at 12 months, & mental

Physical
Social

4 out of 5

biomarkers and
body composition

educational booklet
+ pedometer

- Muscle strength
- Biomarkers:
testosterone, PSA,
insulin, lipids
panel,
glucose, BP
- waist
circumference

health index at 6
months
- EX arm showed
appendicular skeletal
muscle gain but no
differences on weight
and waist
circumference
- EX arm showed
increased HDL at 12
months
- No differences in
PSA, testosterone or
BP

Huri M, Huri E,
Kayihan H, et al.
(2015)

To identify the
effect of
cognitivebehavioral based
occupational
therapy (OTCBSM) on
occupational
participation and
QOL

2- armed
randomized
controlled
trial

Faculty of Health
Sciences, Hacettepe
University, Ankara,
Turkey
Men with localized,
locally advanced or
metastatic Prostate
cancer
N = 34

To explore which
areas of daily life
are most affected
and in need of
support

OT-CBSM arm
(n=19):
12-week
intervention:
individualized
daily living
training + group
recreational
activity + CBSM
education/information about
prostate cancer &
relaxation
Control arm
(n=15):
printed home
program +
instruction on
effects of activity
training, recreation,
stress management
and relaxation
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One week before
and after the
intervention

- 94.7% of participants
experienced
improvement

Physical

- Occupational
Performance

- Affected areas:
self-care (grooming,
driving, bathing,
dressing), productivity
(stairs, typing, storing
groceries, home repair,
watching
grandchildren),
leisure (playing,
walking pet, going to
café, moving after rest,
using phone, reading
newspaper in bed)

Informational

- Self-perception
& identify issues
in self-care,
productivity &
leisure
- QOL
- Prostate-specific
QOL (urinary,
bowel, sexual &
hormonal
symptoms)

- OT-CBSM group
reported a significant
increase in physical,
role & emotional &
social functioning
compared to controls in

Social

Emotional
Practical

4 out of 5

QOL
- Urinary, bowel,
sexual & hormonal
symptoms were
decreased in OT group

Mina DS, Connor
MK, Alibhai SMH,
et al.
(2013)

To examine if 6months of homebased aerobic
and/or resistance
exercise training
can beneficially
increase
adiponectin,
leptin, and IGFaxis protein
levels

2-group,
randomized
controlled
trial

Several urban health
centers, Ontario,
Canada
Men with all stages
of Prostate cancer
N = 26

EAT arm (n=13):
Preferred modality
of exercise at
moderate/vigorous
intensity-60 min,
5/week for 6
months; heart
monitor provided

At baseline, 3 and
6 months
- BMI
- Body fat %
- Waist
circumference
- VO2 peak

Resistance arm
(n=13):
10 exercises
targeting major
muscle groups

- Changes in
physical activity
- Biomarkers:
Insulin-growth
factor-1, IGF
binding protein 3,
leptin &
adiponectin

- At 6 months, AET
group showed
significant decrease in
IGFBP-3 while RET
group showed
significant increase

Physical

4 out of 5

Physical

4 out of 5

- At 3 months, RET
group showed
significant reduction of
IGF-1
- Reductions in weight,
BMI & waist
circumference
associated with
reductions in leptin
- Increases in VO2
peak associated with
reductions in leptin
- Home-based exercise
intervention (RET)
may have beneficial
effects on adipokines
and IGF axis, maybe
due to improvements in
body composition
because of the exercise.

Paterson C,
Primeau C, Nabi G.
(2018)

To test the
hypothesis that
the ThriverCare
intervention

Pilot
randomized
controlled
trial

Four hospitals in
Scotland, U.K.

ThriverCare arm
(n=19):
4-component
intervention:
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At baseline and 3
months
- Supportive care

- Less prevalence of
unmet needs in
ThriverCare arm
(fatigue, pain, fear,

Informational

would improve
supportive care
needs,
psychological
outcomes, health
related QOL and
self-efficacy

Men with metastatic
prostate cancer
(n=38)
Survivor´s caregivers
(n=10)

informational selfmanagement
booklet + holistic
needs assessment +
individual self-care
plan + group-based
seminar

N = 48

needs
- Anxiety
- Depression
- QOL

worries, sexuality,
information)
- No significant
differences in anxiety
and depression

- Confidence in
self-management

- No significant
differences in QOL

Standard care
(n=28):
usual care by
clinicians

Primeau C,
Paterson C, Nabi G.
(2017)

To gain
understanding of
a multimodal
supportive care
intervention
(ThriverCare)
compared to
standard care

Qualitative

Two cancer hospitals
in Scotland, U.K.
Men with localized,
locally advanced and
metastatic prostate
cancer (n=19)
Caregivers (n=7)
Interprofessional
team members (n=7)

4-component
intervention:
holistic care
assessment at
baseline +
individualized selfmanagement care
plan + group
seminar +
educational
materials

N = 33

- No significant
differences in selfefficacy

At 3 months after
the intervention
- Exploratory
semi-structured
interviews
- Field notes

Themes:
- Physical needs:
managing the sideeffects of treatment,
lack of selfmanagement support
- Psychological needs:
uncertainty on cancer
progression, lack of
compassion from care
team
- Practical needs: lack
of motivation, financial
burdens
- Sexual needs: change
in sexual function
- Patient-clinician
communication:
limited time, lack
information
Intervention group:
- Emotional support:
enough time to share,
received info about
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Emotional

Social
Informational
Emotional

4 out of 5

their process,
additional emotional
support
- Informational
support: no unmet
needs identified

- Evidenced-based
self-management
plans & seminar:
perceived benefit
- Multimodal
supportive care
intervention improves
care and decreases
unmet needs over time

Serda BC, Vesa J,
Del Valle A, et al.
(2010)

To share a design
and
implementation
of a progressive
rehabilitation
program with the
purpose of
reducing the
urinary
incontinence
symptom and
improving QOL

Cohort quasiexperimental

Hospital of Figueres,
Girona, Spain
Men with localized,
locally advanced, and
metastatic prostate
cancer
N= 33

24-week
progressive
strength program: 3
consecutive
ordered levels
based on the
recognition,
control, &
tonifying the pelvic
floor musculature

At baseline and
24-weeks:
- Type of urinary
incontinence
- Leakage &
frequency
- UI Volume

- 66.66% had UI;
33.33% presented with
lower urinary tract
symptoms only

- Fatigue

- Significant decrease
in intensity
- Significant reduction
of constipation,
difficulty, frequency,
limitation of activities
& nocturia

- Hip-waist index,
waist perimeter &
fat percentage

- Non-significant
decrease in fatigue and
pain

- BP
- Treatment
toxicity

- Non-significant
improvement in QOL
after the program

- QOL

- Significant decreases
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Physical
Social

5 out of 5

Taaffe DR, Newton
RU, Spry N, et al.
(2017)

To report the
efficacy of a 1year long RCT of
varying
supervised
exercise
modalities on
fatigue and
vitality

3-armed
randomized
controlled
trial

Perth & Brisbane,
Australia
Men with localized
and locally advanced
prostate cancer

ILRT arm (n=58):
Impact loading &
resistance training
ART arm (n=54):
Aerobic &
resistance training

N = 163
DEL arm (n=51):
Usual care &
delayed exercise

- Exercise habits

in hip-waist index,
waist perimeter and fat
percentages

At baseline, 6,
and 12 months

- Reduced fatigue in
ILRT at 6 & 12 months

- Fatigue

- Reduced fatigue in
ART at 12 months

Physical

4 out of 5

Social

- Vitality
- Cardiovascular
fitness
- Muscle strength

- No change in fatigue
or vitality in DEL at 6
months
- Increased vitality in
all 3 groups at 12
months
- Increased muscle
strength in ILRT group
at 6 & 12 months & in
ART after 6 months
- All exercise
modalities have
beneficial effect on
fatigue & vitality

Villumsen BR,
Jorgensen MG,
Frystyk J, et al.
(2019)

To explore the
effects of 12week
unsupervised
home-based
exergaming
compared to
usual care

Singleblinded, 2armed
randomized
controlled
trial

Outpatient clinics at
Regional Hospital
Holstebro and
Regional Hospital
Viborg, Denmark.
Men at all stages of
Prostate cancer
N = 46

Intervention arm
(n=23):
90-min instruction
on exergaming XBox 360 Kinect
system; 1-hour,
3/week aerobic &
strength exercise
Usual care (n=23):
normal daily
activities
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Baseline and 12weeks
- Effects of
exergamingphysical function
- Leg extension
power
- Body
Composition

- 4.2% improvement
favoring the
intervention
LEP:
- No significant
difference between
groups
- Lean mass increased
and fat mass decreased
numerically between

Physical
Practical

4 out of 5

- Self-reported
QOL
- Fatigue

groups-no statistically
significant
- No difference in QOL
between groupsnumerical increase in
global health status in
ntervention arm
- No improvements in
fatigue in intervention
arm
- Study shows trends
favoring the
exergaming
intervention

Winters-Stone KM,
Dobek JC, Bennett
JA, et al.. (2015)

To report effects
of POWIR on
muscle strength,
physical function,
and disability
To explore if
changes in
strength, physical
function or
fatigue mediated
changes in selfreported function
or disability

Single-blind,
2-parallel
groups,
randomized
controlled
trial

Oregon Health &
Science University,
Portland, Oregon
(USA)
Men with localized
and locally advanced
prostate cancer
N = 51

POWIR arm
(n=29):
Supervised
program of
resistance + impact
training
FLEX arm (n=22):
placebo control
program; seated
stretching exercise

At baseline, 6 and
12 months

- Retention for POWIR
arm 90%

- Prevalence
chronic conditions

- Retention for FLEX
arm 75%

- Energy in
physical activity

- Attendance while
supervised 83% & 67%
for POWIR and FLEX
respectively

Social

- Fatigue
- Muscle Strength
- Physical function
performance
battery (objective)
- Self-reported
physical function

- Significant increase
of 7% for bench press
and 17% for leg press
in POWIR group
(muscle strength)
- No significant
changes in objective
measures in physical
function
- POWIR group
increased mean self-
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Physical

5 out of 5

reported physical
function on EORTC
QOL and decreased
disability on LLFDI
subscale
- No significant
differences in fatigue
or 36-item health
survey
- Overall, men in
POWIR reported better
levels of hysical
function & less
disability than men in
FLEX

Yanez B, McGinty
HL, Mohr DC, et
al.
(2015)

To evaluate the
participation &
retention of a
Web-based
intervention
targeting
symptom burden
and HRQOL
To assess
participant
satisfaction
To report
preliminary
evidence for the
efficacy of a
cognitive
behavioral stress
management
(CBSM) on
HRQOL and
intervention
targets

2-armed
randomized
controlled
trial

Robert H. Lurie
Com-prehensive
Cancer Center of
Northwestern
University and the
Jesse Brown VA
Medical Center
Chicago, IL (USA)

Men with locally
advanced (III) or
metastatic (IV)
prostate cancer

CBSM arm (n=37):
Group session
targeting stress
reduction, coping
skills, interpersonal
skills, social
network
HP arm (n=37):
Health info and
education on sleep,
nutrition, &
physical fitness

N = 74

At baseline, and 6
months

- Recruitment rate was
31.3%

- Feasibility &
acceptability:
recruitment,
retention &
attendance rates

- Retention rate at 6 mo
was 85.7% for CBSM
and 86.1% for HP

Informational

- Cancer-related
stress
- Depressive
symptoms
- Health-related
QOL
- Intervention
targets: selfefficacy in stress
management skills
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Social

Emotional
Practical

- HP group attended
more sessions
- Acceptability:
confidence in material
learned was “quite” for
CBSM and
“somewhat” for HP
group
- CBSM fewer
depressive symptoms
than HP
- HP reported better
social well-being

Psychological

4 out of 5

- CBSM reported
higher scores for
relaxation than HP over
time
Findings support
feasibility,
acceptability, and
preliminary efficacy of
a web-based
psychosocial
intervention

Yennurajalingam S,
Atkinson B,
Masterson J, et al.
(2012)

To describe the
impact of an
outpatient
palliative care
(PC) consultation
on symptoms of
advanced prostate
cancer

Retrospective
descriptive
study

M.D. Anderson
Cancer center,
Houston, TX (USA)

Outpatient
palliative care
consultation

Charts of patients
with metastatic
prostate cancer

- Age
- Disease state: 10symptom severity
Performance
Status
- Survival

N = 55

- Biomarkers:
hemoglobin,
testosterone, PSA
- Medication
changes

- Most relevant
symptoms: fatigue,
drowsiness & pain

Physical

- Statistically
significant
improvement in 7 out
of 10 symptoms after
the PC consultation:
pain, depression,
drowsiness, fatigue,
sleep, sense of wellbeing & anxiety

Emotional

4 out of 5

Informational

-Longer duration
between PC referral
and death than in
previous studies: 175
days versus 141 & 42

Abbreviations: BP, blood pressure; BMI, body mass index, CR, cardiorespiratory; Hb, hemoglobin; HDL, high density lipoproteins HR, heart rate; IGF, insulin
growth factor; PC, palliative care; PRD, polyamide reduced diet; PSA, prostate specific antigen; QOL, quality of life; RTC, randomized controlled trial; VO2,
oxygen uptake; UI, urinary incontinence; WBC, white blood
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Figure 1. PRISMA flow diagram of the study selection process 24
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Abstract
Men with advanced prostate cancer can endure a wide range of long-term side effects
from cancer and therapies, negatively affecting their quality of life. Few studies have been
published about the supportive care needs for this specific population and the correlation of
needs with the quality of life. The aim of this study was to conduct a holistic supportive care
needs assessment among advanced disease PC survivors guided by the Supportive Care
Framework for Cancer Care. Using a convergent mixed-methods approach, 188 American
survivors diagnosed with advanced prostate cancer completed a cross-sectional survey
(Supportive Care Needs Survey-Short Form 34, PC module, Functional Assessment of
Chronic Illness Therapy – Spiritual Well-Being, European Organization for the Research
and Treatment of Cancer Quality of Life Questionnaire). A subset of 20 survivors agreed to
participate in qualitative interviews. Participants identified unmet supportive care needs in
every domain of the framework. A negative correlation between needs and quality of life was
also established. Results revealed that 95.2% of the survivors had at least one unmet need.
The item with the highest prevalence (62.2%) was “fears about the cancer spreading.” The
findings’ integration revealed several areas of convergence (fatigue, sexual dysfunction,
practical, and emotional/psychological domains) and divergence (informational and spiritual
domains, depression, urinary dysfunction). A priority goal is for advanced prostate cancer
survivors to maintain quality of life while reducing their unmet supportive care needs. This
study’s results can inform the future development of individualized supportive care
interventions that meet this population’s needs.
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Despite massive screening and development of novel treatments, the incidence of
prostate cancer (PC) in the United States continues its ascending trend, from 98.8 new cases
per 100,000 people in 2014 to 108.0 per 100,000 in 2017.1 Furthermore, this incidence is
estimated to rise 33.6% by 2040, partly due to an increase in men aged 65 years and older. 2
There are more than 3.6 million PC survivors living with this disease in the U.S., a third of
whom will experience progression or recurrence (stage III-regionally advanced, stage IVmetastatic, or recurrent / refractory).3,4,5,6 Treatment with curative intent is no longer an
option for survivors with advanced PC. These survivors are typically managed with a
combination of therapeutic agents, such as chemotherapy, androgen-deprivation therapy
(ADT), and ongoing clinical trials testing individualized immunotherapy, DNA repair
inhibition, vaccines, or prostate-directed radiotherapy.7,8 Although promising, these
treatments are often associated with long-term and negative effects that significantly
compromise overall quality of life (QOL) and health outcomes.9,10,11 Unmet physical,
emotional, social, psychological, informational, spiritual, and practical supportive care (SC)
needs often stem from those effects, costing the U.S. health care system more than $9 billion
annually. 4,9-16
SC needs are defined as survivors’ desire for support to maximize QOL and minimize
functional and psychosocial deterioration for a problem that arises from the illness or
treatments.17 Evidence from past studies suggests that, despite current cancer survivorship
recommendations and guidelines, between 33% and 81% of PC survivors report SC needs
that have not been adequately addressed.14,18 Specifically, the unmet needs include emotional
needs (52.9%), physical needs (47.1%), practical and spiritual needs (23.5%), and social
needs (11.8%), further impacting QOL.18 SC is a patient-centered approach that focuses on
the prevention and proper management of the side effects of PC and its treatments,
improvement of coping and decision-making skills, and reduction of functional impairments
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throughout the entire cancer continuum, including survivorship.16,20,21 The Institute of
Medicine, the American Society of Clinical Oncology (ASCO), and the American Cancer
Society (ACS) endorse SC as a way to improve QOL and rehabilitation, and lessen the
economic hardship of cancer care on healthcare systems.21 However, the implementation of
SC varies significantly across settings, partially due to the SC needs remaining unknown for
this subset of survivors.19,21
Research to date has investigated PC survivors’ lived experiences, predictors of QOL,
and the sequelae of PC treatments with curative intent at various stages of the disease. But
relatively few published studies have focused solely on advanced disease PC survivors and
their specific needs, or have investigated the relationship between unmet SC needs and QOL
in this population.11,15,23,24 Some literature exists on unmet physical and informational SC
needs in advanced PC survivors using quantitative or qualitative approaches, but not mixed
methods.11,25 Therefore, a holistic needs assessment was warranted to enhance the
understanding of this vulnerable subset of survivors’ perception regarding their unmet SC
needs. The findings of this study can be translated into development of patient-centered, costeffective SC interventions aimed at enhancing advanced PC survivors’ QOL and reduce
burdens to healthcare systems.
The purpose of this convergent parallel mixed-methods study was to conduct an SC
needs assessment among advanced disease PC survivors guided by Fitch’s Supportive Care
Framework for Cancer Care (SCFCC). Specifically, the authors addressed the following
research questions: (1) What are the unmet supportive care needs in advanced disease
prostate cancer survivors? (2) How do these unmet SC needs relate to QOL?
Methods
Theoretical Framework
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Outlining a comprehensive taxonomy of seven domains (physical, emotional, social,
spiritual, practical, informational, and psychological), the SCFCC served as the guiding
theoretical framework for this study (Figure 1). The SCFCC was initially developed as a tool
for healthcare providers to understand the global and complex needs of diverse cancer
patients throughout the illness continuum.26 This framework has been used successfully in
previous needs assessment studies with various types of cancer survivors.27,28 The SCFCC
guided the identification and selection of a previously validated instrument to measure unmet
SC needs due to the similarities between the framework and the Supportive Care Needs
Survey (SCNS) domains.29 It has also helped inform the development of the qualitative
interview guide because of its holistic view of SC for cancer.29,30 Lastly, it has guided the
categorization and interpretation of the findings, identifying SC needs across domains that
were particularly prevalent and had the potential to impact this population’s QOL and overall
health outcomes negatively.
Study Design and Setting
This exploratory study used a convergent parallel mixed-methods design. After
obtaining IRB approval, cross-sectional quantitative and qualitative data were collected
concurrently from advanced disease PC survivors between July and October 2020. We used a
multichannel recruitment strategy to identify eligible participants. For the quantitative phase,
recruitment settings included a prominent cancer center of an academic medical institution in
the southern U.S., Research Match (an online research recruitment tool), various prostate
cancer support groups and organizations, and online social media. The study had a waiver of
informed consent; however, every eligible participant was provided with a written statement
of research with all pertinent study information along with the survey introduction. The
survey assessed overall and PC-specific unmet SC needs, spiritual well-being, and cancer
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QOL. For the qualitative phase, a subset of survey participants was invited to participate in
the interview.

Figure 1: SCFCC Diagram Applied to advanced PC (with permission) 26
Study Sample
In the quantitative phase, a convenience sample of survivors were enrolled if they
reported meeting the following inclusion criteria: (1) had an advanced disease PC diagnosis
(stages III, IV, or recurrent); (2) were ≥18 years; (3) were able to read, understand, and speak
English; and (4) resided in the United States or its territories. Excluded were those who
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endorsed being enrolled in palliative or hospice care or having a physical or mental
impairment preventing survey completion.
For the qualitative phase, we purposively enrolled a subsample of participants who
completed the survey and indicated willingness to participate in the qualitative interview.
Diversity by sociodemographic and clinical factors (e.g., race, ethnicity, age, disease stage,
treatments, time since diagnosis, level of education, marital status, and geographical location)
was prioritized when possible to ensure maximum variation and to capture the perspective of
potentially neglected and underserved populations. Recruitment continued until data
saturation was achieved.31
Data Collection
Quantitative Data: A cross-sectional online survey was administered nationally using
Research Electronic Data Capture (REDCap). Respondents who were eligible and completed
the entire survey (n=188) received an electronic gift card as compensation for their time and
effort. The survey included the following validated measures:
Socio-demographic and clinical questionnaire. Self-reported data included age, race,
ethnicity, marital status, employment, years of education, insurance status, state of residence,
age and stage at diagnosis, treatments received, and current disease stage.
Supportive Care Needs Survey-Short Form 34 (SCNS-SF34). The participants’ unmet SC
needs were assessed with a self-report questionnaire consisting of 34 items mapped onto five
domains: physical & daily living (5 items), health care & information (11 items),
psychological (5 items), patient care & support (10 items), and sexual (3 items). This
instrument has robust similarities with the most relevant domains of the SCFCC.32,33
However, some domains are not separated within the instrument subscales. For example, the
items that measure emotional needs are included in the psychological subscale. The items
that measure psychological needs are included in two separate subscales (psychological and
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health system and information). Respondents reported the extent to which they needed help
with each item over the past month on a 5-point Likert scale (1=not applicable (no need),
2=satisfied (had need but need for help was satisfied, 3=low need, 4=moderate need, 5=high
need). All responses were summed within need domain and standardized from 0 to 100, with
higher scores representing higher level of needs. The instrument has excellent internal
reliability (Cronbach´s α coefficients between .86 and .95), internal consistency, and robust
content validity (coefficients between .87- and 96).34
Supplementary SCNS PC Module. This module assessed PC-specific unmet needs and it is
appropriate for use with patients at varied PC disease stages, treatment modalities, and time
since the initial diagnosis. It consists of 8 additional items with the same SCNS-SF34
response set and scoring.34
Functional Assessment of Chronic Illness Therapy – Spiritual Well – Being (FACIT-Sp 12).
This questionnaire was used to collect data on the participants’ spiritual well-being (meaning,
faith, and peace). It includes 12 items, derived from a longer questionnaire, with summary
scores ranging from 0 to 48. A higher score indicates greater spiritual well-being.35 This
subscale has been validated across multiple cultures and has strong reliability (Cronbach
coefficient 0.87).36 To adapt to the other instruments used in this study, a minor change to the
FACIT-Sp questionnaire was made, modifying its time frame from 7 days to one month so
that all the unmet needs findings are consistent with the same specific time frame.37
European Organization for the Research and Treatment of Cancer Quality of Life
Questionnaire (EORTC QLQ-C30. The EORTC QLQ-C30 is an integrated system consisting
of 30 items divided in five functional scales, three symptom scales, one global health/QOL
scale and 6 individual symptom items. It uses a four-point Likert response set for all the items
except for the health status and QOL scales, which are measured on a 7-point scale. Scores
were calculated by scale or by item and transformed into a 0 to100 summary score with a
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higher score representing higher QOL or higher symptomatology level. It possesses a high
degree of consistency with Cronbach’ s α coefficients ranging between .70 and .96.4,38
Qualitative Data: Qualitative description guided the qualitative arm of the study. Individual,
semi-structured interviews were conducted via telephone to explore the influence of SC
unmet needs on the QOL of survivors more in-depth. Following the identification of the
participants, the principal investigator (PI) contacted them to arrange the interview at a
day/time of their convenience. Socio-demographic and clinical information were collected
including age, race, ethnicity, education level, marital status, employment status, insurance
status, PC stage at diagnosis, current PC stage, age at initial diagnosis, and treatments
received. The interview guide was developed based on the SCFCC. Probes were used
throughout the interview to elicit additional explanations or to redirect the participant. 31,39
The PI maintained a reflective journal to record impressions about the interview. Every
interview lasted between 15-52 minutes, depending on how much the participant wanted to
share and was audio-recorded and professionally transcribed using Rev.com.
Data Analysis
Quantitative Data. All statistical analyses were performed using SPSS v25. software.40
Socio-demographic and clinical data were analyzed using descriptive statistics to provide a
summary of the sample characteristics. The SCNS-SF34 and the EORTC-QLQ-C30
instruments were scored according to the manual and the scores converted to a standardized
0-100 scale.34,38 To identify the unmet SC needs, the mean number of needs, and the
prevalence (i.e., frequency, proportion, mean, standard deviation, range) were calculated per
domain and individually per item of the SCNS-SF34, the PC-module, and the FACIT-Sp
instruments. A total score for the FACIT-Sp and the EORTC-QLQ-C30 was also obtained.
The SC needs items with the highest prevalence were also identified and reported. Bivariate
correlational analyses with Pearson’s r computation were performed to determine the strength
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and direction of the relationship between each domain of SC needs and QOL. A p value of
less than 0.05 was used to determine a statistically significant value.41 Missing data were
reported; no imputation was carried out.
Qualitative Data. Descriptive statistics were used to summarize the sample’s characteristics.
The recordings were transcribed verbatim. The PI cross-checked and read each transcript
several times for accuracy, removing any identifying information. Qualitative deductiveinductive content analysis was conducted using NVivo12 to provide a rich account of the
data.16,42,43 The PI performed several coding levels that were further categorized into final
themes/subthemes guided by the domains of the SCFCC. An iterative comparative method
was followed throughout the qualitative data collection and analysis until data saturation was
achieved, using each interview’s analysis to inform subsequent interviews 39,44,45 Throughout
the analyses, emergent themes were compared across transcripts.
The concepts identified by Lincoln and Guba were followed to ensure rigor.46
Credibility was established by providing a statement of research to each participant prior to
the interview, by writing impressions about the interview, by conducting several levels of
data coding, and by having several members of the research team verify the transcripts and
themes (S.N and S.Q). Dependability was achieved by keeping an audit trail of all decisionmaking procedures. Confirmability was established during the interviews through repetitive
questioning and probes for clarification, and by including direct quotations as evidence of the
data collected. Transferability was ensured by the sampling strategy and documentation of
the recruitment and data collection processes.46 Additional triangulation was performed by
contrasting the results with those from the quantitative survey and comparing the final results
with prior studies conducted with similar populations.11,16,39
Quantitative and qualitative data were analyzed separately. The merging and
integration occurred in a subsequent step. Both sets of results were reviewed and synthesized
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to compare and contrast emerging themes. This process enabled side-by-side comparison of
quantitative and qualitative data to find similarities, differences, and/or inconsistencies. 39
Results
Demographic and Clinical Characteristics
From a total of 670 survivors who accessed the quantitative survey, 188 were eligible
for inclusion in the study. The remaining did not meet the inclusion criteria or started the
survey but exited it before completion. Overall, the mean (SD) age of the sample was 69.0
(8.8) years. Most men were White (93.1%), married (82.4%), college degree holders (79.3%),
and retired (68.1%). The majority (63.5%) lived in southern states. Almost half of the
participants (49.7%) reported having a stage IV cancer. The mean (SD) age at diagnosis was
61.6 (8.1) years. Most participants had completed multiple treatments, such as ADT (74.5%),
radiation (63.3%), or surgery (60.1%) (Table 1).
A total of 43 survivors were invited to participate in the qualitative semi-structured
interview, but 21 declined or were lost to follow-up. A total of 22 interviews were performed,
but two were not included in the analysis because the participants did not meet the inclusion
criteria due to a discrepancy on the current disease stage discovered as the interview
progressed. The mean (SD) age for the 20 participants was 67.4 (8.4) years (Table 1). Most
were White (90%), married (70%), retired (50%), and held a college degree (90%). Current
disease stages of III, IV, and recurrent were somewhat evenly represented (25%, 40%, and
35%, respectively). The mean (SD) age at diagnosis was 59.4 (8.8) years. Surgery, radiation,
and ADT were also the most commonly received treatments.
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Table 1. Sample Demographic and Clinical Characteristics

a Some

of the participants did not provide an answer for some of the sociodemographic and clinical characteristics.
Abbreviations: ADT, Androgen-Deprivation Therapy; HIFU, High-Intensity Focused Ultrasound
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Theme 1: Survivors’ Perception and Prevalence of Supportive Care Needs
Overall, needs were reported in all seven domains. Up to 95.2% of the PC survivors
surveyed reported having at least one unmet SC need. The proportion of survivors reporting
PC-specific needs was 83.5%, while 79.8% endorsed emotional/psychological needs, and
74.5% reported sexual needs. Needs were also identified within the physical (64.4%),
informational (59.6%), practical (45.7%), and spiritual domains. The mean total number of
unmet SC needs was 14.9±10, ranging from zero to 42 for each domain.
Of all the SCNS domains, in those reporting some need (either low, moderate, or high
need)32 the highest level of need was endorsed for the sexuality domain (39.4±29.2),
followed by the psychological domain (37.6±22.9) and the physical & daily life (29.9±23.4).
In contrast, the lowest levels of need were endorsed for patient care & support (27.2±21.0). In
three out of the six SCNS domains greater than 50% of respondents reported some level of
need in the psychological, sexuality, and PC-specific module items. In addition, 38.3% of the
participants who completed the spiritual well-being subscale expressed they had “little” or
just “somewhat” level of peacefulness. A detailed account of the unmet SC needs’ mean
scores, frequencies, and percentages is presented in Table 2.
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a Some

of the participants did not provide an answer to some of the SCNS and FACIT questions.
score represents better spiritual well-being.
Abbreviations: FACIT-Sp, Functional Assessment of Chronic Illness Therapy-Spiritual Well-being.
b Higher
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The 12 most prevalent individual unmet SC needs items are presented in Table 3.
Almost half (5 out of 12) of the top 12 needs items were associated with the
emotional/psychological domains. The remaining belonged to the sexuality (2), PC-specific
(3), and physical (2) domains. The three most commonly endorsed items included “fears
about the cancer spreading” (62.2%), “having changes in sexual feelings” (59%), and
“uncertainty about the future” (58.0%).

Table 3. Top 12 Reported Supportive Care Needs.

Quantitative and Qualitative Findings as per SCFCC Domains
1.1. Unmet Physical Needs
Needs that stem from physical symptoms and the inability to carry out activities of
daily life belong to the physical domain, reflected in items in the sexuality, physical, and PCmodules of the SCNS domains.26 A total of 39.5% of the participants reported some degree of
needs in the physical domain. The mean scores of the three subscales were 39.4±29.2
(sexuality), 29.9±23.4 (physical), and 29.6±19.4 (PC-module), ranking first, third, and fourth
out of the six categories in this instrument respectively. Participants reported several types of
cancer and treatment-related unmet SC needs related to this domain. The highest level of
need was related to the respondents’ sexuality/intimacy (59% “changes in sexual feelings”
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and 45.2% “changes in sexual relationships”), followed by fatigue (49.4% “lack energy /
tiredness” and 46.3% “not being able to do the things I used to do”), and “urinary
incontinence” (44.1%). Additional unmet needs included “hot flushes” (43.1%),
gastrointestinal problems (29.3%), and “pain” (25.5%).
The qualitative interviews revealed similar findings. As reflected in the survey data,
men also complained of urinary dysfunction, fatigue, and sexual problems in interviews.
Urinary dysfunction was reported by 14 out of the 20 men in several forms: urinary
frequency, incontinence, and even caring for a urostomy as the result of the treatments. One
participant shared: “Urination, well, my urination, the doctor who removed the prostate left
me incontinent and I worked real hard with physical therapy, didn't gain anything. So I wear
diapers and I have a penile clamp…”
Approximately 65% of the interviewees reported fatigue to the point of sometimes
interfering with their past hobbies, daily activities, and even socialization. Although some
men stated that part of the fatigue was probably the effect of age, some recognized that it
became more evident after the diagnosis and treatments, particularly after radiation or ADT.
One man said: “I am more tired than I ever used to be. And I've noticed that.”
Loss of sexual function was a primary concern for many of the participants (n=10).
The causes were reported to be either surgery or taking ADT. While one participant seemed
content with his sexual function due to a new pumping prosthesis, others qualified sex as
“inexistent” and talked about the deep effect that it had on their overall QOL and well-being:
“Well, it has an effect on my sexual interest…And I didn't realize before the surgery, how
important that was just to my wellbeing and my mental health”
Some of the participants described additional physical needs not captured by the
quantitative survey. Although unpleasant, most have accepted these needs as expected
consequences of advanced PC and the treatments. Participants talked about hot flushes at
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night, pain, weight gain after taking ADT, and sleeplessness, all of which impacted their
daily life: “There's a certain amount of pain that I have to try and manage. So, the pain, in
some ways, prohibits me from doing things that I would like to do. So, I'd say it's a great
impact.”
1.2. Unmet Emotional Needs
Emotional needs arise from a lack of reassurance and comfort related to living in
distress due to the cancer.26 The mean score of the psychological subscale was 37.6±22.9,
reflecting the second highest reported by the total sample, with 44.4% of the respondents
endorsing some needs in this domain. The greatest reported emotional needs included “fears
about cancer spreading” (62.2%), and “uncertainty about the future” (58%), followed by
“worry about results of treatment” (50%), “anxiety” (46.6%), and “depression”/”feelings of
sadness” (42.6%).
In the interviews, men spoke of emotional health as one of the most affected areas.
Some of the survivors were diagnosed a few years earlier and were still facing unresolved
needs related to feelings of anxiety, fear, or depression. Four men even expressed anger and
regret about the decisions that they had made after the initial diagnosis. They believed that if
they had been better informed, their outcomes, including emotional outcomes, would have
been more optimal and they would not feel angry or regretful. One survivor shared: “And I
wish I knew then what I know now, I guess is what I'm trying to say, regarding just the literal
day-to-day, how is this going to affect your life.”
Nine men also spoke about the emotional consequences of advanced PC and the
treatments, emphasizing that sometimes existential concerns trigger excessive worry and loss
of confidence about the future, mainly due to a possible loss of role within their family: “I
spend a fair amount of time thinking about the future and worrying. It all has impacts. I
spend a lot of times trying to figure out how to deal with the side effects and that takes time

74

away from the things I want to do.” However, only 25% of the participants revealed strong
fear about the disease recurring in the near future. The reason may be that many of those men
already had a recurrent or metastatic disease at the time of the interview.
One survivor talked about the emotional toll of becoming an advanced cancer
survivor. Anxiety was a problem for half of the interviewees (n=10). Consciously or not, they
have suffered from high levels of anxiety at some point during their advanced disease
trajectory: “Sure, definitely as I've mentioned it, I get a kind of a little great worry or anxiety
always kind of running in background” Depression was also a concern reported by 25% of
these men, primarily tied to the effects of surgery or as a consequence of prolonged ADT
treatment: “Initially, I had quite a terrible experience my second year of my cancer. And that
was due to the Lupron, Leuprolide that I was taking. I was severely depressed…”
1.3. Unmet Informational Needs
Informational needs stem from a lack of or insufficient information for adequate
decision-making.26 27.2% of the sample reported some informational needs.
The mean score (29.5±21.5) was the second lowest, after patient care & support. The top two
needs reported under this domain included “be informed about things you can do to yourself
to get well” (34%) and “have member of hospital staff with whom you can talk about all
aspects of condition” (30.8%). All the remaining items had a prevalence of less than 30%.
During the interview, all the participants said that they received information on
advanced PC and related treatments from various sources. These sources were formal,
through their medical team (e.g., pamphlets), or informal, by joining support groups or by
personally researching about topics online. However, up to 80% voiced repeated
dissatisfaction with the type and/or amount of information they received throughout their
journey. For some, the problem arose from the time of diagnosis: “…the conventional
wisdom, the cliché that you're going to get is, "Oh, prostate cancer's no big deal…” For
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others, the information was insufficient regarding the side effects of the therapies: “But the
hormone therapy, the side effects from it, I had no idea what they were. I was told... I was
kind of jokingly told that, "Oh, you're going to have difficulty with a lot of things like sexual
ability, et cetera." And it's injecting the female hormone, so I will have a lot of different
issues that women have with women's hormones. So that was the end of it. It really didn't go
into great detail about it.” Some complained about the lack of information regarding
available sources of support. But no less important was the insufficient guidance regarding
latest treatments developments outside their healthcare team that they could benefit from: “I
think one of the challenges is trying to access kind of more emerging information about for
example, clinical trials that might be going on. Finding that kind of information seem to be a
little bit harder to kind of pinpoint.”
One survivor expressed regret about not asking questions or communicating
effectively with the medical team. However, this was not the only problem. 20% of the
participants explained that they had issues understanding the information received, not
finding the information they were looking for, or feeling anxious about the information
overload: “Well, reading a lot about prostate cancer in itself is anxiety-provoking.”
1.4. Unmet Practical Needs
Practical needs are related to the cancer journey itself and the demands of the disease
on the person and their daily life.26 In total, 25.1% of the survey participants reported some
needs under this domain and patient care & support items had the lowest total prevalence
among the various SCNS subscales, with a mean of 27.2±21.0. Only 22.3% responded
having needs with “hospital staff to attend promptly physical needs”. However, a third of all
respondents wished for “more choice about cancer specialist you see”. Practical needs
stemming from transportation or finances were not specifically measured by any item of the
SCNS or the FACIT, despite the topic coming up during the qualitative interviews.
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Most interview participants felt that they were sufficiently supported regarding their
disease, whether it was by their medical team or the informal internet support community,
and none reported transportation challenges. However, some reported having other unmet
practical needs. 35% explained that, due to the illness and the side effects of the treatments,
they encountered difficulties working around the house. Some even wished they had some
assistance with certain home chores: “I do have difficulty bending over and picking things up.
And so housework, a good stove... I get behind on the housework. I could use help there.
That's for sure.” In addition, finances were also cited as a reason for worry in some cases.
Most participants expressed satisfaction about their medical insurance and monetary situation
but 45% of the interviewees said that paying for the insurance premium or for medical
expenses related to advanced PC was challenging at times: “So, from a financial viewpoint, I
guess we kind of keeping an eye on our situation because we're somewhat anxious over
possible and unanticipated additional medical expenses.”
1.5. Unmet Spiritual Needs
Needs arising from a loss of meaning in life and changed personal values are included
under the spiritual domain.26 The mean FACIT-Sp total score was 27.0±9.2, on a 0-48 scale.
Survey respondents expressed a high level of peace/meaning with a mean subscale of 22.9
(range 0-32). Likewise, their level of faith was expressed as slightly above average, with a
mean of 8.2 (range 0-16). Regarding individual items, 50% of the participants endorsed “My
illness has strengthened my faith/beliefs” and 38.3% endorsed “I find strength in my
faith/spiritual beliefs” as none or little.
Interviews highlighted that 65% of the participants considered that spirituality had a
prominent role in their lives despite individual differences in spiritual beliefs. Most did not
experience any spiritual crises or changes in their relationship with God. For some, their level
of faith grew throughout their cancer journey or came back after a brief turndown:
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“…gradually, I started going back to church to see how it would go, and it came back. I'm
not even sure when and how, but it did. And it's very supportive for me right now.”
None of the participants specifically blamed their disease on themselves or their
beliefs/religion or searched for a special meaning regarding their diagnosis. Overall, their
spirituality and related activities (e.g., church) did not change and they expressed belief that
life had become more precious since the time of diagnosis. However, 30% reported that their
current PC situation had some degree of impact on their spirituality or personal values:
“Okay. I don't hold on to my own life as fiercely as I once did. I'm more content now to see
myself as part of a much larger process…”
1.6. Unmet Social Needs
Social needs derive from affected social roles and/or lack of social support during the
cancer experience.26 Aside from one isolated item included under the health system &
information subscale, “feeling like what you say is not taken seriously by others”, the social
domain was not evaluated thoroughly in the quantitative data. However, “feeling like what
you say is not taken seriously by others” was endorsed as a need in 22.8% of the participants
who completed the survey.
The qualitative data also highlighted the limited impact of advanced PC on social
well-being. The majority of participants explained that their social life was maintained more
or less as usual (e.g., going out to eat, visiting friends or family). Up 50% of the survivors
described having some sort of social support, whether it was family members, spouse,
friends, church, or the medical or internet communities. However, 25% acknowledged PC
having some impact on social life, whether it was in the form of intimacy changes, lack of
understanding, or changes in socialization: “…having cancer is like living in a different
world that a lot of people don't understand and will never.”
1.7. Unmet Psychological Needs
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According to the SCFCC, psychological needs are associated with inappropriate
coping styles or problems with changes in body image.26 The SCNS and PC modules do not
measure any changes in body image but do evaluate coping through three separate items. The
item “learning to feel in control” had 42.5% of respondents expressing some degree of need.
The other two items, “keeping a positive outlook” and “have access to professional
counseling”, showed needs in 37.2% and 32.9% of the respondents respectively.
Interview participants explained that they did not have much difficulty coping with
the disease. Coping mechanisms were varied and included learning to live with it,
considering advanced PC a wake-up call in life, trying to keep a positive attitude, praying,
exercising, or showing resignation:“…it's more it's becoming a resignation, if you will, that
either I'm going to live with this and die from something else or I'm going to die from this.”
However, 4 participants shared having some problems with their coping. A couple of
survivors even admitted needing professional help: “In terms of coping with the
psychological aspect, I realized pretty early on that I was mentally going into a very bad
place, dark place. I knew that I needed to reach out to someone…”
Theme 2: Survivors’ Perception of Quality of Life
In terms of survivors’ QOL, the mean EORTC-QLQ-C30 total score was 78.6±14.6
(out of possible 100). The global health/QOL subscale had the lowest score (68.5±20.8). A
statistically significant negative correlation was found between all the domains of the SCNS
and the total QOL score (all p<.001), indicating that a higher level of unmet needs was
associated with a lower QOL. The correlation magnitude ranged from -.37 (sexuality domain
and QOL) to -.76 (physical and QOL).
Most survivors participating in the qualitative interviews had a positive perception of
their QOL. However, five men spoke openly about the reasons why they believed their QOL
was poor. Often times these reasons were related to the harmful effects of the advanced PC
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therapies: “I feel like I have a good quality of life right now, in part because I'm not in active
treatment.” By contrast, others believed that a lower QOL was associated directly with their
impaired emotional health: “Probably a four, probably sounds terrible but it's more
emotional than it is physical. Quality of life physically, I'm probably an eight. But quality of
life overall, four or five and that's anxiety related…”
Integration of Results
After analyzing both strands of data separately, the integration was completed in a
separate step. A joint display was created guided by the SCFCC domains (Figure 2). Through
triangulation, we were able to note the extent to which both sets of data produce a more
comprehensive understanding of the prevalence and type of unmet SC needs among
advanced PC survivors and the relationship of those unmet needs with QOL through
convergent and divergent points.39 For instance, while talking to participants about their
informational needs (under theme 1), most complained about receiving insufficient
information regarding the various aspects of their condition (grey box qualitative codes,
figure 2). Notably, this was an area of divergence, as the quantitative findings described a
totally different picture (grey bar quantitative mean); only between 17.6% and 34% of the
respondents expressed having unmet needs under this domain.
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Discussion
To the best of our knowledge, the present study is among the first to categorize the
prevalence and types of unmet SC needs in American men affected by advanced PC using a
mixed-methods design. There were several important findings. First and foremost, this study
reported that respondents had unfulfilled needs in every item representing every domain of
the SCFCC. This suggests that these survivors experience a wide variety of unmet SC needs.
Second, we found that more unmet SC needs were associated with lower QOL among these
PC survivors. These findings coincide with multiple past studies conducted in Canada,
Australia, and Europe that suggested an association between advanced PC and greater levels
of unmet needs and poorer QOL in this population.4,11,47 Third, more than fifty percent of the
items in the three instruments used to collect the quantitative data reflected needs in at least
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30% of the participants. This is important for two reasons: (1) most of those needs were also
identified during the qualitative interviews, and (2) the prevalence exceeds the threshold
suggested by the SCFCC, indicating clinically relevant unmet SC needs that have not been
addressed effectively by healthcare systems.26,30
There were several areas of convergence between the two sets of data. Consistent
with prior research reporting high prevalence of fatigue and sexual dysfunction among
advanced PC survivors, both survey and interview respondents identified those as unmet
priority physical SC needs. Further, they explained how both fatigue and sexual issues
interfered with daily life, leading to a range of negative feelings.47,48 Regarding fatigue, most
of these participants explained that they tried to continue with their life as usual despite its
complex and multidimensional effects. Some even described becoming more aware of their
health, and making appropriate lifestyle changes regarding nutrition, for example. This
finding is not supported by some studies that suggested that the level of fatigue did not
improve despite advanced cancer patients’ use of several fatigue-reducing strategies.49,50
Additional research is warranted to explore potential causes for discrepancy.
Sexual dysfunction was found to be the most troubling unmet physical need for
almost half of all participants. Although some differences in the study approach and sample
can exist, this prevalence is similar to findings in other studies.16,48 The survivors explained
that they would have opted for alternative treatments other than prostatectomy or ADT if they
had known the true impact on libido and sexuality. Decision regret has been highlighted as a
common experience by many PC survivors. Past studies have associated decision regret with
lack of literacy or self-education utilizing the Internet as their primary source for information.
51,52 To

ensure that the treatments fulfill the survivor’s expectations and preferences regarding

expected side effects, clinicians must provide individualized information about the expected
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impact of the different treatments on sexual and other body functions consistently and in a
proactive manner.51,53
Another area of convergence included the emotional and psychological domains. As
in other similar studies, many participants felt fortunate having PC over other types of cancer.
They acknowledged several coping mechanisms in dealing with the disease, such as
acceptance or looking at it in a more positive light.54 However, some men also revealed
anxiety and fear regarding their own mortality, the cancer spreading, the future, and the
results of treatments, making them extremely aware about their current situation. These
findings coincide with previous research reporting that 54% of advanced PC survivors
manifest uncertainty, anxiety, or regret about treatment decisions.55,56 Further, it has been
found that between 66% and 84% of survivors from PC and other cancers (i.e., lung)
experience long-term psychological distress and up to 30% clinically relevant levels of
anxiety that need professional involvement.57,58
On the surface, the findings regarding physical and emotional needs appear to be
foreseeable, as the extant literature has associated advanced PC therapies with fatigue, pain,
decreased libido, impotence, anxiety, and existential concerns.4,12,13,21,25 However, the high
prevalence of physical and emotional needs is concerning and may be clinically relevant.
Despite the profound impact that physical and emotional unmet SC needs have on survivors,
despite all the current ACS and ASCO survivorship guidelines, and despite recommendations
to connect survivors to appropriate physical and psychosocial screening and interventions,
the SC they received beyond routine clinical care appears to be suboptimal at best.19,20,56,59
Even though the quantitative and qualitative questions did not match in the practical
needs domain, a lower number of practical SC needs were reported in both strands of data.
Survivors voiced that areas such as choice of treatment, healthcare team, and transportation
were sufficiently met throughout their disease trajectory. However, a few of these men
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encountered difficulties dealing with housework and finances. One previous U.S study
suggested that the survivorship stage can be the most expensive of all.25 The few survivors
still employed struggled with medical expenses or insurance premiums. This burden will
likely continue as they will need further treatments to keep advanced PC under control. More
research is necessary to develop and implement strategies that mitigate practical needs and
prevent financial toxicity among this subset of survivors.60
We found several areas of divergence during the integration process. As reported in
Table 2, quantitative reports of unmet informational needs were relatively low. Furthermore,
no informational needs were included in the top 12 needs categorized in Table 3. This finding
is significant and somewhat unexpected, as during the interviews, 80% of the participants
voiced informational deficiencies at some point during the care process. Although a few
survivors felt highly confident about the amount and type of information received from their
medical team, many highlighted the importance of becoming more knowledgeable through
self-education as a way to cope and stay ahead of the illness.
Treatment side effects affecting QOL, or the existence of more novel therapies that
could have provided long-term benefit were never explained to some of the participants
making them “feel unprepared for future possibilities.” This finding correlates with past
reports of variability in the amount and quality of information that is given to advanced PC
survivors during routine care.61 The discrepancy among the data indicates that more research
is warranted to determine the true sources of these informational deficiencies and the timing
of informational needs. Causes may include medical factors (i.e., healthcare providers seeing
larger amounts of survivors, prioritizing survival to SC), information overload, or patientrelated factors (i.e., stoicism, lack of readiness to learn about harmful effects,
misunderstanding), as suggested by several studies on prostate and rectal cancers.54,62,63
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Findings regarding the spiritual domain were also somewhat mixed. Advanced cancer
may lead to loss of hope, affecting the individual’s body, mind, and soul.64 Up to 79% of
Americans identify with some type of spiritual doctrine despite differences in what
spirituality may mean to them.65 Further, many advanced cancer patients tend to rely on
spirituality to cope with the disease, suggesting that higher levels of spirituality are associated
with better overall QOL and less prevalence of SC needs.66 The majority of our cohort
described various coping strategies and identified that spirituality played an active role in
their life. Despite peace and faith subscales scoring above average, 30% spoke about the
conversion of spiritual health into a different process: “I'm more content now to see myself as
part of a much larger process…” Additional empirical evidence is needed to determine the
true impact of advanced PC on spirituality, a domain that continues to be relatively under
investigated.21
Additional areas of divergence included urinary dysfunction (physical domain) and
depression (emotional domain). While only 44% of the survey respondents reported urinary
dysfunction, a different picture unfolded as the interviews progressed, with 70% identifying
urinary SC needs as a priority. The qualitative findings are congruent with multiple studies
suggesting that urinary functional needs are an unavoidable consequence of some common
advanced PC therapies.11 The same applies to depression, usually associated with ADT and
the times when test results are revealed. This discrepancy makes it difficult to determine if
the depression suffered by these survivors requires professional consideration. More research
in this area is needed to quantify depression and make appropriate recommendations.
The findings from this study categorize the unmet SC needs in advanced PC survivors
from the United States, highlighting the magnitude of the problem. Understanding these
needs is essential as advanced PC survivors will live with these needs for the remainder of
their lives. Most of the identified unmet needs stem directly from the harmful effects of the
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aggressive treatment approaches usually taken to treat more advanced PC stages. However,
some of the SC needs may also be the result of other factors, such as a lack of physical
activity, insufficient contact with an oncology nurse, not having a life partner, not knowing
about the availability of specific treatments or counseling, or informational
deficiencies.25,47,55 For example, several past studies found that survivors who exercise in a
consistent manner or saw cancer specialist nurses throughout the care process reported higher
vitality scores, improved sexual functioning, lower anxiety, and higher wellbeing.67-71 A
study by Oliffe et al. found that married or partnered PC survivors were more prone to seek
help, lowering their chance to suffer from SC needs. Regardless of the cause, men described
an array of ongoing unmet SC needs that warrants further research and addressing by the U.S.
healthcare system.72
Studies exploring the SC needs in advanced PC and other cancers are not new in the
literature. Our results support the assertion that the high prevalence of fatigue, sexual,
emotional, psychological, and informational needs coincides with countries such as Canada,
Spain, France, or the United Kingdom.16,47,63 However, some inconsistencies were also
evident, particularly within the physical (urinary), spiritual, informational and practical needs
compared with past needs assessments conducted in the United Kingdom, Australia, or
Malasya.30,48,73 The similarities and discrepancies may very well be due to cultural context of
the people or the healthcare systems, but they could also be the result of gender differences. It
has been demonstrated that women with breast cancer for example, are more likely to voice
their concerns and needs, and obtain the necessary help.55 Although it was not always the
case of this study, many men still hold fiercely to traditional masculine stoic roles, and it is
possible that they are reluctant to discuss sexual, emotional or physical needs with their
healthcare team. Further research is needed to clarify the implications that these important
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geographical and gender-related factors may have in order to achieve a more patient-centered
SC delivery for all advanced PC survivors.
It is important to note the challenges using the SCNS and the SCFCC. Despite being a
validated instrument previously used on multiple needs assessments, it was difficult to assess
social, practical, psychological, and spiritual needs. This short-coming has already been
reported by at least one other mixed-methods study. Fong et al. recommended the inclusion
of 11 additional items assessing needs in the spiritual, practical, and social domains to
supplement the existing SCNS-SF34, justified by the constructs of Fitch’s SCFCC.74 Using
the SCFCC made the categorization of some of the needs difficult, due to an overlap within
several of the domains. For example, based on the framework, sexual unmet needs could be
classified as either a physical or a psychological need, depending on the investigator’s
perspective. Also, some themes resulting from the study are not currently contemplated
within the SCFCC constructs (i.e., masculine roles, cognitive decline). These minimal but
relevant categorization obstacles might have led to different conclusions and omissions
depending on the researchers’ opinions and interpretations.
Strengths and Limitations
One of the primary strengths of this study includes the use of Fitch´s SCFCC. Despite
some minimal aspects not captured by the framework (e.g., cognitive decline), it addresses a
broad cluster of SC needs experienced by PC cancer survivors, providing a robust structure to
conducting holistic needs assessments in this subset of survivors.26 Additionally, with a
convergent mixed-methods design, the quantitative findings could be further crossmatched
with the qualitative data for common trends, places of disconnect, and aspects that were
missed by the data. Lastly, we chose previously well-validated instruments with high
reliability and validity coefficients used in diverse several cancers past SC needs assessments.
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This study had several limitations. The study was cross-sectional, providing only a
snapshot at the unmet needs at a particular point in time. The sample size was adequate but
was primarily comprised of White, married, retired participants holding a college degree.
However, the sample reflected diversity regarding age, advanced PC stage, treatments
received, and age at diagnosis. Some caution is advised when interpreting these findings. The
needs assessment must be repeated using a larger and more diverse sample of survivors with
advanced PC. Convenience and purposive sampling strategies were used in the quantitative
and qualitative phases respectively. Self-selection bias is likely, and results may not be
generalizable to all advanced PC populations. Although the use of one coder to analyze both
strands of data is a limitation, the tables and the codebook were developed in collaboration
among all the authors, holding regular meetings to enhance trustworthiness. Also, a female
researcher conducted all the data collection. A male researcher may have prompted different
responses from some of the participants.
Implications for Research
The findings of this study complement the existing literature but highlight several
important gaps. First, most previous studies assessing the unmet SC needs in advanced PC
survivors were conducted in countries other than the U.S. More research is warranted to
understand the true impact of these unmet SC needs in this specific population. We also
emphasized some significant variations in the type and prevalence of SC needs compared to
previous work. Most of these men expressed high levels of satisfaction with the overall
cancer care they received. However, ongoing unmet SC needs were present in a relatively
large proportion of survivors regarding physical, and emotional/psychological domains, and,
to a lesser degree, the informational and spiritual domains. Although some survivors felt like
they could go on with their life with a positive attitude and self-education, others were
evidently seeking help. These results are significant enough to recommend further SC
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research. Lastly, quantitative results suggest a preliminary but moderate negative association
between unmet SC needs and QOL—the more unmet SC needs the survivors had, the lower
their QOL. However, for the purpose of this study, this relationship was not evaluated based
on socio-demographic and clinical variables. Additional research is needed to determine if
these needs are dependent or vary according to individual demographic and clinical
characteristics.
Conclusion
Men with advanced PC suffer from a complex incurable disease. Despite being crosssectional, our study provides comprehensive information to understand the prevalence and
types of SC needs in a population that has received limited attention in the survivorship
literature so far. The needs assessment confirms and extends previous work describing the
specific unmet SC needs in a sample of diverse American advanced PC survivors.The
development and implementation of adequate SC is essential, as the prevalence of SC needs
remains high, especially among the physical, emotional/psychological, and informational
domains. To improve QOL and outcomes, the SC must be individualized, multidisciplinary,
and delivered continuously long after the treatments are finalized, as PC is a cancer with a
much longer trajectory than most cancers.
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Abstract
Background: Individualized supportive care has been recommended to prevent and manage
the debilitating effects of advanced prostate cancer and its treatments. Yet, the
implementation of supportive care in practice remains limited and inconsistent.
Methods: PubMed, SCOPUS, CINAHL Complete, ProQuest, and PsycINFO were searched
for relevant studies published between 2011 and 2020. The sample included studies with
original research reporting on a supportive care intervention and including a description of
implementation barriers and/or facilitators. The Theoretical Domains Framework was used to
characterize implementation barriers and facilitators.
Results: We identified 620 articles, out of which 13 met the inclusion criteria. Primary
barriers related to the domains Environmental Context and Resources (time constraints,
reduced access, limited resources), Knowledge (insufficient knowledge on availability and
efficacy of supportive care and technology), and Beliefs About Capabilities (lack of
confidence in materials, difficulty navigating the system, limited competency). The main
facilitators fell under Environmental Context and Resources (partnerships with local services,
uninterrupted availability, supervised group approach), Reinforcement (partners inclusion,
flexible scheduling, multimodality), and Skills (delivery by professionals, specialty nurse).
Conclusions: This review highlighted barriers and facilitators that affect supportive care
implementation. Future research that focuses on overcoming barriers and maximizing
facilitators is vital to improve, modify, or supplement existing supportive care
implementation practices.
Implications for Survivors: As the number of advanced prostate cancer survivors continues
to rise, supportive care has the potential to become standard of care. Future interventions
must incorporate the following: increased knowledge and funding, alternative delivery
models, and consistent use of specialty nurses.
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According to a recent American Cancer Society report, the most common cancers
found in males include prostate cancer, colorectal cancer, and lung cancer [1]. Prostate
cancer (PC) survivors make up to 22% of all United States’ cancer survivors, currently
numbering more than 3.7 million men [2]. Recent incidence data from the Global Cancer
Observatory suggest that the number of new PC diagnoses will rise from 1.3 million in 2018
to 2.3 million by 2040 [3]. Most men are diagnosed with PC at a localized stage. However,
30% of men will progress into regionally advanced or metastatic disease or will suffer a
recurrence at some point during the illness [4,5].
Effectively managing diverse PC morbidities has become a substantial health and
financial challenge. Despite progress in treatments that prolong life, some population-based
studies have reported that many advanced disease PC survivors continue experiencing
devastating and sometimes life-long side effects requiring ongoing supportive care [5,6]. The
American Society of Clinical Oncology and the American Cancer Society have published
guidelines advocating for comprehensive supportive care at all stages of PC. The
Multinational Association of Supportive Care in Cancer (MASCC), founded in 1990, has
defined supportive care as “the prevention and management of the adverse effects of cancer
and its treatment” [7], and includes PC surveillance, evaluation and management of all
treatments’ harmful effects, and psychosocial support [8]. The concept of supportive care has
progressively evolved from the 1960s modern hospice movement, gaining momentum in the
past few years among worldwide health providers and researchers [9]. Furthermore,
supportive care entails the provision of all necessary individualized interventions to meet the
advanced PC survivors’ physical, emotional, social, informational, practical, spiritual, and
psychological needs through the entire cancer care continuum, as advanced PC has a
tremendous impact on the person’s life beyond the physical body [10].
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Despite enhancing PC survivors’ experience of care, rehabilitation, and quality of life
(QOL), the prevalence of supportive care delivery continues to remain consistently low
[11,12,13]. A recent study determined that up to 81% of cancer survivors had unmet
supportive care needs and reported dissatisfaction with current supportive care services [14].
Advanced PC survivors report an array of overlapping supportive care needs encompassing
the emotional, social, psychological, informational, physical, practical, and spiritual domains
[4,5,13,14]. Left untreated, these unmet needs may lead to additional morbidity and distress.
In order to be most effective, supportive care interventions must follow a multidimensional
approach and be provided by a multidisciplinary team in a timely manner [15,16]. Since
every PC survivor is unique, the interventions need to be tailored to the patient’s specific
needs, objectives, and coping style [13].
Given the increasing number of advanced PC survivors and the multidomain needs
they experience, several organizations and agencies have recommended integrating
supportive care services into standard cancer care [16]. However, the implementation remains
complex. The extant literature primarily focuses on the functional outcomes of PC therapies,
survivors’ needs assessments, and barriers and facilitators of PC survivors’ individual
behavior [6,12]. A closer exploration of the barriers and facilitators affecting the
implementation of supportive care in PC using a theoretical framework is critical to
advancing knowledge on the factors that contribute to more sustained and cost-effective
delivery [12]. Thus, the aims of this scoping review are to (1) identify supportive care
interventions for advanced PC survivors using the Supportive Care Framework for Cancer
Care (SCFCC), and (2) synthesize the barriers and facilitators to implementing supportive
care interventions through the lens of the Theoretical Domains Framework (TDF) as reported
by advanced PC survivors and healthcare professionals (HCPs).
Methods
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Theoretical Frameworks
Scoping reviews are helpful in exploring the extent of the literature for topics that are
under-researched [17]. This scoping review was performed with the guidance of two
theoretical frameworks. First, supportive care was defined and the supportive care
interventions in the selected studies were identified using the SCFCC for advance PC. The
SCFCC framework was initially developed to assist clinicians in meeting the unique and
complex needs of cancer patients. It outlines a comprehensive taxonomy of seven domains of
needs, including physical, emotional, informational, social, practical, psychological, and
spiritual [13]. The SCFCC has been used in multiple prior needs assessment studies as well
as in guiding supportive care interventions development worldwide [13,18,19].
Once the interventions were identified using the SCFCC, the TDF provided structure
for classifying and synthesizing the barriers and facilitators in implementing those supportive
care interventions. TDF was initially developed to guide implementation research and has
proved useful in identifying factors affecting the implementation of many types of care
interventions [20]. The TDF can be applied to qualitative and quantitative studies to
understand patients and HCPs behaviors [20]. It is an integrated theoretical framework
consisting of 14 domains: Knowledge; Skills; Memory, Attention, and Decision Processes;
Behavioral Regulation; Social/Professional Role and Identity; Beliefs About Capabilities;
Optimism; Beliefs About Consequences; Intentions; Goals; Reinforcement; Emotions;
Environmental Context and Resources; and Social Influences [20,21].
The TDF uses an evidence-based schema derived from theory that has been
successfully used in many past literature reviews [22]. In a 2020 scoping review, Moncion et
al. used the TDF to describe factors influencing aerobic exercise implementation in stroke
rehabilitation [23]. In addition, TDF was also used by Adrian et al. to identify the barriers and
facilitators influencing HCPs’ behavior in the care of infants with neonatal abstinence

100

syndrome [24]. Accordingly, the TDF provides a useful framework to identify and synthesize
behavioral factors that may affect the implementation of supportive care interventions in PC
survivors suffering from advanced disease.
Design and Search Strategy
This scoping review followed Arksey and O’Malley s’ methodology, which includes
five well-distinguished stages: (1) research problem identification; (2) literature search; (3)
selection of appropriate studies; (4) extraction of the data into a matrix; and (5) summary and
report of the results [25]. The search strategy started by consulting an expert reference
librarian who suggested the use of Boolean operators and MeSH terms to find the most
relevant studies. The following electronic databases were searched: PubMed, SCOPUS,
CINAHL Complete, ProQuest, and PsycINFO. The following key search terms were
searched in each database: (prostate cancer OR prostate neoplasm) AND (interventions OR
intervention OR programs OR program) AND (supportive care). We decided not to include
the term implementation in the search strategy, as this may have significantly limited the
number of studies involving supportive care interventions relevant to the review. Hand
searching of the resulting studies’ reference lists identified additional pertinent articles for
evaluation.
Inclusion and Exclusion Criteria
Studies were eligible for inclusion in this review if they reported quantitative,
qualitative, or mixed methods original research. Studies had to (1) include a supportive care
intervention or program directed at advanced disease PC survivors and (2) have a direct or
implicit description of the barriers and/or facilitators to implementing the intervention. For
the purpose of this review, a barrier was defined as any “circumstance or obstacle that keeps
people or things apart and /or prevents communication or progress,” whereas a facilitator was
described as “a person or thing that makes something possible” [22]. Exclusion criteria
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consisted of other types of cancers, studies focusing on solely localized PC, reviews, and
unrelated subjects such as pharmacological or surgical interventions. The search was limited
to studies published in English from 2011 to 2020 to ensure that the most recent studies were
included. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement guided the articles selection to ensure methodological rigor (Figure 1)
[26].
Data Extraction and Analysis
The database search identified 620 potentially relevant articles. Two additional
articles were added from the reference lists hand searches due to relevance to the topic. After
duplicates were removed, the first author independently screened 478 titles and abstracts for
eligibility. A final count of 35 articles underwent a full-text evaluation by the first author
with 22 articles excluded for being non-original research (n=9), describing other than
supportive care intervention implementation (n=12), or investigating localized PC only (n=1).
Twenty percent of the title, abstracts, and full text were reviewed by a second reviewer (SQ)
for validity and trustworthiness of the studies selected. Ultimately, all authors agreed to
include a total of 13 articles meeting the inclusion and exclusion criteria.
The primary goal of data extraction includes drawing a rigorous conclusion about the
research problem by ordering, coding, categorizing, and synthesizing the data from the
selected studies [25]. The data extraction process was based on prior literature and guidance
to perform systematic scoping reviews. The following data were ordered, extracted, and
exported into a comprehensive evidence table: author(s), year, purpose, design, setting,
sample, intervention, key results, TDF domain, and level of evidence (Table 1). Any
facilitators or barriers identified in the selected studies were critically appraised and classified
according to the 14 domains of the TDF to facilitate the analysis of issues and variable
characteristics (Table 2 & 3). Despite not being required for scoping reviews, the sample’s
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level of evidence was also evaluated using the John Hopkins evidence level and quality guide
[27].

Figure 1. PRISMA flow diagram of the study selection process.

Results
Study Characteristics
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Table 1 displays an overview of the selected studies’ characteristics. The sample of
studies included original intervention research, and all were published between 2011 and
2020. Six of the studies used a quantitative methodology, of which three were randomized
controlled trials [29-31], one was a retrospective cohort study [6], and two were crosssectional descriptive studies [32,33]. The remaining seven studies utilized either a qualitative
design (n=4) [22,34-36], a mixed-methods methodology (n=2) [37,38], or a quality
improvement design (n=1) [28]. The chosen studies also represent wide geographic settings,
as they were undertaken in Canada [7,28,33,37], Australia [22,29,34,36,38], or the United
Kingdom [30-32,35]. All 13 studies included a sample of advanced stage PC survivors
(stages III, IV), either exclusively or in combination with other stages. Five studies included
the partners or caregivers in the program [28,30,33,35,37]. Only one study applied the TDF
or any other conceptual theory to guide the design and the categorization of the results [22].
Regarding the studies’ levels of evidence, three provided a level I, two studies a level II, and
eight studies a level III. Every study was included in the review due to the relevance to the
topic and the valuable information it provided regarding barriers and facilitators to supportive
care implementation.
Supportive Care Interventions
Numerous resources, including past literature and several published clinical
guidelines, assist HCPs in developing and implementing appropriate interventions according
to the survivor’s domains of need (physical, emotional, social, spiritual, informational,
practical, and psychological) [13,39,40]. Figure 2 displays the supportive care interventions
implemented in the sample of selected studies, categorized according to the SCFCC domains
of needs. Many interventions in the selected sample of studies addressed the SCFCC
informational domain (n=6). PC survivors were informed or educated about various topics
such as nutrition, side effects of the treatments, psychological management, or available
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resources for PC [28,30-32,35,37]. Five interventions addressed the physical domain,
whether it was by implementing an exercise program, a pelvic muscle rehabilitation
intervention, yoga training, or by applying principles of a healthy diet [7,28,29,33,34].
Mindfulness, psychosexual therapy, and yoga covered the emotional domain in three of the
studies [32,33,38]. Most interventions (n=9) addressed the social domain by implementing
them in a group format, motivating relationships, collaborative activities, and camaraderie
[22,29,30,32-37]. Interventions delivered by teleconference, conducted online, or
emphasizing individual needs assessment addressed the practical domain by decreasing the
demands on the individual’s life at home [22,30,35,36,37].

Some programs aimed at alleviating several domains of needs, such as psychosexual
counselling or coping skills development, which addressed not only the emotional domain
but also the psychological domain [7,31]. By contrast, the spiritual domain was the only
domain not addressed directly by any intervention; however, programs focusing on supportbuilding or yoga may have an effect in strengthen PC survivors’ personal sense of meaning in
life and spirituality [13,22,33,36]. Some interventions involved the survivor alone, and some
involved the survivor and their partner/caregiver [30,33,35]. The instruction methodology
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differed from accredited HCPs being in charge of the implementation [22,29,31,32-34,36] to
nurses or implementation [22,29,31,32-34,technicians facilitating the sessions [7,28,30,35,37,
38].
Barriers and Facilitators to Supportive Care Interventions Implementation
All 13 studies in this sample included facilitators and/or barriers to implementing
supportive care interventions for advanced PC survivors, whether they were directly
mentioned or indirectly discussed [7,22,28-38]. For each study, the number of barriers ranged
from zero to 15, and the number of facilitators ranged from zero to 10. A total of 137 factors
were identified in the selected articles, with 58 coded as barriers and 79 as facilitators,
according to the TDF constructs. In nine studies, patient-related and healthcare providersrelated (HCPs) barriers and facilitators were identified [7,22,28,30,31,33-35,37,38], while the
remaining four studies involved HCP perspectives exclusively [29,30,32,36]. Twelve studies
addressed both barriers and facilitators, with one study addressing only facilitators [29].
All 14 TDF domains were represented across the sample, and barriers and facilitators
were coded across the 13 out of 14 TDF domains. No barriers were mapped under Emotion
and no facilitators were found coded under Behavioral Regulation. The TDF domains most
frequently identified for barriers included Environmental Context and Resources
[7,22,28,29,31-38], Knowledge [22,28,30,32-34,36,37], and Beliefs about Capabilities
[21,27,30,34,36]. Facilitators fell most frequently under Reinforcement [7,22,28,30,3235,37,38], Skills [28,30-33,35,37], and again Environmental Context and Resources. Two
factors —“partners/caregivers’ involvement” and “accessibility to the program” (one
centralized location)—were identified as both barriers and facilitators, depending on the
stakeholders’ perspective. Three other factors were given codes from two different TDF
domains. For example, “discomfort posting on forums” and “muted preferences on
supportive care due to stoicism” were coded under Social/Professional Role and Identities
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and Social Influences. The facilitating factor of “materials/software easy to understand” was
mapped to the TDF domains of Skills and Beliefs about Capabilities. The results were
arranged giving a special emphasis to the three most influential TDF domains under which
the numerous barriers and facilitators were found. Then, factors under the remaining TDF
domains were subsequently described. To summarize the data, Table 2 lists the frequencies
and percentages of every barrier and facilitator found per TDF domain. Table 3 summarizes
all the identified factors and the corresponding TDF domains per each study included in this
review .
1. Barriers
1.1.Environmental Context and Resources Domain
The most predominantly identified barriers to supportive care implementation appear
to be in the Environmental Context and Resources (ECR) domain, which includes constructs
such as resources/materials used during the intervention, organizational climate or culture of
the facility, interactions between the persons (HCPs/patients) and the interventional
environment, or environmental stressors (e.g., location, time of the day) [21]. All studies
except for one identified barriers under the ECR domain. Major barriers to supportive care
implementation included time constraints, lack of sufficient resources, and reduced
accessibility to the programs. For example, additional survivors could have benefited from a
yoga program if accessibility had been boosted by a clearer physician referral pathway [33].
Despite the benefits reported from a group mindfulness intervention, only 38.5% of the
participating survivors agreed with the excessive time commitment to carry out all the
program activities and requirements [38]. HCPs specifically reported challenges with their
conflicting schedules as well as time constraints to promote or deliver supportive care due to
an increase in patient overload during office hours [33,36]. Scarce resources (e.g.,
technology) and lack of funding to offer the interventions to larger groups of survivors were
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two of the largest barriers to appropriate implementation, reported in four of the studies
[22,28,31,32]. Further, limited funds leading to long waiting lists for survivors to be called
has been suggested to impact optimal program implementation [32].
1.2 Knowledge Domain
The second most predominant domain was Knowledge, which includes knowledge
about how to proceed with a supportive care intervention as a patient or as a provider,
knowledge about the condition/scientific rationale (e.g., benefits) regarding the intervention
implementation, and knowledge of task environment [21]. In five separate studies, both
survivors and HCPs described lack of knowledge regarding supportive care programs
availability and effectiveness, variations in HCPs’ expertise on supportive care, challenges
maintaining knowledge currency, and deficient technology proficiency, as barriers to
implementing supportive care programs appropriately (Table 3) [22,28,30,36,37]. For
example, two studies reported HCPs’ notable unawareness of the importance and benefits
that physical activity may provide to these survivors [33,34]. Ralph et al. conducted two
consecutive studies in 2019 and 2020. The first one aimed at understanding the
implementation context of a telephone-based nurse-led supportive care intervention, and the
second one at identifying barriers and potential solutions for an optimal implementation
[22,36]. The data collected during those two studies suggested that the frantic speed at which
treatment options for advanced disease PC are progressing and the uncertainty about which
treatment provides survivors the most benefit (based on their clinical characteristics) create
challenges for clinicians to keep up with the latest developments on supportive care in terms
of effectiveness. Since advanced PC is a progressive disease with a long trajectory, being
aware of the newest advances is essential, as information may lose relevance over time [22].
Additionally, wide variations in HCPs’ knowledge and expertise regarding supportive care
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within the same health system or region create difficulties for developing more standardized
supportive care plans that meet the recommended survivorship guidelines [30].
1.3 Beliefs About Capabilities Domain
The third most common TDF domain, Beliefs About Capabilities, addresses HCPs’ selfconfidence in implementing a supportive care intervention or in carrying out the activities of
the intervention, perceived professional competence, self-efficacy, perceived behavioral
control, beliefs in being capable of delivering or receiving the intervention, self-esteem, and
empowerment [21]. Five separate barriers were identified in three studies concerning this
domain. The barriers were associated primarily with the program materials/resources or the
delivery methodology. For example, many survivors expressed their discomfort with posting
personal or clinical information on the online program forum, because they believed that they
lacked the necessary proficiency to avoid unforeseen loss of confidentiality [37]. In the same
study, HCPs believed that a purely online format was not always an acceptable format for
intervention delivery, advocating for more hybrid formats that facilitate every survivor’s
capability and learning style [37]. A separate qualitative study exploring the experiences of
survivors, partners, and the interprofessional team with a multimodal supportive care
intervention found that patients were not always capable of navigating the health system in
search for adequate supportive care [35]. Additionally, HCPs experienced a moderate degree
of frustration addressing certain topics with their patients, such as sexual dysfunction,
therefore not meeting the survivors’ needs and expectations effectively [31]. This frustration
could stem from a lack of competency in those fields or conflicting professional capabilities
[35,41].
1.4. Additional Identified Barriers
Several other barriers were identified in the sample of studies (Table 3). Three studies
found that limited training of HCPs in oncological supportive care (Skills) was a major
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barrier to the implementation of the intervention [22,28,31]. Interprofessional disagreement
regarding the intervention focus (e.g., weight management versus disease progression),
coordination challenges, and persistence of survivors’ traditional masculine roles
(Social/Professional Role and Identity) decreased the uptake of supportive care despite the
high demand [22,28]. Survivors also described feelings of discomfort and anxiety posting
personal information in interventional online forums or voicing personal preferences
regarding certain supportive care modalities (i.e., sexual rehabilitation, mental health) due to
fear to opinions and reactions from the surrounding environment (Beliefs about
Consequences) [22,37].
Three barriers were identified under Goals, which were associated with not meeting
the survivors’ needs, the partners’ expectations, or not easing coordination of the program
[22,28,32]. For example, data from a nutritional education intervention suggested that
additional objectives, such as describing the role of certain nutritional components,
addressing individual nutritional concerns, and practical meal planning tips, should have been
included as part of the intervention description [28]. One other study reported that survivors
tend to prioritize treatments that extend life over supportive care, complicating HCPs’
referrals to appropriate programs (Intentions) [22].
Because of the existing social norms and stigma around PC, survivors identified
social pressure as a barrier to seek supportive care when needed (Social Influences) [22,36].
However, they also found motivators to participating in certain programs involving
mindfulness or peer navigation, for example. Studies that prevented caregivers from
participating in the intervention activities or that lacked a complete in-person interaction were
found to incentivize participation and continuity the least (Reinforcement) [37,38]. In some
cases, successful implementation meant empowering survivors enough for them to break old
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habits (e.g., sedentarism or poor diet) or make them believe in the benefits that the supportive
care intervention can bring into their daily life (Behavioral Regulation) [22,31].
Some pessimism was identified among survivors whose PC was managed exclusively
by urologists (Optimism) [22]. One study specifically reported that supportive care is a field
that may fall outside the scope of practice of this type of HCPs. Thus, survivors are forced to
live for long periods of time with the side effects of the treatments believing that they cannot
obtain an appropriate referral from these medical specialists leading to gloomy feelings.
Furthermore, many of these specialists did not revisit important information regarding PC
and supportive care processes (Memory, Attention, and Decision Processes).
Facilitators
2.1 Environmental Context and Resources Domain
The most predominantly identified facilitators also fell under the ECR domain and
included recognition of the extra resources (e.g., locations, educational materials) and
capacity (e.g., staff) needed to deliver the intervention (Table 2) [32]. Partnerships with local
PC support groups and supportive services enabled to approach and care for larger groups of
survivors with different needs at once [32,37]. Uninterrupted availability of supportive care
programs during longer periods, such as in exercise programs, as well as increased
accessibility to the program professionals via in person or technology were essential to
maintain the beneficial effects of the intervention over time [28,29,31,35]. Cultural
competency, such as using translators and linguists, brought a robust sense of self-efficacy to
the providers in charge in the ability to implement a supportive care program more
effectively [36]. Structured, supervised group approaches were also reported in two separate
studies, not only as implementation facilitators, but also as a way to deliver more costeffective programs reaching a greater number of survivors simultaneously [34,38].
2.2. Reinforcement Domain

111

The second most predominant domain for facilitators was Reinforcement, which
relates to rewards (e.g., benefits) from completing an intervention or program, incentives for
participation (e.g., financial compensation, further referrals), consequences from not meeting
the patients’ needs or not completing all the prescribed activities, reinforcement,
contingencies, and sanctions due to procedural errors, for example [21]. Fifteen facilitators
were identified in ten separate studies under Reinforcement. These facilitators were primarily
associated with the inclusion of the partners/caregivers during the intervention, flexibility in
scheduling interventional sessions, and the multicomponent approach taken with the
intervention. Four of the studies found that involving direct caregivers in the intervention
activities led to higher patient engagement, increased social and emotional support, and
enhanced information retention due to the additional reinforcement provided by the
partners/caregivers [33-35,37]. HCPs reported that flexibility in scheduling the intervention
sessions helped meet the survivors’ needs in terms of time and location, encouraging
accessibility and reach [32,38]. Multimodality in intervention delivery (i.e., combining
several different modules or activities) was also essential to incentivize participation among
advanced PC survivors [22]. Furthermore, five separate studies determined specifically that
the multicomponent delivery option offered a more comprehensive view of the disease and
the treatment side effects, promoting a more holistic care to meet the survivors’ supportive
care needs and expectations [7,28,32,35,38].
2.3. Skills Domain
The Skills domain was the third most prevalent domain, and it is associated with the
necessary skills to deliver supportive care, skills development (e.g., HCPs’ continuing
education on the latest developments; patients’ increasing abilities in terms of the
intervention activities), competence to implement this type of programs, ability, skill
assessment, interpersonal skills to encourage participation, and practice/professional
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experience with this line of work [21]. Interventions that were supervised and moderated by
accredited, trained professionals, such as nutritionists or exercise physiologists, reported
positive results on the outcomes and a higher level of satisfaction among participants
[29,31,32,34,36,38]. For example, in a mixed-methods study to investigate the acceptability
and effectiveness of a supervised mindfulness-based cognitive therapy delivered by
psychologists, the authors reported statistically significant improvements in the survivors’
level of anxiety (p=.027), avoidance (p=.032), and mindfulness skills after three months of
implementation (p=.019) [38]. Through qualitative interviews, exercise physiologists were
identified as pivotal in helping participants understand the physiological and psychosocial
benefits of exercise [34]. Two additional studies endorsed the use of trained nurse specialists
in the delivery of supportive care, as it was found that this approach enhanced survivors’
well-being [31,36]. This delivery strategy is well supported in the existing literature and has
demonstrated feasibility and cost-effectiveness. Additionally, the ability to develop
alternative gentle physical activity options for advanced disease PC survivors such as yoga,
was found to be a facilitating factor. Not only was the program successfully implemented, but
it also reported high adherence (87%) and statistically significant results in improving mood
(p=.000), fatigue (p=.000), and stress (p=.004)[33].
2.4. Additional Identified Facilitators
When HCPs had clear referral pathways and evidence-based information at hand on
how to provide patient-centered supportive care (Knowledge), it facilitated survivors in
obtaining appropriate interventions in a more timely manner [32,36]. Further, when
supportive care interventions and health awareness campaigns were individualized with
tailored shared objectives (Goals), it helped address supportive care needs in a more holistic
manner, whether it was by increasing participation or reducing social stigma about advanced
PC [22,30,31,35,36]. Interventions that intentionally approach supportive care holistically
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have been found to be more cost-effective in addressing more supportive care needs at once
(Intentions) [35].
Certain intervention materials and resources provided confidence to support goals or
intentions in facilitating a supportive care intervention (Beliefs about Capabilities). For
example, a Peer Navigation Training Program was found to be feasible, acceptable, and
effective in promoting eHealth literacy and satisfaction because participants felt capable of
using the intervention materials [37]. User-friendly sessions enhanced empowerment and
benefits in a separate nutrition educational program [28]. However, an optimistic team
climate has also been found to be helpful (Optimism) as the demand for specific supportive
care interventions can sometimes be high when the availability is low [36].
Appropriate program length, inclusion of a multidisciplinary team, and adapting the
intervention to the most common masculine ideals were reported as facilitators in four
separate studies (Social/Professional Role and Identity). These factors led to a network of
services that was more comprehensive, had better control of advanced PC side effects, and
higher completion rates (88%) [28,31,32,34]. Likewise, small group and social learning
formats indicated better intervention adherence (87%), social identification, information
retention, and a strong bond of camaraderie among participating survivors [29,33,34,37,38].
Equally important for implementation success were
continuous program evaluations and diary keeping (Memory, Attention, and Decision
Processes) or program safety (Beliefs About Consequences) as they helped facilitating
session planning, benefits, sustainability, and currency over time [29,31-33].
In addition to all added benefits, supportive care interventions have also been found to
be the optimal setting to share experiences. These opportunities often led to higher emotional
cohesion among the participating survivors, which subsequently, increased attendance
(Emotion) [33]. The same benefits were seen in the case of authentic in-person interaction
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and role-playing formats, which were highly valued and contributed to enhancing selfefficacy and e-Health literacy [37].
Discussion
This scoping review examined the barriers and facilitators to supportive care
implementation in advanced PC, focusing primarily on the most prevalent domains of the
TDF. Advanced PC survivors report a wide range of supportive care needs due to the effects
of cancer and its various therapies. Effective supportive care interventions can assist with
preventing and managing the harmful effects at the physical, emotional, social,
psychological, informational, practical, and spiritual levels to improve outcomes [13]. All the
studies in this review focused on supportive care and identified barriers and facilitators to its
implementation. However, there was considerable variation among the supportive care
interventions regarding focus (e.g., physical activity and mindfulness), content (e.g., nutrition
education and aerobic exercise routines), method of delivery (e.g., in-person, online and
group sessions), and expected outcomes (e.g., domain of needs) (Table1). The studies
revealed a wide range of barriers and facilitators related to all TDF domains, further
sustaining the multifaceted nature of supportive care implementation in advanced PC.
Stakeholders consistently reported that the absence of the barriers or the enhancement of
facilitators would significantly benefit the implementation of more patient-centered
supportive care programs [7,12,22,28-36,38,42]. Therefore, future research and action must
be directed towards these goals. It is important to note that the study sample explored patient
and HCP perspectives regarding barriers and facilitators, with slightly more studies focusing
on HCPs alone [7,21,29,31-33,35-38]. For both barriers and facilitators, individual factors
(e.g., time constraints, in-person interaction) and contextual factors related to all organization
levels (e.g., scarce resources, multiapproach programs) were identified.
Barriers Affecting Supportive Care Implementation
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The majority of the studies’ participants viewed supportive care implementation
positively, highlighting more facilitating factors than barriers (Tables 2 and 3). More barriers
were referenced under ECR, Knowledge, and Beliefs about Capabilities domains. Commonly
perceived barriers under Knowledge included unawareness of supportive care interventions
availability and/or effectiveness, variations in providers’ knowledge and expertise, lack of
technical proficiency, and challenges keeping up with the latest developments in PC
supportive care [22,28,30,33,36,38]. This mirrors the results of published studies conducted
with PC and other cancer survivors which found that many supportive care programs are not
accessed either because the survivors are unaware of the programs or because the HCPs lack
adequate prostate-specific expertise [10,43]. Further, some of those studies reported that
HCPs often focus on seeking information regarding disease progression, prognosis, or the
physical aspects of the disease, encouraging patients to seek support through peer groups
[10]. In order to provide PC survivors with optimal supportive care that meets all their
complex needs, it is vital for HCPs to possess the requisite knowledge regarding supportive
care during survivorship and act proactively in prescribing the appropriate interventions
[16,43]. HCPs have expressed willingness to further their PC supportive care-specific
knowledge so that needs identification and care coordination can be carried on more
effectively [43].
Survivors and HCPs have expressed that a lack of adequate resources and
accessibility to interventions, as well as time commitments, are major barriers under the ECR
domain [7,22,28,31-33,36,38]. Previous studies have reported that the urologist is the
provider who predominantly delivers information and prescribes services to advanced PC
survivors [12]. Furthermore, some researchers have found that HCPs are sometimes
responsible for caring for a growing number of survivors in already overly stressed healthcare
systems, inhibiting them from allocating sufficient time and attention to their patients’
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supportive care needs [10,43]. For example, in line with our findings, a study conducted with
metastatic PC survivors and their partners showed that up to 36% of the HCPs shared an
apparent desire to improve supportive care by allocating further resources, such as increased
access to specialty nurses, in-home nursing care and education, more time and locations, or
access to support groups [10,14,23].
Additional barriers worth mentioning included “discomfort to post in online forums”
(Beliefs About Capabilities, Beliefs About Consequences), “male stoicism or stigma”
(Social/Professional Role, Social Influences), “a purely online as an always acceptable
format” (Beliefs About Capabilities), and “lack of program comprehensiveness” (Goals)
(Table 3). Many studies have highlighted the fact that men are often reluctant to seek support
as it reflects traditional male norms of being stoic, strong, and capable [5,44]. “Masculinized”
supportive care interventions (e.g., exercise and education) that connect survivors could
promote male camaraderie, positive masculinities, and commitment to solving shared
advanced PC issues, particularly pertaining to emotional support [45,46]. Despite the Internet
offering a convenient and cost-effective way to provide supportive care to advanced PC
survivors by narrowing social disparities, many providers have expressed that an exclusively
online format is not always an acceptable format [37,47]. Survivors favored care modalities
with additional in-person interaction, which has also demonstrated a better acceptance in a
study conducted with breast cancer survivors [48].
Facilitators Affecting Supportive Care Implementation
Most perceived facilitators were derived from the ECR, Reinforcement, and Skills
domains. Stakeholders particularly appreciated interventions that were conducted in small
groups [29,33-35,38], involving additional local PC support services [32,37], and providing
greater access to a specialty nurses or accredited therapists [29,31,32,34,36-38]. Supportive
care interventions delivered in a group format, whether in person or via technology, were
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found to significantly improve outcomes such as social support or social well-being in past
studies [35,49,50]. In addition, supportive care interventions based on established
partnerships with available PC support groups and community services increase accessibility,
reduce centralization, and address individual survivors’ needs more effectively [32,37]. This
finding is supported by a study conducted in Michigan that tested a partnership between
several academic health providers, PC support groups, and PC survivors and their partners in
facilitating broader dissemination of supporting information materials directed at PC
survivors [51].
A notable finding of this review is that a nurse specialist in the role of primary
intervention deliverer was regarded positively in more than 50% of studies [29,31,32,34,3638]. Despite supportive care interventions being implemented by providers from diverse
health disciplines, a significant imbalance of nurse specialists in caring for PC survivors was
found in several studies [10,52]. For example, a qualitative study conducted in Australia with
PC survivors found that the inclusion of nurses with oncology expertise in the
multidisciplinary team increased care coordination and overall well-being in this population
[46]. Additional separate studies determined that supportive care delivered by PC specialist
nurses improved satisfaction, coordination, and continuity of care at the different points of
the cancer journey making the role of nurses an increasingly integral part of multidisciplinary
supportive cancer care [10,52,53]. Limited nursing-led supportive care may be due to
insufficient training in provision of supportive care, limited resources for coordination, or the
actual structure of the specialty cancer services [54,55]. However, it appears evident that
despite the existing variations, nurse-led programs demonstrated higher retention and
satisfaction rates and have the potential to overcome some of the implementation barriers
previously mentioned (e.g., time constraints, better use of limited resources, disjointed care).
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Other facilitators to supportive care implementation included “multimodal
intervention” (Reinforcement), “inclusion of partners/caregivers” (Reinforcement),
“appropriate intervention length” (Social/Professional Role and Identities), and
“materials/software easy to use and understand” (Skills and Beliefs About Capabilities)
[7,22,28,32,35,37,38]. Despite the benefit of connecting with other men facing similar needs,
involving caregivers in the programs appears to have a reinforcing role and to improve the
wide range of unmet needs of the dyad as a whole [35,56].
There were three additional findings from this review. First, some factors, such as
“discomfort posting on forums,” “muted preferences on supportive care due to stoicism,” or
“materials/software easy to understand” were coded under several TDF domains. Additional
work needs to focus on developing clearer operational definitions of each domain and the
associated constructs so as to avoid “overlap” between domains [57]. Second, there were no
facilitating factors found under the Behavioral Regulation domain. This can be an area of
potential future research as behavioral regulation is key to sustain new healthier habits over
time. Third, there was a notable lack of information available regarding barriers and
facilitators of supportive care implementation from the United States, as all 13 studies were
conducted in Australia, Canada, or the United Kingdom. This review has synthesized some of
the factors but the extent of their role as well as the actors involved remain unknown.
Strengths and Limitations
There are several strengths to this scoping review. An expert reference librarian
assisted with the search keywords, databases, and overall strategies. There was a variety of
settings, supportive care programs, and study designs within the selected sample of studies.
Additionally, Arksey and O’Malleys’ rigorous methodological framework, along with the
SCFCC and TDF, helped guide the synthesis of the evidence and the organization and
interpretation of the findings, respectively. The use of theory has proven to enhance the
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understanding of how and why the interventions are developed and implemented successfully
[58].
However, several limitations must also be acknowledged. Although most studies
included both survivor and HCP perspectives on supportive care implementation, more
studies focused on the HCPs’ opinions exclusively, which could have altered the
interpretation of the results [7,22,28,30-33,35 -38]. In addition, despite their high
methodological quality, only three out of the 13 studies provided level I evidence. Studies
were limited to the English language and the last 10 years, resulting in the possible omission
of relevant information. Finally, the review was primarily conducted by one reviewer,
increasing the risk of bias.
Implications for Survivors
As therapies for advanced PC continue to improve, there will be a growing number of
advanced PC survivors, particularly in developed countries [48]. This scoping review
expands understanding of the factors that may influence supportive care implementation for
this population. Overcoming existing barriers and enhancing facilitators has the potential to
better inform future research regarding how to develop and implement more cost-effective,
patient-centered supportive care interventions that meet all PC survivors’ needs. Based on the
results of this scoping review, future supportive care initiatives must focus on the following
critical elements to close the existing knowledge gap: (1) improving accessibility and
knowledge, increasing resources, considering several formats of supportive care, and
overcoming masculine help-seeking behaviors; (2) giving special attention to factors that are
coded under the ECR domain, whether as a barrier or a facilitator, as they are significantly
more prevalent, and (3) developing and implementing nurse-led programs, as they have
demonstrated efficacy and high levels of satisfaction among PC survivors.
Conclusion
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Our scoping review has highlighted the multifactor barriers and facilitators affecting
the implementation of supportive care in advanced PC survivors. The findings from this
review are unique because, for the first time, these factors were categorized and classified
according to the TDF domains. The resulting knowledge provides details about the barriers
that need to be addressed and the facilitators that can be maximized to develop and deliver
supportive care to advanced PC survivors. Future research must focus on improving,
modifying, or supplementing current supportive care implementation practices. This scoping
review contributes to the existing literature with novel findings that will help bridge the
existing knowledge-practice gap.
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Table 1. Evidence Table of Selected Studies

Authors
(Year)

Study Purpose

Design

Setting;
Sample
(N)

Bender JL,
Flora PK,
Milosevic
E, et al.
(2020)

To evaluate the
feasibility,
acceptability, and
effectiveness of the
Peer Navigation
Training Program
among prostate
cancer survivors

Explanatory
sequential
mixed methods

Toronto (Canada)
Survivors &
Caregivers
(N=28)

Intervention
Type

Educational
Online Peer
Navigation
(12 weeks)

Primary Results

Online training program
feasible and acceptable

Factors

TDF Domains

Level
Evidence

Facilitators;
Barriers

Knowledge
Beliefs about capabilities
Beliefs about consequences
Reinforcement
Intentions
Environmental
context/resources
Social influences
Emotion

III

Facilitators;
Barriers

Skills
Reinforcement
Environmental
context/resources
Social influences

III

Satisfaction score 9.4/10
Perceived usability
84.5/100
Statistically significant
differences in learning
(p<0.0001)
Self-efficacy increase
(p<0.0001)
Increase in eHealth
literacy (p<0.0001)

Chambers
SK, Foley
E, Galt E, et
al. (2012)

To investigate the
acceptability and
effectiveness of
mindfulnessbased cognitive
therapy for men
with advanced
prostate cancer

Pilot
exploratory
mixed methods

Queensland
(Australia)
Advanced
prostate cancer
survivors
(N= 9)

Group
mindfulness
sessions +
written manual
(8 weeks)

Improvements in anxiety
(p<0.027), avoidance
(p<0.032), and fear of
recurrence (p<0.062)
No QOL differences
Increased mindfulness,
non-significant
Urban group quotas ideal;
low quotas in regional
groups
Qualitative themes: (1)
group identification; (2)
acceptance of diversity;
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(3) peer learning; (4)
acceptance of disease
progression

Cormie P,
Turner B,
Kaczmarek
E, et al.
(2015)

Cormie P,
Taaffe DR,
Spry N, et
al. (2013)

To provide an indepth description of
the experience of
exercise programs
among men
with prostate cancer
and to identify
elements critical to
optimizing patient
engagement and
participation

Qualitative

To report the effect
of a 12-week
exercise program on
sexual activity in
prostate cancer
patients

RandomizedControlled
Trial
(2-armed)

Perth, Australia
Prostate cancer
survivors
(N=12)

Group aerobic
and resistance
exercise sessions
(12 weeks)

Themes:
(1) Health-related
benefits: physical and
mental well-being

Facilitators;
Barriers

Knowledge
Skills
Social/professional role
identity
Optimism
Reinforcement
Environmental
context/resources
Social influences

Facilitators

Skills
Beliefs about consequences
Environmental
context/resources
Social influences

I

Facilitators;
Barriers

Knowledge
Skills
Social/Professional role and
identity
Reinforcement
Goals
Memory

III

(2) Support from exercise
physiologists as
educational resource

III

(3) Peer support: social
connections and
camaraderie

Western Australia
Prostate cancer
patients
(n=29)

Moderate to high
intensity group
resistance and
aerobic exercise
(12 weeks)

Usual care (n=27)
(N=56)

Intervention group:
Level of sexual activity
maintained
Statistically significant
changes in general health,
vitality, physical health
Statistically significant
higher percentage in
interest in sex
No difference in sexual
function scale between
groups

Ferguson J
& Aning J.
(2015)

To describe the
early experience
and impact of
implementing a
nurse-led service
model

Descriptive

Newcastle, U.K
Men with prostate
cancer
(N=76)

Face-to-face
appointments
with nurse
specialist
(tailored care)
and Living With
& Beyond
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90% participants reported
engaged in at least one
component of the program
High user satisfaction

Hedden L,
Pollock P,
Stirling B,
et al. (2019)

To examine
registration rates,
timing/intensity of
follow-up with
prostate cancer
supportive care.

Retrospective
cohort

Vancouver,
Canada
Patients with
prostate cancer:
participated in the
program (n=526)

To explore clinical
and sociodemographic factors
associated with
participation and
non-participation

Did not
participate
(n=92)

educational
course
(6 weeks)

Reported improvement in
QOL

Prostate cancer
supportive care
(PCSC) program
with individual
clinical
appointments
and group
educational
sessions

Men on ADT had
significantly lower odds of
registering

Environmental
context/resources

Facilitators;
Barriers

Reinforcement
Intentions
Environmental
context/resources

II

Facilitators;
Barriers

Knowledge
Skills
Social/Professional role and
identity
Beliefs about capabilities
Beliefs about consequences
Reinforcement
Goals
Environmental
context/resources

III

Men with larger travel
distances and lower
income had lower odds of
registration
Radical prostatectomy was
a predictor in participation
(4 times more)

(N=618)
Kaplan-Meier curves
varied significantly by
treatment modality and
Gleason score
85.58% of registrants
completed the program
No difference in
participation by age,
distance to clinic,
socioeconomic quintile, or
other variables

McLaughlin
K, Hedden
L, Pollock
P, et al.
(2019)

To advance
understanding of (1)
the nutritional needs
of men with
prostate cancer; (2)
health providers´
assessment of
nutritional services;
(3) existing
nutritional services

Quality
Improvement

Vancouver,
Canada
Patients with
prostate cancer
(n=135)

Prostate cancer
supportive care
(PCSC) program
nutrition
education
session

Patients and partners:
88% agreed session was
right length
94% found it useful
63% participants found it
beneficial

Patients’ partners
(n=72)

Thematic analysis:
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for men with
prostate cancer

Healthcare
providers
(n=38)

(1) high level satisfaction
(2) inclusion of partners
useful for processing
information and
supporting changes at
home

(N=245)

(3) 27% reported gaps in
information – dietary
components, individual
concerns, and practical
meal planning
HCPs:
85% reported that patients
expressed nutritional
concerns
60% agreed that patients
need more nutritional
support
No significant differences
in responses between
physicians and dietitians
except for focus on
nutritional support
67% believed that
nutritional support should
be continuous

Paterson C,
Primeau C,
Nabi G.
(2018)

To determine the
effectiveness of a
multimodality
supportive care
intervention on
prevalence of unmet
needs in men with
advanced prostate
cancer and their

Pilot parallel
randomized
controlled trial
(2-armed)

Scotland, UK
Patients with
advanced prostate
cancer and
partners
(n=19)
Usual care
(n=29)

ThriverCare with
4 components;
informational
materials,
holistic needs
assessment,
individualized
self-management
care plans,
group-based
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No significant difference
in prevalence of unmet
needs at baseline
Statistically significant
difference after 3 months
post-intervention in
prevalence of unmet needs
(p<0.002)

Facilitators;
Barriers

Knowledge
Reinforcement
Goals

I

partners
(ThriverCare)

(N=48)

educational
seminar

Greatest improvements in
physical symptoms, fear
recurrence, fear of death,
changes in sexual feelings,
concerns of those closest
to you
No statistically significant
differences in selfefficacy, anxiety,
depression, QOL

Primeau C,
Paterson C,
Nabi G.
(2017)

To explore the
experiences of
patients with
metastatic prostate
cancer and their
partners as well as
an interprofessional
team with a
multimodal
supportive care
intervention

Qualitative

Scotland, UK
Patients
(n=19)
Partners
(n=7)
Interprofessional
team members
(n=7)

Intervention with
4 components;
informational
materials,
holistic needs
assessment,
individualized
self-management
care plans,
group-based
educational
seminar

(N=26)

Patients and partners
themes:
(1) emotional support:
given time for expression
and provided additional
support
(2) Informational support:
nurse seen as a hub of
supportive care
(3) Evidence-based selfmanagement plans:
facilitated referrals to
exercise programs or
tailored self-management
plans.
(4) Evidence-based
educational group
seminar: perceived benefit
in looking after
themselves at home
Interprofessional team:
(1) Reported benefits in
the holistic approach to
patients care
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Facilitators;
Barriers

Beliefs about capabilities
Reinforcement
Intentions
Goals
Environmental
context/resources

III

(2) Greater access to
specialist nurses and
ability to target unmet
supportive care needs

Ralph N,
Chambers
S, Laurie K.
et al. (2020)

To identify barriers
to implementing
supportive care for
men with prostate
cancer

Qualitative

Queensland,
Australia
Healthcare
providers
(N=21)

Individualized
supportive care
program
(ProsCare) preimplementation

To inform the
creation of a
preimplementation
plan for a nurse-led
supportive care
intervention
(ProsCare)

Low awareness about
supportive care
effectiveness
Difficulty keeping
knowledge currency
Gap in care coordination
Traditional male roles
influence uptake of care
Patients don´t know how
to navigate the healthcare
system
Participants expressed
pessimism about the
perceived effectiveness of
supportive care
Participants believed
being stoic does not allow
men to express their
preferences for supportive
care
Several modalities of care
necessary
Participants believed that
patients prioritize living
longer than QOL
Participants called for a
decentralized access to
care and increase
awareness
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Facilitators;
Barriers

Knowledge
Skills
Social/professional role and
identity
Beliefs about capabilities
Optimism
Beliefs about consequences
Reinforcement
Intentions
Goals
Memory, attention, decision
processes
Environmental context and
resources
Social influences
Emotion
Behavioral regulation

III

Concerns about decisions
not being revisited
Challenges to supportive
care include cost, time,
access difficulty
Stigma seen a social
challenge
Participants called for
improvement in
psychosocial care
Participants emphasized
patients´ preference to
discuss supportive care
with nurses

Ralph N,
Chambers
S, Pomery
A, et al.
(2019)

To explore the
insights of clinical
nurse specialists
regarding the
context and delivery
of the delivery of
supportive care
program (ProsCare)
for men with
advanced prostate
cancer

Qualitative

Queensland,
Australia
Specialist nurses
(N=30)

Individualized,
telephone-based
supportive care
intervention to
facilitate
decision support,
training for
symptoms selfmanagement,
screening for
psychological
distress,
communication
with HCPs

Participants reported that
ProsCare is innovative,
with high level of
adaptability and
trialability
Intervention easy to
implement
Intervention met the needs
of patients and HCPs
Intervention allows
continuity of supportive
care
Intervention will be
successful if health
services network with
major prostate cancer
services
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Facilitators;
Barriers

Knowledge
Skills
Social/Professional role and
identity
Optimism
Goals
Environmental
context/resources
Social influences

III

Teleintervention well
supported by participants
Participants advocated for
an inclusive learning
climate for nurses
Importance of a culturally
competent delivery of
Proscare.

Ross
Zahavich
AN,
Robinson
JA,
Paskevich
D, et al.
(2012)

To examine the
feasibility and
benefit of a
therapeutic yoga
program offered to
prostate cancer
survivors and their
partners

Cross-sectional

Alberta, Canada
Prostate cancer
survivors (n=15)

Supervised yoga
classes
(7 weeks)

Partners (n=10)

High attendance (6.1/7)

Facilitators;
Barriers

Knowledge
Skills
Beliefs about consequences
Reinforcement
Environmental
context/resources
Social influences
Emotion

II

Facilitators;
Barriers

Skills
Social/Professional role and
identity
Beliefs about capabilities
Goals

I

Statistically significant
improvements in survivors
and partners’ mood, and
decrease in fatigue and
stress

(N=25)
Non-statistically
significant differences
changes in physical
activity
Non-statistically
significant changes in
QOL
Ratings of perceived
social support higher for
those bringing a partner
Improvement in flexibility
(p< 0.048)
No improvements in other
anthropometric measures

Watson EK,
Shinkins B,
Matheson
L, et al.
(2018)

To test the
feasibility and
acceptability of a
nurse-led psychoeducational

Pilot
Randomized
Controlled
Trial

Oxford,
Cambridge, UK
Patients with
prostate cancer:

Nurse-led
psychoeducational
intervention with

134

No between group
differences in urinary,
bowel, sexual, or
hormone-related
symptoms

intervention versus
usual care
(PROSPECTIV)

Intervention
group (n=42)
Control group
(n=41)
(N=83)

initial face-toface appointment
tailored face-toface nurse
contacts, and
final follow-up
telephone
contact.
(6 months)

Non-statistically
significant reduction in 4
domains of unmet needs in
interventional group
No differences in
psychological well-being
Intervention group
reported improved selfefficacy across majority of
items – non-statistically
significant
Qualitative evaluation:
Completion rates high 95% interventional group
All participants found
intervention duration and
schedule appropriate
Intervention benefited
sense of well-being and
emotions
Few participants reported
no changes in physical
symptoms
Program useful for men
avoiding help seeking
Nurses praised the tailored
follow-up design but were
disappointed to find some
men failing to act on their
advice

Abbreviations: QOL, quality of life; ADT, Androgen-deprivation therapy; HCPs, healthcare providers
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Memory
Environmental
context/resources
Behavioral regulation
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Table 3. Identified Barriers and Facilitators using the Theoretical Domains Framework
STUDY
BENDER JL,
FLORA PK,
MILOSEVIC E, ET
AL. (2020)

CHAMBERS SK,
FOLEY E, GALT E,
ET AL. (2012)

STAKEHOLDERS

FACILITATORS

TDF DOMAIN(S)

Patients

- Discomfort posting in
An online forum
- Need for more in- person interaction
(not all online)
- Lack of technology proficiency

- Motivation to guide other survivors
- Intensive but manageable workload
- Flexible online environment
- E-learning software easy to use
- Authentic in-person role-playing
and interaction

Knowledge
Beliefs about capabilities
Beliefs about consequences
Reinforcement
Intentions
Environmental context/resources
Emotion

HCPs

- Lack of prior knowledge on
qualities needed to recruit effective peer
navigators
- Purely self-study online not always
acceptable format

- Partnerships with local PC support groups
- Use of social learning (forum)
- Inclusion of caregivers

Knowledge
Beliefs about capabilities
Reinforcement
Environmental context/resources
Social influences

- Lack caregivers’ involvement
-Excessive time commitment

- Group approach
promotes identification

Reinforcement
Environmental context/resources
Social Influences

- Lower attendance from regional areas
vs. urban

- Supervised sessions facilitated by trained
psychologists
- Intervention implemented in
multiple locations
- Cost-effectiveness group approach
- Multicomponent

Skills
Reinforcement
Environmental context/resources

- Acknowledgment
importance of
exercise

- Pivotal role of exercise
physiologists on compliance
- Value of group format (support)
- Humor as contributing element to foster
supportive group dynamic
- Exercise fits masculine ideals
- Positive feedback from
family/friends motivated
engagement

Knowledge
Skills
Social/professional role identity
Optimism
Reinforcement
Social influences

- None identified

- Structured, supervised program
- Small group approach

Skills
Environmental context/resources

Patients

HCPs

CORMIE P,
TURNER B,
KACZMAREK E, ET
AL.
(2015)

BARRIERS

Patients

HCPs
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- Run by accredited exercise physiologists
- Program free of charge
CORMIE P, TAAFFE
DR, SPRY N, ET AL.
(2013)

FERGUSON J &
ANING J.
(2015)

Patients

- None identified

- None identified

HCPs

- None identified

- Small group approach
- Supervised by expert exercise
physiologists
- Exercise is non-invasive
- Intervention highly accessible

Patients

- None identified

- None identified

- Waiting lists due to limited resources and
funding
- Program did not address partners’ needs

- Recognition of extra capacity needed to
deliver program
- Innovative patient-centered program
delivered by nurse
specialist
- Inclusion of multidisciplinary team
in program planning/ development
- Involvement of several local services
accessible to patients
- Clear referral pathway
- Flexibility in scheduling sessions
- Multiapproach: counseling and education
- Homely environment
- Continuous program evaluation
- Partner involvement

- Lack of continuity due to treatments
- Long travel distance

- None identified

Intentions
Environmental context/resources

- Low income
- One centralized location
- Program for patients/partners

- Multimodal: group educational and
individual clinical sessions
- Materials free of charge

Reinforcement
Environmental context/resources

- Not comprehensive
(missing topics)

- Materials easy to understand
- Appropriate length

HCPs

HEDDEN L,
POLLOCK P,
STIRLING B, ET
AL.
(2019)

Patients

HCPs

MCLAUGHLIN K,
HEDDEN L,

Social influences

Patients
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Skills
Beliefs about consequences
Environmental context/resources
Social influences

Knowledge
Skills
Social/Professional role and identity
Reinforcement
Goals
Memory
Environmental context/resources

Skills
Social/Professional role and identity

POLLOCK P, ET
AL. (2019)

- Inclusion of partners

HCPs

PATERSON C,
PRIMEAU C, NABI
G.
(2018)

Patients

HCPs

PRIMEAU C,
PATERSON C,
NABI G.
(2017)

Patients

HCPs

RALPH N,
CHAMBERS S,
LAURIE K. ET AL.
(2020)

Patients

Beliefs about capabilities
Beliefs about consequences
Reinforcement

- Unaware of current nutritional programs
for PC
- Belief of nutrition not being critical for
PC
- Interprofessional disagreement focus
of nutritional program
- Lack of funding
- Limited dieticians with oncology
experience

- Individual benefit from various formats
- Ongoing availability through cancer
continuum

- None identified

- None identified

- Variation in providers’
knowledge/expertise

- Personalized program
- Precise standardization of
EB self-management interventions
- Discussion of SC needs with clinician

- Difficult phone access to nurse
after appointment

- Individualized information
- Ample time with nurse
- Non-technical language
- Focus on self-management
- Inclusion of partners

Beliefs about capabilities
Reinforcement
Goals
Environmental context/resources

- None identified

- Holistic approach
- Greater access to specialty nurse
- Multimodal intervention

Reinforcement
Intentions
Environmental context/resources

- Inability to navigate
health system
- Muted preferences
on additional SC
due to stoicism
- Prioritizing extension of life
vs. quality life
- Stigma
- Fear, stress and unawareness of
symptoms on psychosocial well-being

- None identified
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Knowledge
Skills
Social/Professional role and identity
Reinforcement
Goals
Environmental context/resources

Knowledge
Reinforcement
Goals

Beliefs about capabilities
Beliefs about consequences
Intentions
Social influences
Emotion

HCPs

RALPH N,
CHAMBERS S,
POMERY A, ET AL.
(2019)

Patients

HCPs

ROSS ZAHAVICH
AN, ROBINSON JA,
PASKEVICH D, ET
AL. (2012)

Patients

HCPs

WATSON EK,
SHINKINS B,

Patients

- Low awareness of
SC programs
- Challenging to maintain
knowledge currency
- Uncertainty on SC effectiveness
- Lack of skills on SC and care
coordination
- Patient stoicism
- Pessimism about specialists engaging on
SC
- Centralized access of SC
- Lack of revisitation
- Scarce resources
- Lack of specialty nurses
- Challenges breaking habits

- Various formats of SC
- Campaigns to reduce stigma

- None identified

- None identified

- Knowledge base on
nurses’ teleconference
delivery
- Concerns on adding program to nurses’
workload
- Coordination challenges
- Time constraints
- Peer pressure

- Easy delivery via teleconference
- Individualized program
- Intervention delivered by specialty
nurses
- EBP intervention
- High level of adaptability
- Care continuity
- Cosmopolitanism
- Ideal team climate-optimism
- Cultural competency

- Time constraint
- Accessibility

- High acceptance
- Safe intervention

- Lack of knowledge optimal physical
activity for PC
- Lack of referrals

- Feasible activity
- Group format enhances support
- Inclusion of caregivers/partners

- None identified

- Appropriate length
- Welcoming and safe environment
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Knowledge
Skills
Social/professional role identity
Optimism
Reinforcement
Goals
Memory
Environmental context/resources
Behavioral regulation

Knowledge
Skills
Social/Professional role and identity
Optimism
Goals
Environmental context/resources
Social influences

Beliefs about consequences
Environmental context/resources
Emotion

Knowledge
Skills
Reinforcement
Social influences
Social/Professional role and identity
Environmental context/resources

MATHESON L, ET
AL. (2017)
HCPs

- Strain meeting patients’ needs
- Lack of right timing for all patients
- Frustration dealing with some topics
- Hard to motivate some patients
- More training needed
- Need for more resources/funds

Abbreviations: PC, prostate cancer; SC, supportive care; EBP, evidence-based practice
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- Nurse delivered intervention
- Program based on self-management
- Tailored individual follow-up
- Open availability
- Ability to work ahead

Skills
Beliefs about capabilities
Goals
Memory
Environmental context/resources
Behavioral regulation

Summary
Overview
This dissertation compendium includes three manuscripts investigating interrelated
and essential aspects of supportive care among advanced disease prostate cancer (PC)
survivors. The first manuscript describes an integrative review that critically appraised the
availability of supportive care interventions for this population and its effects on quality of
life using the Supportive Care Framework for Cancer Care (SCFCC). In the second
manuscript, results are reported from a holistic needs assessment conducted using a mixedmethods approach, also guided by the SCFCC. The third and final manuscript delineates a
scoping review identifying common supportive care interventions and exploring barriers and
facilitators to their implementation using the Theoretical Domains Framework (TDF).
Prior research has reported that advanced PC survivors suffer from greater unmet
needs that affect all individual dimensions, lowering their quality of life (QOL).1 Ongoing
and consistent supportive care has demonstrated to be an effective way to prevent and
manage these overlapping unmet needs, maximizing QOL and rehabilitation.2-4 However,
despite all the recommendations from the Institute of Medicine, the American Society of
Clinical Oncology, and the American Cancer Society, implementation of supportive care
among this subset of survivors is limited and irregular.5 The contributing results from the
integrative review confirmed that, in fact, supportive care interventions for advanced PC
survivors are not as widely available as they should be, despite some positive results on the
outcomes. Supportive care efforts focus mainly on exercise, cognitive-behavioral, and
educational interventions, leaving domains such as the spiritual, practical, and psychological
lacking appropriate addressing in need for development of additional interventions. This
deficiency doesn’t but amplify even more supportive care needs in this population. Therefore,
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a mixed-methods study that explored these needs in a comprehensive manner was necessary
to strategize additional supportive care interventions.
The results from the mixed-methods convergent study indicated that advanced PC
survivors have unfulfilled needs in every domain and that in fact, more needs were associated
with lower quality of life. Up to 30% of the survivors reported having needs in at least half of
the items, which is highly concerning. Areas of data convergence included sexual
dysfunction and fatigue (physical domain), anxiety and existential concerns (emotional
domain), and help around the house (practical domain). Numerous other needs identified in
the mixed-methods study did not triangulate, leading to divergence among the data. Needs
related to information were found to be most prevalent and important during the qualitative
interviews but barely identified in the quantitative survey. The same was true for spiritual
needs and urinary dysfunction, but not for depression, which had a higher prevalence in the
quantitative data. In order to develop and implement successfully supportive care
interventions that address the multidomain needs identified during the mixed-methods study,
it was necessary to have a better understanding of the barriers and facilitators that have an
effect on supportive care delivery.
The 13 studies included in the scoping review revealed a myriad of factors
influencing supportive care implementation. Despite vast differences in supportive care
interventions regarding focus, content, methodology, and outcomes, most of those barriers
and facilitators fell primarily under three TDF domains. Barriers were identified under
Environmental Context and Resources (ECR), Knowledge, and Beliefs About Capabilities,
while most facilitators were categorized within the ECR, Reinforcement, and Skills domains.
Primary barriers included lack of knowledge on supportive care interventions availability
and/or effectiveness from both perspectives, patients and healthcare providers, variations in
providers’ expertise, insufficient technical proficiency, limited resources and access, time
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constraints, lack of self-confidence in the intervention materials, hardships navigating the
health system, and little competency. Main facilitators included making partnerships with
local services, continuous availability, supervised group formats, partners inclusion, flexible
scheduling, multimodality, delivery by professionals, and specialty nurse involvement.
Additional barriers and facilitators from other TDF domains were also identified and
included in the findings to better understand all potentially influencing factors to supportive
care implementation.
Implications for Nursing and Cancer Care
Extensive past research has focused primarily on PC survivors’ unmet needs at the
early stages of the disease or undergoing specific treatments, such as androgen deprivation
therapy.6,7 More nursing research efforts in this area of cancer care are needed to decrease the
morbidity associated with advanced PC and reduce disparities in supportive care
implementation. For example, five out of the 12 most prevalent supportive care needs
identified in the mixed methods study belong to the psychological/emotional domain. The
integrative review findings support these results as they indicated insufficient interventions
addressing this specific domain, potentially contributing to the higher prevalence of unmet
needs. That limitation in interventions may be due to some of the barriers identified on the
scoping review with the TDF guidance (knowledge, resources). Healthcare providers must
concentrate their efforts on researching novel ways to provide patient-centered, costeffective, multimodal supportive care that improves QOL and maximize health outcomes. In
particular, as direct providers of care, specialty nurses are in an optimal position to assess the
evolving needs of advanced disease prostate cancer survivors and become primary deliverers
of supportive care.8-10 Although the implementation of these interventions by accredited
multidisciplinary professionals is vital, results from the three manuscripts emphasize the role
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of specialty nurses. Although limited, interventions that were nurse-led reported higher levels
of satisfaction and well-being among participating survivors.10
Future Directions
There are several diverse areas for future research based on this dissertation work.
This was the first study exploring the unmet supportive care needs of advanced PC survivors
living in the United States at a national level. Additional needs assessment in this population
guided by multidomain frameworks is needed to confirm the study results and their
generalizability, mainly longitudinally. Further, there is a need to investigate if the unmet
needs in this subset of survivors vary according to socio-demographic and clinical
characteristics and if needs predict QOL. The results also provide a future opportunity to
conduct a review on all available instruments used to collect information regarding unmet
supportive care needs and quality of life to determine their efficacy in providing
comprehensive and accurate information. Additionally, the next steps necessarily include
expanding and testing new patient-centered, cost-effective interventional research in order to
narrow down the existing gaps in supportive care implementation. Interventions must focus
on the needs with the highest prevalence, such as information regarding advanced PC
treatments and self-care, physical and sexual functionality, and emotional/psychological
support. However, it must also promote spiritual and practical well-being, as these domains
can significantly improve QOL and sense of overall meaning among these survivors. Lastly,
special attention must be given to the areas of data divergence (urinary dysfunction,
depression, information and spiritual well-being). Further exploration is necessary to confirm
these points of disconnect and the possible causes behind the differences.
Lessons Learned
Despite reaching the sample size for both the quantitative and the qualitative arms,
participants were primarily non-Hispanic White, married, retired, and with higher education,
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limiting the generalizability of the findings. It is possible that the recruitment efforts and
settings led to this lack of diversity of survivors. The same was true for the sample of studies
selected for the integrative review. Future work must ensure sociodemographic diversity and
larger samples to increase generalizability. Further, investigators need to start incorporating
diversity based on sexual orientation as well, since the supportive care needs can differ
between heterosexual and homosexual advanced PC survivors.
The use of the SCFCC and TDF frameworks provided a solid structure for this
dissertation work. This is unique, as the extant literature on supportive care for advanced PC
survivors typically lacks guidance from theoretical or conceptual models. Selecting
appropriate theoretical frameworks eases the understanding of how and why supportive care
interventions are successfully or unsuccessfully implemented and if they address supportive
care needs effectively, for example.11 The SCFCC was a key element in categorizing not only
the available supportive care interventions but also the unmet supportive care needs, all based
on its holistic view of cancer.12 However, some challenges were faced with the use of the
TDF in synthesizing barriers and facilitators to supportive care implementation, mainly due
to its numerous domains. Additional exploration of these factors is warranted using other
suitable frameworks, such as the social-ecological model.
Conclusion
The three manuscripts of this dissertation explore several aspects of supportive care in
advanced PC survivors. This research has indicated that this subset of survivors has a wide
variety and prevalence of supportive care needs that do not appear to be appropriately
addressed by existing cancer care services. This may be due to supportive care interventions
being limited and inconsistent because of the existing barriers to their implementation. In the
coming years, as the number of advanced PC survivors continues its ascending trend, more
holistic, cost-effective supportive care will be vital to meet those multidomain needs and
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optimize the QOL and overall health outcomes. The findings of this dissertation can be
applied to the development of new interventional programs that focus on areas of most need,
maximizing community partnerships, availability, multimodality, and specialty nurse
involvement.
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APPENDIX B. Hollings Cancer Center Protocol Review Committee Approval

May 29, 2020
Alejandra Schimmel, MSN, MBA, BSN, RN
Doctoral Student
Department of Nursing
Medical University of South Carolina
Charleston, SC 29425

Dear Dr. Schimmel:

At the May 29, 2020 meeting of the Protocol Review Committee (PRC), your research protocol
entitled “A Mixed-Methods Study to Investigate the Unmet Supportive Care Needs in Advanced
Disease Prostate Cancer Survivors” (CTO #: 103280/Sponsor: MUSC; protocol version May 27,
2020) was approved as written for use at Hollings Cancer Center.
As required by the NCI for all Designated Cancer Centers awarded a Cancer Center Support
Grant (CCSG), MUSC-HCC must report all oncology clinical trial activity occurring at MUSC.
Because the abovementioned study has qualified for PRC review and approval, this study is
subject to ongoing reporting requirements to the PRC to ensure compliance to CCSG standards.
Furthermore, since this trial is an investigator-initiated trial sponsored by MUSC faculty,
additional reporting requirement to the NCI Clinical Trials Reporting Program (CTRP) is
required.
As Principal Investigator, it is your responsibility to ensure the following information is
submitted to the HCC PRC at hccprms@musc.edu. Please make sure that CTO#103280 is
listed in any email correspondence.

1) MUSC IRB Initial Approval Letter and Date of Study Activation
Please note that consideration for approval of this study by the MUSC IRB is pending. The
MUSC IRB will require the provision of a PRC approval letter within your IRB application. Once
a study is IRB approved, please submit the IRB approval letter to the PRC. If the study does not
receive IRB approval and the study is withdrawn, please contact the PRC of this status. Study
Activation is defined as the time when the study is eligible to begin enrollment to the trial. When
the study is activated, please provide the PRC this activation date.
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2) All Significant Protocol Amendments require PRC approval
Significant Protocol changes are defined as changes in any of the following: a) Study objectives,
b) Research plan or study design, c) Eligibility, d) Statistical Consideration, e) Patient population
and/or accrual figures. Any significant change requires PRC approval prior to IRB submission.
It is required that a marked document and/or detailed summary of changes and the PRC
Amendment Form be provided to the PRC. The PRC form is located at
http://horseshoe.musc.edu/hcc/clinical-trials/prc.The PRC Chair will initially review the
documents and may approve under expedited review. Should there be additional concerns,
the PRC chair has the authority to request full board review of the amendment.

3) Monthly Accrual Updates and Biannual Accrual Review
On a monthly basis, it is required that updated accrual information is provided. In addition,
PRC conducts a biannual trial performance review in which the level of accrual is reviewed.
Should your predicated accrual period or accrual estimate change from your in initial form
submission, please contact the PRC.
4) Changes in Study Status
When the study is closed to accrual or terminated, it is required that the updated status be
provided to the PRC. Any applicable IRB letter regarding this change in status should be
provided.
5) Copies of all Protocol and/or Consent amendments and Continuing Renewal Applications
The PRC helps ensure compliance to NCI’s CTRP reporting requirement by submitting
protocol updates on your behalf. Please notify the PRC of any changes to current study
documents and related approval letters to the PRC. As an ancillary entity of the MUSC eIRB,
PRC may request guest access to eIRB applications. However, should your study use an
external IRB, you would be required to notify the PRC of protocol or consent changes and
renewal approvals as they occur. All protocol or consent amendments and continuing renewal
approvals require submission to the NCI’s CTRP. For more information about CTRP please
visit http://www.cancer.gov/aboutnci/organization/ccct/ctrp.
Conducting research is a critical component of our University’s mission. Thank you for your
efforts and should you have any questions regarding PRC, please feel free to contact the PRC
chairs or administrator.
Sincerely,

Graham Warren, MD, PhD
Chair, Protocol Review Committee
cc: CTO Binder #103280
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APPENDIX C. Study Protocol
SPECIFIC AIMS
Prostate cancer is the fourth most common cancer globally and a tremendous physical, emotional
and financial burden for individuals, families, and healthcare systems.1 From the 3.6 million prostate
cancer (PC) survivors living in the United States, 30% suffer from advanced disease stages
(regionally advanced-III, metastatic-IV, recurrent or refractory).2,3,4 Advanced disease in survivors,
considered treatable but no longer curable, is managed with chemotherapy, radiation, androgendeprivation, or trials. Although the exact prevalence remains unknown, men with PC report
substantial unmet supportive care (SC) needs due to a more prolonged illness pathway and the
debilitating effects of therapies, leading to poor quality of life (QOL) and health outcomes.5 These
unmet needs, more widespread in advanced PC, are due primarily to physical, emotional, social,
spiritual, informational, and practical impairments such as pain, urinary incontinence, bowel and
sexual dysfunction, fatigue, hot flashes, depression, distress, anxiety, isolation, deteriorating bone
health, weight changes, risk for suicide, cognitive decline, and financial burdens, costing the U.S.
health system more than $9 billion annually.4,6-13 Extensive research has examined QOL predictors
and the impact of PC treatments on survivors who have completed curative treatment.10,14-17. Research
also reports the lived experiences of PC survivors but have not specifically focused on advanced
disease. 5,18,19 Most studies attempting to examine unmet SC needs have been conducted with PC
patients in earlier stages of the disease and using quantitative or qualitative approaches alone.7,15,17,19,20
Therefore, there is a major gap surrounding the perceptions of the vulnerable subset of advanced PC
survivors regarding their unmet SC needs.12,13
A preliminary integrative review revealed a significant lack of SC interventions for advanced
disease PC survivors. This finding is supported by recent studies in which 33% - 81% of the surveyed
survivors reported inadequate SC care despite guidelines recommending survivorship care for all PC
survivors.5,10 Given the magnitude of the problem, it is essential to develop and implement holistic,
cost-effective, patient-centered SC interventions that maximize the QOL of advanced disease PC
survivors. However, a critical first step is to examine this population’s existing unmet SC needs, any
additional difficulties faced during crisis such as the 2020 COVID-19 pandemic. Also, it is important
to evaluate the feasibility of the research methodology used to measure unmet needs and QOL in this
population (recruitment, enrollment, and data collection methods).7,8,11,15,18-20 The rationale for
conducting this study with advanced disease survivors solely is that they face different, and often
underestimated and underreported, unmet SC needs than survivors at earlier stages.12,13,21 If
demonstrated to be feasible, the study’s methodology can provide a more comprehensive picture of
the needs in this subset of survivors and contribute as empirical evidence for optimizing their overall
cancer survivorship care.
The purpose of this convergent parallel mixed-methods study is to conduct a supportive care
unmet needs assessment in advanced disease prostate cancer survivors through the lens of
Fitch’s Supportive Care Needs for Cancer Care Framework (SCNCCF) while assessing the
feasibility of the research methodology. The overarching research question that guides the study is:
"What are the unmet supportive care needs in advanced disease prostate cancer survivors, and
how do they relate to the quality of life and disease stage?
The specific aims are as follows:
Aim # 1: To characterize unmet supportive care needs and QOL in advanced disease PC survivors
using a nationally administered survey.
a. Determine the prevalence of unmet needs according to the different SCNCCF domains.
b. Examine the relationship between SC unmet needs and QOL as well as analyze differences in
SC unmet needs by age, race/ethnicity, insurance status, marital status, time since diagnosis,
treatments, stage, and confinement for COVID-19.
Hypotheses include: (1) QOL will be negatively correlated to the prevalence of SC unmet needs, and
(2) SC unmet needs will be higher in those with more advanced disease stage.
Aim #2: To explore the implications of physical, emotional, social, psychological, spiritual,
informational, psychological, and practical needs in advanced disease PC survivors’ quality of life.
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a. Conduct key-informant, semi-structured interviews with a small subset of advanced disease
PC survivors.
b. Perform interviews deductive-inductive content analysis to identify common themes per
SCNCCF domains.
Aim # 3: To identify advanced disease PC survivors’ unmet SC needs by synthesizing survey and
interview findings.
Secondary Aim: To evaluate the feasibility of the research methodology in assessing advanced PC
survivors’ unmet SC needs for future applicability in similar clinical problems and populations
(participant recruitment, enrollment, and consenting strategies as well as the data collection methods survey and interview).
Impact
The results of this study may provide valuable understanding of the unique unmet SC needs of an
understudied population that has been “suffering in silence” the devitalizing effects of cancer, and the
prolonged treatments they complete.20,22 Moreover, the findings will highlight the feasibility of future
research utilizing mixed-methods designs and will inform the development of culturally appropriate,
patient-centered, comprehensive SC strategies aimed to improve the QOL of this vulnerable and
progressively growing population.
A. Significance
A.1. There is limited holistic needs assessment research for advanced-stage prostate cancer
survivors.
PC is the leading cause of cancer death in American men.23 Although the total yearly incidence
rate has progressively fallen due to improvements in screening and curative treatments, it is projected
that the burden of advanced PC will steadily increase in the upcoming years, particularly in younger
men (≤ 69 years).24,25 It has been well documented that advanced disease PC survivors suffer from a
vast array of SC needs as they live with this chronic illness for the remainder of their lives 7,12,14 The
available various therapeutic modalities are critical to them for staying alive but are often associated
with profound and long-term side effects.8,9,13,18,20 Past needs assessment studies done with advanced
stage PC survivors have focused primarily on physical and informational needs.18,19,21 However, many
suffer disproportionately from multiple overlapping SC needs that significantly diminish overall QOL
and impact health outcomes negatively. Since up to 30% of all PC patients will eventually progress
into advanced disease, it is essential to address this gap by conducting further holistic SC needs
assessment research to improve these survivors’ QOL.8,21 The proposed study may provide significant
insight into the prevalence and type of specific SC needs in advanced disease PC survivors, which are
not being met within the current U.S. health care system. This insight is vital to improving their SC
throughout survivorship until the end of life, particularly at times of need such as during the 2020
COVID-19 pandemic or other potential future public health crises.16
A.2. Failure to address traditional male roles may prevent optimal supportive care.
An extensive body of evidence indicates that PC is a threat to masculinity.26,27,28 This is
particularly true in men who hold traditional male role identities. One study highlighted that sexual
dysfunction, urinary incontinence, and the emasculating way in which these issues are discussed in
media and support forums can be particularly threatening and emotionally debilitating for many
men.26 This fact and other individual barriers - such as the need for control, self-blame, a more
restricted emotional response, personal perception of the disease, and embarrassment - may hinder the
verbalization of their unmet SC needs. Subsequently, there prompt SC may be delayed, leading to a
negative impact on the QOL and the morbidities associated with more advanced stages of the
disease.27,28 These unmet needs remain largely unknown and unmanaged by healthcare providers.
Therefore, this study will examine the prevalence and type of unmet SC needs of this population, so
that holistic, patient-centered SC interventions that respect culturally accepted masculine roles can be
better informed and developed. These interventions may promote higher engagement and potentially
improve the overall QOL of these survivors.
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A3. Current guidelines recommend holistic and continuous supportive care throughout
survivorship.
The Institute of Medicine (IOM), the American Society of Clinical Oncology (ASCO) and the
American Cancer Society (ACS) recommend uninterrupted individualized SC across healthcare
delivery settings for PC cancer survivors, including during times of global health pandemics.29,30
However, the implementation of this SC varies widely across health systems partially due to needs
remaining unknown and the differences in screening and care between advanced and localized stages.
As a result, advanced disease PC survivors continue to suffer in silence from a considerable number
of unmet needs, may not receive the recommended care they require, and many times die from these
and other long-term effects of the various cancer therapies.29,31 Recent evidence indicates that up to
52.9% of PC survivors suffer from unmet emotional needs, 47.1% from physical needs, 23.5% from
practical and spiritual needs, and 11.8% from social needs.29
Supportive care focuses on person-centered interventions to manage symptoms, improve coping,
optimize decision-making, and minimize impairments in overall functioning.31,32 This study is
significant as it can be a first step to advancing knowledge that can inform the development of more
comprehensive, cost-effective, patient-centered SC interventions that lessen the economic burden of
cancer care on healthcare systems, while still providing holistic, individualized care.31 Given current
recommendations and guidelines for cancer survivorship care, and the increasing survival rates of
patients with advanced disease, SC should become a standard to optimize QOL in this population.
A4. Unmet needs may be related to poorer quality of life.
Several past studies on PC survivors have investigated the relationship between QOL and specific
socio-demographic and clinical characteristics such as race/ethnicity, stage of the disease,
comorbidities, and time since the initial diagnosis. Results from those studies suggest a significant
relationship between lower QOL and the Black race.16 QOL also decreased -as time since diagnosis or
number of comorbidities increased, or as more advanced stage was reached. 12,16,33 However, the
relationship between unmet SC needs and QOL in advanced disease PC survivors has not been
determined. Some evidence reports that the prevalence of unmet needs increases as age and time since
diagnosis increases.33,34 Further research is needed to validate the hypothesis that QOL in advanced
PC survivors varies depending on the prevalence and type of unmet SC needs. This information will
be valuable in developing and implementing SC interventions more efficiently.
B. Innovation
This study is innovative in several ways. First, it will be conducted with all types of advanced
disease PC survivors solely (III, IV, recurrent). Past needs assessment research has combined PC
survivors in all stages of the illness or has been limited to advanced disease patients receiving a
specific treatment (e.g., androgen-deprivation therapy, chemotherapy).7,10,31 Second, only a handful of
studies have examined the prevalence of a comprehensive set of unmet S0C needs in this subset of PC
survivors. However, the relationship between unmet needs and QOL and socio-demographic and
clinical variables have not been explicitly investigated, warranting further exploration. It is
hypothesized that higher unmet SC needs will be associated with worse QOL and higher disease
stage, for example. Results from this study may provide a more comprehensive perspective of the
types of unmet SC needs experienced in PC and how they relate to QOL and several sociodemographic and clinical variables, so that future development of more specific, patient-centered, SC
interventions can be better informed. Third, the study will be guided by the SCNCCF. This
framework has been proven suitable for investigating unmet needs with other conditions such as
ovarian cancer or a sample of advanced cancer patients undergoing radiation for symptom control.35,36
However, it has never guided a mixed-methods study conducted with adult PC cancer survivors.
Fourth, as mentioned above, this study is the first to investigate unmet SC needs in advanced disease
PC survivors using a mixed-methods approach with a large sample. To the best of our knowledge,
only one study has used this methodology but with a small sample of 31 survivors.12
C. Diversity and Social Determinants of Health
We will recruit a sample of advanced disease PC survivors who are diverse in terms of
race/ethnicity, age, disease stage, treatments, time since diagnosis, level of education, marital status,
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geographical location to capture the perspective of potentially neglected populations. Statistics show
that both the overall incidence of advanced PC and the death rate from the illness are higher in Blacks
and Asian Americans/Pacific Islanders than in all other races/ethnicities.37-39 This trend also holds true
for increased age. Prior research has shown that minority race and lower socioeconomic status are
associated with increased unmet SC needs and lower QOL in advanced PC cancer, partially due to the
influence of masculinity and cancer stigma.32 Additional studies also showed that stage, clinical
treatment, and time since diagnosis usually lead to some common and some very distinct unmet SC
needs in this population.13 All of this evidence emphasizes the need for a deeper exploration of the
unmet SC needs in a diverse sample of advanced PC survivors. The results of this study will
complement previous research adding a level of insight by addressing person-level factors such as
age, race/ethnicity, or stage and social determinants of health such as geography. Gender diversity is
not achievable because of the male-specific nature of the illness.40
D. Guiding Theoretical Framework
This mixed-methods study will use the SCNCCF as the guiding theoretical framework (Appendix
A).41 The SCNCCF outlines a comprehensive taxonomy of seven domains, which include physical,
psychological, emotional, informational, social, spiritual, and practical needs. It was developed by Dr.
Margaret Fitch as a tool to assist clinicians in meeting the overlapping complex SC needs of cancer
patients throughout the various stages of the illness, including survivorship. The SCNCCF is
appropriate for this research because it has been used successfully in previous needs assessment
studies with various types of cancer survivors.35,36 The SCNCCF will be employed in the current
study for several purposes. During the preliminary integrative review (IR), it was used to identify
interventions targeting one or several needs domains (physical and informational) as well as the
domains that have been historically neglected in interventional research (spiritual). It has helped
identify a validated instrument to measure the SC needs of advanced disease PC survivors due to the
similarities between the framework, and the Supportive Care Needs Survey (SCNS) domains (Aim
1).32 It will help inform the development of the qualitative interview guide because of its holistic view
of SC for cancer (Aim 2).32,42-44 Finally, it will guide the categorization and interpretation of the
findings, identifying needs across domains that are particularly prevalent and can impact these
survivors’ QOL negatively and ultimately, their health outcomes (Aim 3).29,32,38
E. Approach
E.1. Preliminary work
The PI conducted an IR previously on SC interventions with reported outcomes for advanced
disease PC survivors. Guided by the domains of the SCNCCF, the review showed that SC
interventions are limited, often representing the physical and informational domains only, despite the
high prevalence of overlapping unmet needs in this population and current survivorship care
guidelines and recommendations. SC interventions have the potential to improve the QOL and health
outcomes of advanced disease PC survivors. However, advanced PC survivors should be recruited to
help inform the development of holistic, patient-centered, multi-domain SC interventions.
E.2. Interprofessional Team
The research team for this mixed-methods study includes a vast array of complementary expertise.
Mrs. Alejandra Schimmel is the primary investigator (PI) and has expertise in urological surgical
oncology. She has worked with multidisciplinary teams for over 10 years. Dr. Qanungo is the
committee Chair and brings unique expertise in both cancer research and overall research
methodology. She has investigated physical, emotional, and psychosocial needs in diverse
communities, both locally and globally. Dr. Newman brings extensive expertise in qualitative
research methodology and has extensively investigated quality of life-related issues in patients with
several chronic conditions. Dr. Sterba is a behavioral scientist whose work in cancer survivorship care
and QOL has been widely recognized. Dr. Mueller is an advanced nurse expert in conducting
complex biostatistical analyses; she will provide statistical support for the study.
E.3. Design Overview
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This study will employ a convergent parallel mixed-methods design guided by the SCNCCF. This
design aims at obtaining a more in-depth understanding of the unmet SC needs of advanced disease
PC survivors, as well as the relationship of these with QOL, disease stage, and several other sociodemographic and clinical variables, by collecting and analyzing two independent sets of
complementary data concurrently (quantitative and qualitative). Equal priority and importance will be
given to both methods in addressing the research question.45 The quantitative data collection will be
done at a national level, and it will include a survey specifically developed to measure the perceptions
of unmet SC needs and QOL. The qualitative data collection will focus on the survivors’ perceptions
of unmet SC needs and QOL through key-informant semi-structured interviews. Deductive-inductive
content analysis (coding) of the interviews will then be performed using the SCNCCF as a guide to
identify and quantify common themes.45-47 The merging and integration of the two sets of results will
occur during the combined interpretation of the findings. This integration will allow a well-rounded
new interpretation about the prevalence and type of unmet SC needs, so future development and
implementation of comprehensive, holistic, patient-centered, guideline-based, and culturally
appropriate SC interventions can be better informed.45 Due to the current COVID-19 extraordinary
circumstances, all recruitment and data collection efforts will be performed remotely.
E.4. Mixed-Methods Methodology
The three study aims, and the secondary aim, are presented individually below.
Aim #1: To characterize unmet supportive care needs and QOL in advanced disease PC
survivors using a nationally administered survey.
We will administer a cross-sectional online survey nationally using REDCap (Research Electronic
Capture Data) with the goal of collecting quantitative data from 200 participants who have advanced
disease PC over 3 months. The survey will include a cover page with relevant study information, the
PI’s contact for questions, and a screening questionnaire with 5 questions. The survey will include a
brief sociodemographic and clinical questionnaire and several validated instruments aimed to capture
unmet needs and QOL in cancer populations. A descriptive, correlational design will be used to
measure the participants’ perception of the prevalence and type of unmet SC needs according to the
domains of the SCNCCF. We will also examine the relationship between unmet SC needs and QOL,
as well as age, race, ethnicity, insurance status, marital status, time since diagnosis, disease stage,
treatments, and time confined for COVID-19. Although not suitable to establish a causal relationship,
this approach may give a better understanding of the underlying mechanisms accounting for the
possible relationship between the study variables.48
E.5. Setting
After securing approval from both, the MUSC Hollings Cancer Center Protocol Review Committee
(PRC) and the Institutional Review Board (IRB), participants for the survey will be recruited from
several settings:
• MUSC urological clinics including Hollings Center Clinics. MUSC is one of the most
recognized centers for urological services nationally. It possesses the most modern
diagnostic, staging, and multi-modal therapeutic capabilities for PC, providing
comprehensive care to more than 2000 PC patients currently.49
• Online research volunteer websites such as Research Match (RM).
• Online PC support groups and organizations including but not limited to American Cancer
Society (ACS), Prostate Cancer International (PCI), Prostate Cancer Research Institute,
Cancer Support Network (CSN), The Reluctant Brotherhood, The South Carolina Cancer
Alliance (SCCA), and YANA.
• Online Social Media advertisement (Facebook, Instagram)
E.6. Sample Population and Eligibility
The PI will use a convenience, non-probability sampling strategy to recruit participants. This
sampling approach, which prioritizes accessibility and availability, is one of the most applicable and
widely used methods in nursing clinical research.45,50 Inclusion criteria are having an advanced
disease PC diagnosis (stages III, IV, recurrent); being 18+ years; being able to read, understand, and
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speak English; and residing in the United States. Minors are excluded because it is extremely rare
having a PC diagnosis during that stage of the lifespan. Exclusion criteria are being enrolled in
palliative/hospice care and having a physical or mental impairment preventing from computer use to
complete the survey (Appendix B).
E.7. Sample size determination and Power Analysis
A correct sample size is critical to ensure accurate conclusions and not lose study rigor.51 The
sample size was determined using GPower version 3.1.9.6 to calculate the observable effect size
(correlation here r=0.2, based on Alpha=0.05, Power=80% and an expected sample size of at least 200
survey respondents) between unmet supportive care needs and quality of life (both continuous
variables).
E.8. Procedures
E.8.1. Recruitment and Retention Strategies
The quantitative component will require a representative cohort of 200 socio-demographically diverse
men who suffer from advanced PC. For MUSC-wide urological clinics, the PI will submit a SPARC
Research Data Request, which will be performed via an Honest Broker, to assist with identification
and recruitment of potential eligible participants with PC from MUSC medical records. Through the
Honest Broker, the PI will gather the telephone number, and email of prospective participants who
have agreed to be contacted for future research by logging their MUSC Research Permissions
preferences in MyChart. All MUSC eligible participants who did not opt-out will be recruited by
sending the secure link to the survey directly via email. For eligible potential participants who did not
opt-out but did not have an email address listed on their chart, recruitment will be done by phone; the
PI will verbally explain the study answering any questions and if interested, will ask for an email
address to send them the secure survey link. For RM participants, an initial invitation will be sent
through the RM electronic site, after the PI fills up a recruitment request. A de-identified “contact
volunteers” page will be provided to the PI by RM with all potential participants. The PI will select
diverse, potentially eligible participants to send them a contact message with the secure REDCap
survey link. Potential participants through PC support groups and organizations will be recruited by
posting an electronic flyer with or without the secure survey link (depending on the organization
policies) on their social media sites (e.g., Facebook, Instagram), news web site, discussion forums, or
invitations to meetings (Appendix C). If the potential participant contacts the PI, all relevant
information about the study will be explained. Any questions will be answered and if the potential
participant is interested, they will be asked to provide a valid email address so that the secure survey
link can be sent.The opportunity to participate in the online survey will be also electronically
disseminated through general and public advertising on various social media platforms and outlets
(including Facebook and Instagram). For all participants, no matter the setting, the survey will finish
with an option to express interest in participating in the qualitative interview (Aim #2). Retention
strategies to minimize attrition will include an electronic $10 gift card as compensation upon
completion of the entire survey. The participants will be asked to provide an email address of their
preference at the end of the survey so that the PI can send them the gift card. The PI will be
responsible for funding and sending all the compensation electronic gift cards.
E.8.2. Screening and Assignment of Participants
The eligibility screening, regardless of the setting, will be determined solely on the inclusion and
exclusion criteria. The screening will be performed via a screening questionnaire with 5 questions
located on the survey cover page. The ones meeting the criteria will be assigned as participants
enrolled in the study. For participants who do not meet the criteria, REDCap will take them to a
screen that will thank them for their time, and they will automatically exit the survey.
E.8.3. Informed Consent
The PI will request a MUSC Hollings Center PRC since potential participants may be recruited
from its urological clinics. The PI will also request a waiver of informed consent to the MUSC IRB
under qualifying category 2, since no interventions will be performed during the proposed study. A
statement of research will appear on the cover page of the survey, and it will include the study
purpose, risks, as well as study aspects being measured, how long the survey should take to complete,
and an assurance of confidentiality. Potential participants will also be informed that they are free to
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exit the survey at any time and for any reason. To progress to the screening questions, they will need
to check a box that indicates their agreement to participate.
E.9. Data Safety and Management
During the MUSC Research Data Request, the Honest Broker will provide the PI with the name,
email, and phone number of potential participants who have agreed to be contacted for future research
for recruitment purposes only. The data will be kept in a password protected MUSC server.
Participant’s email address will be requested at the end of the survey so that the gift-card
compensation can be sent. A telephone number will also be collected at the end of the survey, but
only if the participant records their interest to be contacted for the qualitative interview (Aim #2).
REDCap, provided through South Carolina Translational Research (SCTR), will be used to develop
and store the survey following MUSC s’ data storage requirements. REDCap is a password-secure,
web-based application created with the objective to support data capture for research.52 The PI will
perform all the data management procedures (assessment of completeness and analysis). The
participants’ identifying information (name/email/phone) will not be connected to any survey
responses and will not be disclosed to any non-study or non-regulatory personnel. Each participant
will be assigned a case number that will be referenced on all study procedures. The PI will be
responsible for safeguarding the data (e.g., survey, SPSS files) throughout the study by monitoring the
secure data storage daily and appropriately reporting any protocol deviation, including privacy
breaches and conflicts of interest, to the IRB and the study team. The passwords for the access to the
REDCap study database will be available to the PI, with rights assigned to the study team (for
consultations regarding emerging results but not for editing the actual database).
E.10. Data Collection
E.10.1. Instruments
Supportive Care Needs Survey-Short Form 34 (SCNS-SF34): The participants’ unmet SC needs will
be measured with the SCNS-SF34. The SCNS-SF34 is a self-administered questionnaire that consists
of 34 items mapped onto five domains: physical & daily living (5 items), health care & information
(11 items), psychological (10 items), patient care & support (5 items), and sexual (3 items).
Responses are scored on a five-point Likert scale dichotomized by need level to distinguish between
those with “no current needs” (1-2), versus those with “some degree of need” (3-5). Scoring will be
done by calculating a Likert summated scale: summing the individual items within each domain. The
summated scale can be standardized by summing the individual items, subtracting m (the number of
questions within a subscale), and then multiplying the resulting value by 100.32,42,53,54 This instrument
has robust similarities with most relevant domains of the framework guiding this study and was
originally created to obtain a direct index of cancer patients’ perception of their unmet SC needs.32,53,55
Although the long and the short forms are recommended for use in assessing unmet needs in cancer
patients, the second-generation core SF-34 survey has been recently created from the long-form after
further psychometric development.53 The SCNS-SF34 has been successfully utilized in multiple
studies with advanced cancer patients and has an excellent patient acceptance rate. Scores are reported
standardized. The SCNS-SF34 possesses high internal reliability, internal consistency, and strong
content validity.55
SCNS PC Module: This module will be used to measure PC-specific unmet needs. It is selfadministered and applies to any PC disease stage, treatment modality and time since initial diagnosis.
It consists of 7 additional items (with the same SCNS response set) assessing unmet needs associated
with urinary and bowel functions, as well as masculine self-image.53 Scoring will be done the same
way as the SCNS-SF34.
Functional Assessment of Chronic Illness Therapy - Spiritual Well- Being (FACIT-Sp): The
integrative review findings showed that the spiritual domain is as influential for this population as the
other 6 domains, primarily as a coping resource. However, so far, this domain has been neglected in
advanced cancer needs assessment questionnaires and interventional research. Since the SCNS-SF34
does not include a spiritual domain, the PI will use the FACIT-Sp 12 questionnaire. The FACIT-Sp 12
is a subscale of a longer questionnaire and it is the most widely used scale for spiritual well-being in
patients with cancer.56 It contains 12 items with summary scores ranging from 0 to 48. The instrument
identifies the items that must be reversed before being summed. Once reversed, all subscale items are
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summed to a total. A higher subscale score indicates greater spiritual well-being. This subscale has
been validated across multiple cultures and has strong reliability.56,57
European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire
(EORTC QLQ-C30): Participants’ health-related QOL, will be measured with the EORTC QLQC30. The EORTC QLQ-C30 is an integrated system consisting of 30 items and intending to measure
global health in patients who have cancer. It is composed of multi-item subscales and single-item
measures. It includes 5 functional scales (physical, role, cognitive, emotional, social), 3 symptom
scales (fatigue, pain, nausea & vomiting), a global health status (1 item) and a QOL (1 item) scale,
and 6 single items for symptom measures. It uses a 4-point response set for all the items except for the
health status and QOL scales, which are measured on a 7-point scale. Scores are calculated by scale or
by item and transformed into a 0 to100 scale with higher summary scores representing higher QOL or
higher level of symptomatology. The mean score, standard deviation, and range will be reported. The
EORTC QLQ-C30 is considered an excellent instrument to measure QOL and has been widely
employed in studies with different cancer populations, including PC.4,12,58
E.10.2. Data Collection
The PI will collect quantitative data through a survey distributed electronically using REDCap.
The actual survey will have two sections: first, a brief sociodemographic and clinical questionnaire,
and then, several reliable and validated instruments (Appendix D). To adapt the instruments for this
study, the PI made a minor change to the FACIT-Sp questionnaire, modifying its time frame from 7
days to one month so that all the unmet needs findings are meaningful around the same specific
timepoint.59 If possible, The PI will pretest the survey with 1-2 volunteers for clarity and flow. Data
will be collected at a single point in time. To overcome commonly existing survey low response rates,
participation and completion will be encouraged by ensuring confidentiality, by reposting the
advertisement on support groups and organizations sites every 2 weeks, by sending 3 friendly
reminders to potential participants who did not complete the survey the first time (after 3, 6 weeks,
and 9 weeks) and by offering compensation for their time.48,60 The survey will be available for
potential participants for 3 months. Table 1 summarizes a description of the variables in this study, as
well as the data sources for all the variables and the psychometric properties of all the instruments.
The completion of the survey will take approximately 15-20 minutes.
Table 1- Study variables and measures
VARIABLE

MEASURE

PSYCHOMETRIC PROPERTIES

Age, race, ethnicity, marital status, education
level, employment status, insurance status

Brief socio-demographic/clinical survey

n/a

PC stage at diagnosis, time since initial
diagnosis, treatments received, current stage

Brief socio-demographic/clinical survey

n/a

Quality of Life (subjective)

- EORTC QLQ-C30

- EORTC QLQ-C30: Cronbach’s α coefficients
between .70 and .96.58

Perceived Unmet Needs (subjective)

- SCNS-SF34
- SCNS PC module
- FACIT-Sp 12

- SCNS-SF34: Reliability coefficients Cronbach
Alpha .86-.95 and internal validity coefficients .87.96 53
- SCNS-PC: Preliminary evidence indicates
internal consistency & reliability 53
- FACIT-Sp 12: Cronbach’s α coefficient .87 57

E.11. Data Analysis
Rigorous data analysis in mixed-methods research involves several steps: 1) prepare the data for
analysis, 2) explore the data, 3) analyze the data, 4) represent/display the data, 5) interpret the results,
and 6) validate the data and results.45 The PI will prepare the quantitative data for analysis by
exporting the data from REDCap into SPSS v26 software, by visually checking for errors in the
database, and by recoding variables as appropriate. The exploration of the data will include creating
frequency distributions to determine missing data and checking the amount and pattern of the missing
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data, which is paramount to maintain the overall integrity of the research. If the missing data represent
less than 5% of the entire data, SPSS will use listwise deletion by default.51,63 If missing data are
between 5% and 30%, multiple imputation (MI) will be performed using SPSS so that participants are
not lost due to SPSS deletion. MI uses available data to predict respondents’ missing values, given
their observed values on other variables. This procedure has been demonstrated to yield the best
estimations of missing data. Its benefits include no loss in statistical power and maintenance of
internal and external validity against biases resulting from nonresponse.51,63 If more than 30% of the
data are missing, the variable will be deleted altogether.
The PI will analyze the data using the SPSS v. 26 software package. Descriptive statistics will be
used to summarize the sample characteristics – means and standard deviations for continuous
variables and frequencies, proportions, and ranges for categorical variables – and the level of unmet
needs – by reporting the prevalence (%, mean, standard deviation, range) per domain and individually
per item, as well as the total score.
The PI will also assess the frequency with which respondents reported each item as moderate/high
need (at least 25% of the sample).34 Assuming normal distribution, a bivariate correlational analysis
with Pearson’s r computation will be performed to determine the strength and direction of the linear
relationship between each domain of unmet SC needs and QOL as well as between each domain of
unmet needs and several socio-demographic and clinical variables (age, race/ethnicity, marital status,
insurance status, stage, time since diagnosis, treatments received, and confinement time for COVID19). If data are non-normally distributed but the sample is large (above 20), type I and II errors will be
minimized by calculating non-parametric Spearman s’rank-order instead. 51 The PI will also conduct
appropriate statistical analyses to compare socio-demographic (age, race/ethnicity, insurance status,
marital status, confinement time), and clinical characteristics (disease stage, years since diagnosis,
treatments received) by SC unmet needs domain. In addition, the PI will perform a series
of regression analyses to examine whether unmet SC needs can be predicted by age, stage, treatment
received, years since diagnosis, race/ethnicity, insurance status, marital status, and confinement time.
Also, linear regression will be conducted to investigate if QOL is predicted by SC unmet needs. The
results of both, the descriptive statistics and the inferential statistical tests, will be represented using
tables and graphs for a better visualization. The results of the tests will be compared and contrasted
with the two Aim 1 hypotheses and interpreted with reference to prior studies from the literature,
considering the limitations of the proposed study. Data validation will rely on the already established
construct validity and reliability of all the instruments used during the data collection.45,51
Aim #2: To explore the implications of physical, emotional, social, psychological, spiritual,
informational, psychological, and practical needs in advanced disease PC survivors’ quality of
life.
This component will follow a qualitative descriptive methodology and involves a separate brief
socio-demographic and clinical questionnaire and an individual semi-structured key-informant
interview conducted via telephone or Doxy.me, a secure telehealth platform that uses encryption
protocols ensuring data integrity and privacy. Doxy.me is free, user-friendly, and HIPAA compliant
platform that enables real-time audio-visual communication.64 Qualitative description is the optimal
methodology as the proposed study has a mixed methods design and it seeks information to
understand and to describe the phenomenon under investigation from those directly experiencing
it.45,65
E.12. Setting
The participants will be recruited from several settings. All of the participants enrolled in the
quantitative component of the study (Aim #1) will be invited to participate in the qualitative
component (Aim #2). In addition, the online PC support groups and organizations will advertise the
study via flyer as described in Aim #1 for both, the survey and /or the qualitative interview. For this
qualitative portion, the PI will solely interview PC survivors who suffer from advanced disease PC
(stages III, IV, recurrent).
E.13. Sample and Eligibility
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To ensure a diverse representation of all PC advanced stages, ages, and races/ethnicities, the PI
will use a purposive sampling plan. The PI will select and recruit up to 30 participants until data
saturation - no new information from the participants’ interviews - is achieved.65 The primary
inclusion criteria will be advanced disease PC (stages III, IV, recurrent); being +18 years; being able
to read, speak, and understand English; and residing in the United States. Exclusion criteria will
include being enrolled in palliative/hospice care and having a physical or mental impairment that
prevents telephone or computer use (Appendix B).
E.14. Procedures
E.14.1. Recruitment and Retention Strategies
The PI will select and contact a diverse sample of enrolled participants who have completed the
survey (Aim #1) and who have provided a phone number. Participants will also be recruited via flyer
from online support groups and organizations, until data saturation is achieved. The PI will schedule
the key-informant interview at a day/time of the potential participant’s choice, either via telephone or
electronically (Doxy.me). The PI will maintain a recruitment log to track all participants who were
selected, contacted, recruited, screened, and enrolled for the interview.
Retention strategies will include scheduling the interview at a day/time of the participant’s choice.
Interviews will be held by telephone or Doxy.me based on availability and participant’s preference.
Attrition will be minimized by obtaining additional contact information during the first contact (a
family member or friend), by offering a $20 electronic Amazon gift card as compensation upon
completion of the socio-demographic questionnaire and interview, and by sending an electronic
thank-you card as a way to leave a more long-term positive effect.66 The PI will request an email
address of their preference at the end of the interview so that the gift-card compensation and the
electronic thank-you card can be sent. The PI will be responsible for funding and deliver all the
electronic gift cards and the thank-you cards.
E.14.2. Screening and Assignment of Participants
Eligibility screening will vary according to the recruitment setting. For the participants enrolled
via quantitative survey, the PI will explain the study purpose and risks involved and answer any
questions during the initial contact. Once the potential participant expresses interest in participating in
the interview, the PI will screen for eligibility based on the inclusion/exclusion criteria by asking the
same 5 screening questions than on the survey. If agreed, the participant will be enrolled in the
qualitative part of the study. For potential participants who contact the PI via electronic flyer through
support groups and organizations, the PI will explain all the pertinent aspects of the study (purpose,
risks, confidentiality) and answer any questions during that first contact. If interested, the PI will
screen them for eligibility based on the inclusion/exclusion criteria by asking the 5 same screening
questions. If the criteria are met, the PI will enroll the potential participant for the semi-structured
interview.
E.14.3. Informed Consent
The PI will secure a PRC from the Hollings Center and a waiver of informed consent under
qualifying categories 2 for both aims since no interventions will be performed. Regardless of the
interview method, prior to start, the PI will provide a statement of research to inform the enrolled
participants about all pertinent aspects of the study, including risks, benefits, special protections,
audio recording, and assurance of confidentiality. The PI will answer all of their questions. The PI
will also inform them how long the interview will take to complete and that they can take a break or
withdraw from the interview altogether at any time and for any reason. The participant will have to
provide verbal consent to continue with the interview.
E.15. Data Safety
The PI will perform all the data management procedures. The participant’s name will be collected
during the interview for addressing purposes only. The participants’ telephone and email will be
collected during the recruitment for eligibility screening, and interview scheduling purposes.
However, all identifiable information used prior and during the interview will not be connected to any
data on the interview transcripts or the brief socio-demographic and clinical questionnaire files. The
brief socio-demographic survey will be computer-based and will be uploaded securely into a
password protected REDCap database according to MUSC storage requirements. Interview audio
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recordings will be transcribed for analysis using Rev.com (MUSC-approved), and then, uploaded, deidentified, to a password-protected MUSC Box storage folder to maintain participants’
confidentiality. Afterwards the hard copies of the recordings will be erased from the portable device.
The recruitment log and the reflective journal notes (de-identified) will be uploaded into passwordprotected secure Box files. Each participant’s transcription will be assigned a case number to be
referenced on all study procedures. Data safeguarding and passwords handling are described above on
E.9.
E.16. Data Collection
Up to 30 semi-structured, in-depth, one-time interviews will be performed over 3 months to
explore the implications of physical, emotional, social, psychological, spiritual, informational, and
practical needs in advanced PC survivors’ QOL. The interviews will take place via telephone or
Doxy.me. The interviews will be scheduled at a day/time that is convenient to the participants. Before
the interview, the PI may ask every participant to complete a separate brief demographic and clinical
questionnaire, which will include race/ethnicity, age, education level, marital status, employment
status, insurance status, PC stage at the time of diagnosis and currently, time since the initial
diagnosis, treatments received, and some COVID-19-related questions. The PI developed an interview
guide informed by the literature and guided by the SCNCCF with the objective to capture the seven
domains of needs (Appendix E). Two open-ended, non-directive questions will encourage
participant’s free expression regarding life with PC and current needs. The remaining guided
questions will allow participants to elaborate on what is relevant to them about their current unmet
needs, including any existing differences during COVID-19 pandemic, and care planning based on the
7 domains of the framework. The PI will use probes throughout the interview to elicit clarifications
and/or additional explanations or to redirect the participant.45,67 Notes on a reflective journal will also
be taken to describe the PI’s impressions and feelings about the interview. The interview will take
between 45-60 minutes to complete. All interviews will be audio-recorded with an external portable
recorder and transcribed using a professional MUSC-approved transcription service (Rev.com). The
transcripts will be de-identified, uploaded into a secure folder in Box, and entered into NVivo12 data
analysis software for coding and analysis.
E.17. Data Analysis
E.17.1. Demographic characteristics
The socio-demographic and clinical data collected via the brief survey will be stored securely in
REDCap and analyzed using the NVivo12 software. The PI will use descriptive statistics to analyze
and present the sample characteristics. Measures of central tendency (mean & standard deviation),
frequencies, and measures of dispersion (range) will be reported for all the participants’ demographic
and clinical variables.
E.17.2. Analysis of the survivors’ interview
The unit of analysis will be the interview. After each interview is transcribed using Rev.com, the
PI will perform a comparison between the transcript and the original audio-recording to ensure
content accuracy. Qualitative deductive-inductive content analysis will be conducted as soon as
possible after the interview using NVivo12 qualitative data analysis software to provide a rich account
of the data collected during the interviews.68,69 Commonly used in nursing research, deductiveinductive content analysis aims at both, quantifying and describing the phenomenon under
investigation so that new insight or knowledge can be established.70,71 For each interview, the PI will
use the following analytic strategies: (1) read the transcript, (2) deductively-inductively code the data
until common themes related to unmet SC needs emerge, (3) consider the emergent needs within the
domains of the SCNCCF, (4) look for commonalities and differences among the data and the codes,
(5) determine on common themes generated from the data/codes, (6) use the analysis of each
interview to inform subsequent interviews, by adding questions to the interview guide based on the
data collected/analyzed from prior interviews.45,70,71 The PI will follow an iterative comparative
method throughout the entire data collection and analysis period until data saturation is achieved. The
PI will keep a codebook with coding schemes and definitions as part of the study audit trail. The
outcome of the qualitative component of the study will include a descriptive summary of the data
contents organized according to the SCNCCF domains of needs. The representation of the qualitative
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data analysis results will include a thematic description of the examples of participants’ vivid quotes
for each of the emerging theme categories.
Aim # 3: To identify advanced disease PC survivors’ unmet SC needs by merging and
synthesizing survey and interview findings.
E.18. Overview
In Aim 3, the results from the surveys (Aim 1) and the semi-structured interviews (Aim 2) will be
merged for analysis. Both strands of data will be given equal emphasis. The goal is to compare both
quantitative and qualitative data to find similarities, differences, and/or inconsistencies (Figure 1).45
The PI expects to identify the prevalence and type of unmet SC needs in advanced disease PC
survivors, to determine a correlation between those needs and QOL/disease stage, and how some
socio-demographic and clinical characteristics may affect or predict SC unmet needs so that future
research and development of holistic, patient-centered SC interventions can be informed.
Figure 1. Merging of both sets of data.
Quantitative data
collection & analysis

Qualitative data
collection & analysis

Integration:
merging
quantitative +
qualitative data
results

Interpretation

E.19. Data Analysis
The data from Aims 1 (quantitative) and 2 (qualitative) will be collected concurrently but analyzed
independently. Merging and integration of both threads of results will occur in a separate, subsequent
step. The PI will review and synthesize both sets of results to compare and contrast emerging themes
and understand mechanisms underlying unmet needs experiences, which will be organized according
to the domains of the SCNCCF. For example, a SC need that appears disparately burdensome seen
during an interview will be compared/looked for evidence in the quantitative data and vice versa. 45,68
A joint display will be created to assist with the interpretation of the results – focusing on the extent to
which both sets of results produce a more comprehensive understanding of the prevalence and type of
unmet SC needs in advanced disease PC survivors.45
Secondary Aim: To evaluate the feasibility of the research methodology in assessing advanced
PC survivors’ SC unmet needs for future applicability in similar clinical problems and
populations (participant recruitment, enrollment, and consenting strategies as well as the data
collection methods - survey and interview).
E.20. Overview
To the best of our knowledge, the SC unmet needs of advanced disease PC survivors have not
been examined using a mixed-methods design with a large sample. Several sources of data will be
used to measure and evaluate the preliminary feasibility of the research methodology in assessing the
unmet SC needs of this population. The feasibility components and quantifications for are displayed
in Table 1. These quantifications will be measured for both, the quantitative and qualitative
components using logs.
Table 1. Feasibility components/Quantification measures
Study component
Recruitment plan & procedures

Recruitment (survey & interview)
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Feasibility quantification
Number of participants sent the survey/ contacted the PI or
by the PI

Data collection procedures

Attempts to contact / reminders (survey &
interview)
Approaching (survey & interview)
Screening (survey & interview)
Response (survey & interview)
Completion rate
Psychometric properties (survey only)
Reliability of questionnaires (survey only)
COVID-19 response

Number of attempts necessary more than initial
Number of participants being informed about study
Number of eligible & ineligible participants
Response rate
Number of surveys/interviews with complete data &
reasons for not completion
Established reliability & convergent validity coefficients
Calculation of Cronbach Alpha for existing sample
Number respondents shared COVID-19 info versus PC info

E.21. Data Collection
Data collection on the recruitment and procedures will be an iterative process and will last 3
months. As potential participants for Aims 1 and 2 are approached, contacted, recruited, screened, and
enrolled, entries will be recorded on logs (for the quantitative and qualitative aims). As surveys are
received or interviews are conducted, the data (response and completion) will also be recorded on the
same logs, which will be securely stored in Box. The psychometric properties of the instruments will
be obtained from the literature and recorded on the log as well. The PI will calculate the reliability
coefficient Cronbach's alpha to determine the suitability of the questionnaires for this specific sample.
E.22. Data Analysis and Reporting
The feasibility outcomes, their definition, and the results will be represented as a table or figures
for a better visualization. All the rates will be calculated and reported as amounts and percentages.
The PI will also provide a 95% confidence interval (CI) for means for all continuous feasibility
outcomes.
E. 23. Potential Problems and Alternate Approaches
The study faces several challenges: convenience and purposive sampling plans, unequal
quantitative and qualitative sample sizes, participants’ fatigue/boredom, erroneous data, recall bias
(inability to recall properly due to a prolonged illness pathway) , social desirability response bias
(responses to survey and/or interview questions are intended to please the study team), failure to
resolve conflicting results, and study rigor.71,72 To minimize these challenges, the PI’s recruitment
plans include several and varied settings to add diversity. The PI has secured support from several PC
support groups and organizations gatekeepers to advertise the electronic study flyer on their sites. The
survey and the interview are designed to be completed in the least amount of time to prevent fatigue
or boredom from happening. Erroneous data will be overcome by exploring the data carefully and
implementing the appropriate strategies as needed (e.g., deletion). The social desirability response
bias will be mitigated by establishing appropriate rapport with the participants, educating them about
the importance to respond to all the questions honestly, by emphasizing that there are no right/wrong
responses, and by ensuring them that all the responses will be treated confidentially.71 To overcome
recall bias, the interviews will be scheduled as soon as possible after the recruitment and with the
participants preferences in mind (method, day, time). The PI will also engage in strategies to explain
and represent potentially conflicting results from both components.45
Quantitative rigor will be maintained by recruiting a diverse sample of participants, by reaching
the sample size target, by applying sound statistical processes, and by using previously validated
instruments to collect the data. Qualitative study rigor will be maintained in several ways. The PI will
ensure trustworthiness through credibility, dependability, confirmability, and transferability.
Credibility will be established by the statement of research conducted before the interview to create
rapport and by conducting several levels of data coding. Dependability and confirmability will be
achieved through an audit trail of data collection and analysis procedures, description of the sample
characteristics, and the inclusion of direct quotations as evidence of the raw data collected.
Transferability will be ensured by applying the sampling strategy, and by providing sufficient details
regarding the data collection process, so that replicability can be achieved.48,65,67
E.24. Study Timeline
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Table 1. Study timeline
Study Objectives

Anticipated Time of Completion

Secure PRC approval
Secure IRB approval
Participant recruitment
Data collection
Data analysis
Manuscript preparation
Submission of entire compendium

4/2020-5/2020
5/2020-6/2020
6/2020-9/2020
7/2020-9/2020
7/2020-9/2020
9/2020-10/2020
10/2020-11/2020

F. Human Subjects
F.1. Risks to the Subjects
a. Human Subjects Involvement and Characteristics
There will be 200 study participants for Aim #1 who will be recruited from MUSC urological clinics,
RM, several online support groups and organizations as well through general and public advertising
on various social media platforms and outlets (including Facebook and Instagram). Eligibility
screening will be performed via the 5 questions on the survey cover page. To ensure diversity, the
sample will include various adult ages, races/ethnicities, disease stages, current treatments, time since
diagnosis, level of education, marital status, and national locations. A preliminary feasibility report
done at MUSC urological clinics in February 2020 determined that there were 2,490 potentially
eligible participants, with ages ranging from 36 to 90 years. The races were distributed as 57% White,
40% Black, and 3% unknown. Ethnicity was 96% non-Hispanic (Appendix F). We anticipate
recruiting a sample with similar sociodemographic characteristics.
For Aim #2, all of the participants enrolled for Aim #1 will be invited to participate in the
qualitative component (Aim #2). Additionally, study participants will be recruited from online support
groups/organizations. A purposeful sampling approach will be used to select and recruit a diverse
sample with regard to age, race/ethnicity, and advanced stage. The PI will attempt to recruit up to 30
participants for semi-structured interviews until data saturation is achieved. The interviews will be
conducted via telephone or Doxy.me according to the participant’s preference and availability. We
will request a PRC to the Hollings Center and an exemption of the informed consent based on
qualifying category 2 to the MUSC IRB prior to sending any survey or conducting any interview.
b. Sources of Materials
The PI will collect potential participants’ name, email, and telephone from the SPARC Research Data
Request (conducted by an Honest Broker service) if they have indicated on MyChart that they would
like to be contacted for future research. The only sources of data obtained from human subjects are
described in the above research protocol. These include:
• Sociodemographic and pertinent clinical data
• Electronic data from survey information
• Audio-recordings, transcriptions, and reflective journal notes from the qualitative
interviews
• A telephone number on the survey only if the respondent is interested in participating
in the interview
• A preference email address to send the electronic gift card and the thank-you cards
• A name for addressing purposes during the interview
This information will be stored in password protected MUSC servers REDCap and Box. All data
will be used for research purposes only and the PI will make every effort possible to keep these data
confidential. No identifiers will be connected to any survey or interview data. Neither will identifiers
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be used in any publications resulting from this study. However, the survey and/or interviews
transcripts data may be used in future studies and/or publications.
c. Potential Risks
The PI does not expect significant risks to human subjects related to the completion of the
electronic survey and the semi-structured interviews. It is possible that collecting this information
poses a minimal risk to confidentiality. There is also minimal risk that participants may experience
emotional distress, boredom, or fatigue as they reflect on past experiences or as they answer a specific
question or survey item. But the study poses no physical, social, or legal risks.
To mitigate potential risks, the PI will provide participants with a statement of research with all the
pertinent study information before the survey/interview. The PI also will conduct a debriefing session
after the semi-structured interview. In case the debriefing fails to relieve any emotional distress that a
participant experiences, the PI will arrange a referral to an available health care provider or an
emergency room for further evaluation. All participants will be reminded that they can discontinue
their participation in the study at any time and for any reason. In the event of a life-threatening
emergency, the PI will call emergency services (911).
F.2. Adequacy of Protections Against Risks
a. Recruitment and Informed Consent
Aim #1: For MUSC-wide urological clinics, the PI will submit a SPARC Research Data Request via
an Honest Broker, to assist with the identification and recruitment of eligible participants (who have
advanced prostate cancer diagnosis - stages III, IV, recurrent) from MUSC medical records. The
Honest Broker will provide the PI with the name, telephone number, and email of prospective
subjects who have agreed to be contacted for future research by logging their MUSC Research
Permissions preferences in MyChart. These participants will be approached, recruited screened, and
enrolled directly by sending the secure link to the REDCap survey via email. For MUSC eligible
participants who did not opt-out but did not have an email address on file, approaching and
recruitment will be done by phone; the PI will verbally explain the study answering any questions,
and if interested, the PI will ask for an email address to send them the secure survey link. Screening
and final enrollment will be done via the survey link. RM participants will be sent an initial invitation
via electronic flyer through RM, after the PI fills up a recruitment request. RM will provide the PI
with a de-identified “contact volunteers” page with all potential participants. The PI will select
diverse, potentially eligible participants to send them a contact message with the secure REDCap
survey link. Potential participants through PC support groups and organizations will be recruited by
posting an electronic flyer with or without the secure survey link (depending on the organization
policies) on their social media, news web site, discussion forums, or invitations to meetings, as
described in E.8.1. If the potential participant contacts the PI, all study pertinent information will be
explained, and any questions will be answered. If interested, a valid email address will be asked to
send the secure survey link. The opportunity to participate in the online survey will be also
electronically disseminated through general and public advertising on various social media platforms
and outlets (including Facebook and Instagram). Regardless of the setting, the survey participants
will have the choice to indicate their willingness to participate in the qualitative semi-structured
interview by selecting the option at the end of the survey. REDCap will notify the PI of all
participants interested in doing the interview so that the PI can select them based on age, stage, and
race/ethnicity diversity and contact them via telephone to screen for eligibility. Participants who
complete the entire survey will receive an electronic $10 Target gift card as compensation.
For Aim #2, participants will be invited to participate via the quantitative survey, which will
provide a checkmark at the end as well as a space to submit a phone number for contact. Participants
will also be recruited by electronic flyer via several online support groups and organizations.
Regardless of the setting, all study pertinent information will be explained, and any questions will be
answered during the initial telephone contact. If interested, screening will be conducted as described
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in E.14.2., and the interview will be scheduled at a day/time of the participant’s choice via telephone
or Doxy.me depending on availability and/or preference. Participants who complete the brief sociodemographic and clinical questionnaire interview will receive an electronic $20 Amazon gift card as
compensation for their time.
The PI will request a PRC to the Hollings Cancer Center and a waiver of informed consent for the
entire study to the MUSC IRB based on qualifying category 2, since the proposed study does not
involve any interventions. On the survey, a cover page will serve as a written statement of research
and it will include the study purpose, potential risks, the study aspects being measured, time that the
interview will take to be completed, and an assurance of confidentiality. Participants will also be
informed that they are free to exit the survey at any time without any reason. Respondents will need to
check a box to agree to participate and continue on the survey (Appendix D).
For the qualitative component, the PI will provide a verbal statement of research before the
interview by informing the potential participants about all aspects of the study, including potential
risks, special protections, topics discussed, time needed to complete the interview, and assurance of
confidentiality. The PI will answer all of the questions and inform them that they can take a break or
withdraw from the interview at any time and for any reason. The participant will need to provide
verbal consent to participate All participants, from both, the survey and the interviews, will be
provided with the PI telephone and email address in case they need to contact the PI at any time.
The PI and all other study team members have completed the required human participants research
training courses (e.g., Miami CITI) as well as the mandatory HIPAA training. A log will be kept in a
password-protected Box folder and will include information regarding participant’s date of approach,
recruitment, screening, enrollment, and survey/interview completion as well as the survey completion
rate for analysis purposes of the secondary aim (feasibility).
b. Protection Against Risk and Data Management
The PI anticipates minimal risk of adverse events (AE) based on the study design and the absence
of interventions and invasive procedures. However, if an AE occurs, the participant will be instructed
to contact the PI immediately. Any AE or protocol deviation will be recorded and reported to the IRB
as well as the study team members, following all MUSC institutional requirements and procedures.
There are no anticipated physical, social, or legal risks from participating in the survey or the
interviews.
The PI will undertake every possible measure to ensure the safety of all study participants. Before
the survey, participants will be instructed how to contact the PI and how to exit the survey if they feel
fatigued, or do not want to continue answering the questions. The PI will provide breaks during the
interviews to participants that feel fatigued or frustrated. The interview will also be rescheduled or
interrupted if the participant feels that he cannot continue, with no consequences. All participants will
be reassured that they do not have to answer to any question they do not want to answer. In the event
of a study-related question illness or injury, participants will be instructed on how to contact the PI
and how to access appropriate health care. The participants will be assured that taking part in this
study will not interfere with the clinical care that they are receiving at MUSC or elsewhere.
Several plans are in place to protect all participants’ data confidentiality. For the quantitative
component, personal identifiers (name/email/phone number) will be collected from the Honest Broker
and from the participants at the end of the survey, for recruitment, interview scheduling, and sending
the gift card purposes only. The potential participant’s contact information (name/email/phone) will
not be connected to any data on the survey and will be stored in password protected MUSC servers.
Each participant will be assigned a unique case number that will be referenced on all study
procedures. All the survey data will be stored in the secure password-protected REDCap database.
The password to that database will be accessible only to the PI, with rights assigned to the study team
members for consultations regarding emerging results.
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For the semi-structured interviews, confidentiality will be assured by conducting the interview in a
privately connected session via telephone or Doxy.me (from a private office). The interview transcript
data will be de-identified for analysis. The PI may collect the email address and phone number of
participants, but for recruitment and scheduling the interview purposes only. The contact information
will not be connected to any data on the interview transcripts or the brief socio-demographic and
clinical survey. Each transcript will be assigned a unique case number that will be referenced on all
study procedures. The interview audio recordings will be uploaded and transcribed for analysis from a
portable recorder into an MUSC-approved transcription service (Rev.com) after each interview
session. The resulting transcripts will be de-identified and uploaded into a secure password-protected
storage file in Box. Afterwards, the recordings will be erased from the portable device. The
enrollment log and the reflective journal notes taken during the interview will be also confidential and
will also be kept in a password-protected storage file in Box. The data from the brief
sociodemographic and clinical survey will also be de-identified and kept in a REDCap database
following all MUSC storage requirements. Access to the password-protected REDCap database and
the Box storage files will be limited only to the PI, with rights assigned to the study team members for
consultations regarding emerging results. To further ensure participants’ confidentiality, there will be
no paper copies of any data. However, the digital audio recording transcripts will be stored in a secure
database for a minimum of 6 years.
The PI will perform all the data management procedures for both, the survey and the interview
components, and will ensure that the study is being conducted following the written proposal. The PI
and the study team will adopt all possible measures to ensure that any data and private personal
information are not disclosed to anyone outside the study team. Caution will be used when presenting
the findings from the qualitative interviews. We will provide participants’ quotations from the
transcripts that can support the study results while avoiding unintentional disclosure of the
participant’s identity.
F.3. Potential Benefits of the Research to Human Subjects and Others
The participants may not benefit directly from the proposed study. The minimal risks of the study
outweigh the inconvenience to the participants in terms of the anticipated new knowledge that may be
gained from the study. Participant contributions may hopefully provide health researchers and
clinicians with a better understanding of the unmet SC needs in advanced disease PC survivors so that
more culturally appropriate, patient-centered, efficient SC interventions can be informed and
developed to improve their QOL and health outcomes. In addition, all participants, from both the
quantitative and the qualitative components, will receive compensation for completion of the survey
and the interview.
F.4. Importance of the Knowledge to be Gained
The knowledge to be gained from the proposed study may provide significant insight into the
prevalence and type of unmet SC needs in advanced disease PC survivors. The information obtained
from the study participants may provide a foundation for the development of more culturally
acceptable, comprehensive, cost-effective, and patient-centered SC interventions that improve this
vulnerable population’s QOL and overall health outcomes. The findings may also help validate two
hypotheses: first, that QOL will be negatively correlated to the prevalence of SC unmet needs, and
second, that SC unmet needs will be higher in those with more advanced disease stage. In addition,
the data collected may help evaluate the feasibility of the study methodology.
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APPENDIX D. IRB-Approved Study Flyer

ARE YOU A
PROSTATE CANCER SURVIVOR?
WE CAN USE YOUR INPUT!
Currently Recruiting

A
research study is being
conducted to better understand
the supportive care needs and
quality of life in individuals
with ADVANCED disease prostate cancer. Individuals with advanced
prostate cancer are invited to participate in an online survey and/or interview.
Some compensation may be available.
Below you will find the direct secure survey link (copy and paste into your
browser) or if you prefer, you can use the QR Code above:
https://redcap.musc.edu/surveys/?s=WKK4A9NDAE

For more information, please contact:
Alejandra Schimmel
schimme@musc.edu
APPENDIX E. Advanced Disease Prostate Cancer Survivors Interview Guide
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STATEMENT OF RESEARCH
My name is Alejandra Schimmel and I am a doctoral student at the Medical University of
South Carolina College of Nursing. You are being asked to volunteer for a research study.
Research studies are voluntary and include only people who choose to take part. You are
being asked to participate in this study because you have diagnosis of advanced prostate
cancer. The purpose of this study is gathering information about the different supportive care
needs that advanced prostate cancer survivors may have. By surveying survivors like you, we
hope to understand better the unmet needs that you may have related to your prostate cancer
and help you to care for them better. I am very interested in knowing how important each of
these needs are for you right now.

Thank you very much for speaking with me today about your illness. I would like to talk to
you for about 45 to 60 minutes if that’s OK. Our conversation will be private. The interview
will be digitally recorded. The digital audio files will be transferred from the external
recorder to a secure password protected computer for storage within 48 hours after the
interview is completed. The digital audio files will be deleted from the recorder after that. We
will transcribe the digital recordings, removing any identifying information such as
individual names. These are standard procedures for interviews.
Taking part in the study should not put you at risk for any physical harm. You may feel
uncomfortable, fatigued, or frustrated discussing certain aspects of your cancer. You will be
reminded several times that you are not required to respond to any questions that make you
feel uncomfortable. You may ask for a break or to stop the interview at any time and for any
reason (if you feel fatigued, or bored, or frustrated…).
There is a risk of loss of confidentiality of your information that is used in this study. To
minimize this risk, we will maintain the confidentiality of your information in accordance
with all national and local regulations. All digital recordings and interview transcripts will be
stored on a password protected MUSC server with access limited to the study team only.
Your name will not be on the transcripts. In return for your time and effort, you will receive
$20 by gift card for participation in this study.

I will first ask you some questions about you and your cancer, if that´s OK. Then, we will
continue on with the interview. Are you ready to start?

First, we will go through a few screening questions:
1. HAVE YOU BEEN DIAGNOSED WITH ADVANCED PROSTATE CANCER BY
A MEDICAL PROFESSIONAL (stages 3, 4, recurrent)?
2. ARE YOU 18 YEARS OF AGE OR OLDER?
3. ARE YOU ABLE TO READ, UNDERSTAND, AND SPEAK ENGLISH?
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4. DO YOU RESIDE IN THE UNITED STATES OR ITS TERRITORIES?
5. ARE YOU CURRENTLY ENROLLED IN PALLIATIVE OR HOSPICE CARE?

(If eligible, I will go ahead with the brief questionnaire and interview)

PART 1. BRIEF SOCIO-DEMOGRAPHIC AND CLINICAL
QUESTIONNAIRE
I am aware that you may have already completed this questionnaire, but if
you don´t mind, I would need to gather this information again.
What is your age?
----------- Prefer not to respond
What is your current marital status?
------- Never married
------- Partnership (unmarried)
------- Married
------- Separated
------- Divorced
------- Widowed
------- Prefer not to respond
Are you Hispanic or Latino?
------ Yes
------ No
------ Prefer not to respond
What is your race (check all that apply)?
------ Black / African American
------ White
------ American Indian/Alaskan
------ Asian
------ Pacific Islander
------ Other
------- Prefer not to respond

If you identify yourself with Other regarding your race , please, specify:
--------------------------

How many years of school have you completed?
------ Elementary school/Junior high
175

---------------------

High school graduate or GED
Some college
College graduate and beyond
Prefer not to respond

What is your employment status?
------ Full-time
------ Part-time
----- Unemployed-Actively looking for employment
------ Unemployed-Not looking for employment
------ Disabled
------ Retired
------ Student
------ Prefer not to respond

Do you have medical insurance?
------- Yes
------- No
------- Prefer not to respond.

What treatment have you received for your prostate cancer (check all that apply)?

-------------------------------------------------

Surgery
Radiation therapy
Chemotherapy
Androgen Deprivation Therapy (hormonotherapy)
Radioactive seeds implantation
Cryotherapy
Other (clinical trial, vaccine)
Prefer not to Respond

If Other treatment(s), please, specify:

What year were you first diagnosed with prostate cancer?
------------- Prefer not to respond
What was the stage of your prostate cancer at the time of your initial diagnosis?
------- I – very localized cancer inside the prostate only
------- II – cancer has not spread outside the prostate
------- III – cancer has not spread outside the prostate but has spread to surrounding tissues or
the lymph nodes
------- IV – cancer has spread to lymph nodes or other organs

176

------- Unknown
------- Prefer not to Respond

What is the stage of your prostate cancer right now?
------- I - very localized cancer inside the prostate only
------- II - cancer has not spread outside the prostate
------- III - cancer has not spread outside the prostate but has spread to surrounding tissues or
the lymph nodes
------- IV - cancer has spread to lymph nodes or other organs
------- Unknown
------- Refuse to Respond

What is your state of residence? --------------------

Thank you very much for answering these questions. We will now start with the interview
questions regarding your prostate cancer experiences and needs.

PART 2. INTERVIEW GUIDE
Opening, non-directive questions:
1. Can you please tell me what is a typical day like for you?
2. What is different in your life related to living with prostate cancer?

The following questions will be formulated based on the (7) domains of the
Supportive Care Needs for Cancer Care Framework. Aside from the listed
probes, a general probe will be used as needed in case the PI needs to re-direct
the participant to talk about more current needs: “…that sounds like a
challenging time, …can you comment on any
emotional/physical/social…challenges you currently have?”
PHYSICAL NEEDS:
3. What physical changes in your regular daily functions have you experienced related
to your prostate cancer treatments?
- PROBE - needs from the illness or the medical treatments, for example,
fatigue, pain, urinary or sexual symptoms, changes in bowel habits,
difficulty sleeping, weight changes, or hot flushes, changes in sexuality.
- PROBE – are you able to maintain the same hobbies, activities as before?
EMOTIONAL NEEDS:
4. Tell me about any emotional issues or concerns that you have experienced related to
your PC?
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-

PROBE – do you experience excessive worry, anger, fear about cancer
spreading, distress, anxiety, depression.
PROBE – Do you see or are you willing to see a provider regarding your
emotional health?

SOCIAL NEEDS:
5. Tell me about your social life.
6. How has your prostate cancer impacted your relationships and roles towards others?
- PROBE - communicating with others?
7. What support systems do you have? Family? Friends? Community?
SPIRITUAL NEEDS:
8. What role does spirituality have for you in your life?
- PROBE: Have you experienced any changes regarding your spirituality
since your diagnosis – changes in personal values, any spiritual crisis?
- PROBE – do you maintain the same spirituality (religion…)?
PRACTICAL NEEDS:
9. Tell me about any practical issues or needs that you may have.
- PROBE- like inability to work, assistance at home, access to support
services, or difficulties with transportation (not being able to drive to your
medical treatments or check-ups)
- PROBE – any major changes at home/car?
10. Do you have any financial needs or worry about paying the bills, or not being able to
work, or not having enough income/pension?
INFORMATIONAL NEEDS:
11. What information have you received regarding your prostate cancer and treatments?
Is there any information that you wished you had but did not received?
- PROBE - Do you know where to go for resources or help?
- PROBE - Do you know what information to trust?
- PROBE - Have you received information about all your treatment
choices? From who?
PSYCHOLOGICAL NEEDS:
12. How do you cope with your illness?
13. Please, tell me how you feel about your body and how your PC has affected your
body image.
14. What is the most difficult aspect of your condition?
- PROBE - How do you handle or care for it?
15. What information might have helped you better adapt and make choices that felt right
for you?
- PROBE - Did you have or currently have help making decisions regarding
your illness and treatments?

COVID-19 QUESTIONS:
16. Did you or anyone in your household get COVID-19?
------- YES
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------- NO
------- Prefer not to Respond

17. If YES, who was it?
------------------18. Do you believe your needs regarding your prostate cancer have changed due to the
COVID-19 pandemic?
-------- YES
-------- NO
-------- Prefer not to respond

19. If YES, how have those needs changed? ¿Can you tell me how you have lived this
confinement in terms of your prostate cancer?

Closing Questions:
20. Is there anything else that you would like to tell me today?
21. Do you think that you could have been more supported regarding your needs in any
way?

We have finished the interview. I greatly appreciate you sharing this information about your
illness with me. If necessary, would it be acceptable for me to contact you for further
clarifications during the transcription and analysis of the information? I will provide you with
a brief summary of the study results once the study is finalized.
Could I ask you your zip code please? -------------------

Also, if you could provide me with an email address, I will be happy to send you the
electronic gift card as compensation for your time.

Thank you very much again for agreeing to talking to me today. I truly appreciate it.

APPENDIX F. Permission to Use Quantitative Measurement Instruments
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1) EORTC-QLQ-C30

Dear Alejandra Schimmel,
Thank you for registering on the EORTC Quality of Life Group website.
Your registration to obtain permission to use our tools has been approved. During
the registration process you agreed to our terms and conditions regarding the
academic use of our questionnaires. You can review the terms and conditions here.
Please find below the links to the requested tools:
QLQ-C30 Core Questionnaire - English
Scoring Manuals:
C30 Scoring Manual

EORTC
http://www.eortc.org
http://qol.eortc.org
NOTE:
This email was automatically generated. Since this email is an automatic notification, we
are unable to receive replies. Please do not respond to this email address.
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2) FACIT-SP 12

FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY
(FACIT) LICENSING AGREEMENT
The Functional Assessment of Chronic Illness Therapy system of Quality of Life questionnaires
and all related subscales, translations, and adaptations (“FACIT System”) are owned and
copyrighted by David Cella, Ph.D. The ownership and copyright of the FACIT System - resides
strictly with Dr. Cella. Dr. Cella has granted FACIT.org (Licensor) the right to license usage
of the FACIT System to other parties. Licensor represents and warrants that it has the right to
grant the License contemplated by this agreement. The terms of this license will grant
permission Licensor provides to Alejandra Schimmel (“Investigator”) the licensing agreement
outlined below.
This letter serves notice that Alejandra Schimmel (“Investigator”) is granted license to use
the Spanish version of the FACIT-Sp in one not for profit study:
This current license is only extended to Investigator’s research project subject to the following
terms:
1) (Investigator) agrees to provide Licensor with copies of any publications which come about
as the result of collecting data with any FACIT questionnaire.
2) Due to the ongoing nature of cross-cultural linguistic research, Licensor reserves the right
to make adaptations or revisions to wording in the FACIT, and/or related translations as
necessary. If such changes occur, Investigator will have the option of using either previous
or updated versions according to its own research objectives.
3) (Investigator) and associated vendors may not change the wording or phrasing of any
FACIT document without previous permission from Licensor. If any changes are made to
the wording or phrasing of any FACIT item without permission, the document cannot be
considered the FACIT, and subsequent analyses and/or comparisons to other FACIT data
will not be considered appropriate. Permission to use the name “FACIT” will not be granted
for any unauthorized translations of the FACIT items. Any analyses or publications of
unauthorized changes or translated versions may not use the FACIT name. Any
unauthorized translation will be considered a violation of copyright protection.
4) In all publications and on every page of the FACIT used in data collection, Licensor
requires the copyright information be listed precisely as it is listed on the questionnaire
itself.
5) This license is not extended to electronic data capture by third party vendors. Electronic
versions by third party vendors of the FACIT questionnaires are considered derivative
works and are not covered under this license. Permission for use of an electronic version
of the FACIT must be covered under separate agreement between the electronic data
capture vendor and FACIT.org
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6) In no cases may any FACIT questionnaire be placed on the internet without password
protection. To do so is considered a violation of copyright.
7) Licensor reserves the right to withdraw this license if Investigator engages in scientific or
copyright misuse of the FACIT system of questionnaires.
8) There are no fees associated with this license.
9) This license is effective upon date issued by FACIT.org and expires at the completion of
Investigator’s project.
10) Investigator agrees to provide FACIT.org with a copy of any publication which results
from this study.
Issued on: January 15, 2020 by:
Shannon C Romo
Licensing and Financial Administrator
FACIT.org
151 Bay Cove Drive
Ponte Vedra, FL 32082-4161 USA
www.FACIT.org

3) SCNS-SF34 & PC-module

Hi Alejandra,
Thank you for your email. Attached are a copy of the long and short versions of the SCNS
for use in your study, as well as the User Manual.
Please don’t hesitate to contact me if you have any questions.
Best wishes with your research.
Regards,
Allison
Dr Allison Boyes | NHMRC Early Career Fellow
Faculty of Health & Medicine | School of Medicine & Public Health
T: +61 2 4042 0703
E: allison.boyes@newcastle.edu.au
W: newcastle.edu.au/profile/allison-boyes
orcid.org/0000-0003-1721-0533
The University of Newcastle (UON)
University Drive, Callaghan NSW 2308 Australia
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APPENDIX G. Permission to Use SCFCC Diagram
Re: Framework
Marg Fitch <marg.i.fitch@gmail.com>
Fri 10/16/2020 6:35 AM
Hello Alejandra
Thank you for your email and interest in the Supportive Care Framework. I am pleased to
know it is helpful to you.
I am happy for you to make use of it and adapt the diagram with the appropriate
reference/acknowledgement.
Regards
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